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Abstract 
With the introduction of the technological age, increasing mechanisation has led to labour 
saving devices which have all-but engineered physical activity out of our lives and sedentary 
behaviour has now become the default behaviour during waking hours. Interventions that 
previously focused on improving levels of physical activity are now attempting to 
concurrently increase levels of physical activity and decrease time spent in sedentary 
behaviour. One method that has shown promise in interventions to increase physical activity 
and healthy eating in adults is the behaviour change technique of self-monitoring. There is 
now a robust set of literature indicating self-monitoring as the most promising behaviour 
change technique in this area. Self-monitoring is tied inherently into the recent rise in 
wearable technology. These new devices have the ability to track a variety of behavioural and 
physiological parameters and immediately make the information returnable to the user via 
connected mobile applications. The potential pervasive nature of these technologies and their 
use of robust behaviour change techniques could make them a useful tool in interventions to 
reduce sedentary behaviour. Therefore the overall purpose of this three study dissertation was 
to identify and validate technology that can self-monitor sedentary behaviour and to 
determine its feasibility in reducing sedentary behaviour. 
Study 1 
Purpose: The aim of this study was to review the characteristics and measurement properties 
of currently available self-monitoring devices for sedentary behaviour and/or physical 
activity. Methods: To identify technologies, four scientific databases were systematically 
searched using key terms related to behaviour, measurement, and population. Articles 
published through October 2015 were identified. To identify technologies from the consumer 
electronic sector, systematic searches of three Internet search engines were also performed 
through to October 1PstP, 2015. Results: The initial database searches identified 46 devices and 
the Internet search engines identified 100 devices yielding a total of 146 technologies. Of 
these, 64 were further removed because they were currently unavailable for purchase or there 
was no evidence that they were designed for, had been used in, or could readily be modified 
for self-monitoring purposes. The remaining 82 technologies were included in this review (73 
devices self-monitored physical activity, 9 devices self-monitored sedentary time). Of the 82 
devices included, this review identified no published articles in which these devices were 
used for the purpose of self-monitoring physical activity and/or sedentary behaviour; 
however, a number of technologies were found via Internet searches that matched the criteria 
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for self-monitoring and provided immediate feedback on physical activity (ActiGraph Link, 
Microsoft Band, and Garmin Vivofit) and sedentary behaviour (activPAL VT, the LumoBack, 
and Darma). Conclusions: There are a large number of devices that self-monitor physical 
activity; however, there is a greater need for the development of tools to self-monitor 
sedentary time. The novelty of these devices means they have yet to be used in behaviour 
change interventions, although the growing field of wearable technology may facilitate this to 
change. 
Study 2 
Purpose: The aim of this study was to examine the criterion and convergent validity of the 
LumoBack as a measure of sedentary behaviour compared to direct observation, the 
ActiGraph wGT3X+ and the activPAL under laboratory and free-living conditions in a 
sample of healthy adults. Methods: In the laboratory experiment, 34 participants wore a 
LumoBack, ActiGraph and activPAL monitor and were put through seven different sitting 
conditions. In the free-living experiment, a sub-sample of 12 participants wore the LumoBack, 
ActiGraph and activPAL monitor for seven days. Validity were assessed using Bland-Altman 
plots, mean absolute percentage error (MAPE), and intraclass correlation coefficient (ICC). 
T-test and Repeated Measures Analysis of Variance were also used to determine any 
significant difference in measured behaviours. Results: In the laboratory setting, the 
LumoBack had a mean bias of 76.2, 72.1 and -92.3 seconds when compared to direct 
observation, ActiGraph and activPAL, respectively, whilst MAPE was less than 4%. 
Furthermore, the ICC was 0.82 compared to the ActiGraph and 0.73 compared to the 
activPAL. In the free-living experiment, mean bias was -4.64, 8.90 and 2.34 seconds when 
compared to the activPAL for sedentary behaviour, standing time and stepping time 
respectively. Mean bias was -38.44 minutes when compared to the ActiGraph for sedentary 
time. MAPE for all behaviours were <9%, and the ICC were all >0.75. Conclusion: The 
LumoBack has acceptable validity and reliability as a measure of sedentary behaviour.  
Study 3 
Purpose: The aim of this study was to explore the use of the LumoBack as a behaviour 
change tool to reduce sedentary behaviour in adults. Methods: Forty-two participants (≥25 
years) who had an iPhone 4S or later model wore the LumoBack without any feedback for 
one week for baseline measures of behaviour. Participants then wore the LumoBack for a 
further five weeks whilst receiving feedback on sedentary behaviour via a sedentary vibration 
from the device and feedback on the mobile application. Sedentary behaviour, standing time, 
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and stepping time were objectively assessed using the LumoBack. Differences in behaviour 
were determined between baseline, week 1 and week 5. Participant engagement with the 
LumoBack was determined using Mobile app analytics software. Results: There were no 
statistically significant differences in behaviour between baseline and the LumoBack 
intervention period (p>0.05). Participants engaged most with the Steps card on the 
LumoBack app with peaks in engagement seen at week 5. Conclusion: This study indicates 
that using the LumoBack on its own was not effective in reducing sedentary behaviour in 
adults. Self-monitoring and feedback may need to be combined with other behaviour change 
strategies such as environmental restructuring to be effective. 
 
General Conclusion 
This thesis found that there are currently an abundance of technologies which self-monitors 
physical activity but a lack of devices which measuring sedentary behaviour. One such device, 
the LumoBack, has shown to have acceptable validity as a measure of sedentary behaviour. 
Whilst the use of the LumoBack as a behaviour change tool did not elicit any significant 
changes, its ability to be a pervasive behavioural intervention and the use of user-defined 
nudging can make the LumoBack, and other similar low cost, valid objective sedentary 
behaviour self-monitors key components in multi-faceted interventions.  
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Physical activity has a long standing and established beneficial relationship with health. 
Indeed, increasing levels of physical activity has been shown to have a beneficial relationship 
with a number of non-communicable health related outcomes (1–3) including all-cause 
mortality (4), coronary heart disease (5), high blood pressure, stroke (6), type 2 diabetes (7), 
metabolic syndrome (8), certain site-specific cancers (9–11), and depression (12,13) with 
even small increases in physical activity having beneficial effects on health (14). In spite of 
the large evidence base supporting the health benefits of physical activity, population levels 
of physical activity are low (15). Moreover, the prevalence of sufficient physical activity is 
slow to improve and is worsening in some countries (16). According to the World Health 
Organisation, approximately 3.2 million deaths each year are attributable to insufficient 
physical activity and recent estimates suggest that the cost of physical inactivity to health-
care systems was (international) $53.8 billion worldwide in 2013, of which $31.2 billion was 
paid by the public sector (17). Furthermore, objective data using accelerometers suggests 
there is low compliance with guideline fulfilling physical activity (e.g. 150 minutes of 
moderate to vigorous physical activity [MVPA] per week (18)), at around five percent in 
British (19) and American adults (20), and approximately 15% in Canadian adults (21,22).  
The current levels of physical inactivity are partly related to insufficient participation in 
physical activity due to reduced amounts of leisure time physical activity and partly related to 
increases in sedentary behaviours during occupational and domestic activities (23). 
Increasing automation at work and travel combined with more attractive sedentary options for 
leisure time is engineering physical activity out of daily life and reducing physical activity 
levels (24). Therefore, the nature in which we execute aspects of our daily lives have changed 
in no small part due to these advancements in technology (25), which, in turn, has led to 
substantial reductions in the demands for physical activity (26). Consequently, this transition 
has led to increases in a distinct but related health related behaviour – sedentary behaviour.  
Sedentary behaviour is a prominent, insidious behaviour, which has been linked to 
deleterious effects on cardio-metabolic biomarkers associated with an array of non-
communicable diseases, independent of MVPA, including type 2 diabetes (27), 
cardiovascular disease (28,29) and some site-specific cancers (30). Combine this with large 
segments of the day now being spent in sedentary behaviours (31) accurate and objective 
exposure measurement is essential to identify causal associations with health outcomes, to 
quantify precisely the magnitude of these associations and to describe dose-response 
relationships. Moreover, accurate measurement is required to document patterns of, and 
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changes in, sedentary behaviour between and within individuals over time (32,33). This is 
currently conducted effectively in the physical activity portion of the movement continuum (a 
model used to conceptualise the part sedentary behaviour plays as a distinct behaviour in our 
daily physical activity. Theorising sedentary behaviour as distinct from a lack of physical 
activity is important due to the unique nature of sedentary behaviour), however, it is less well 
conducted at the sedentary behaviour segment of the continuum.  
 
With sedentary behaviour now being seen as a distinct risk factor for health (28), it has 
necessitated a paradigm shift in the way interventions are conducted. Previously, 
interventions targeted increasing physical activity or reducing sedentary behaviour; however, 
interventions are now targeted at concurrently decreasing the amount of time spent in 
sedentary pursuits as well as increasing levels of physical activity (34,35). Whilst 
interventions to reduce sedentary behaviour have used a variety of methodologies, from 
educational programmes (36) to environmental restructuring (traditionally via sit-stand desks 
in office-based workers (37–40)), one method of decreasing sedentary behaviour, which is 
particularly promising is utilising the behaviour change technique of self-monitoring (41). 
Self-monitoring has a growing base of consistent evidence demonstrating its beneficial effect, 
when in conjunction with other self-regulatory behaviour change techniques, on levels of 
physical activity and healthy eating (42). Furthermore, a recent systematic review has found 
self-monitoring to be a particularly promising intervention modality for reducing sedentary 
behaviour in adults (41). Consequently, its use as a modality for inducing beneficial changes 
on sedentary behaviour warrants further investigation.  
 
Current research grade measurement technologies do not have the ability to readily self-
monitor and provide feedback on sedentary behaviour, however, there are a plethora of new 
commercially available technologies, which can measure (with varying levels of accuracy) a 
number of both behavioural parameters, most prominent of which is step tracking, distance 
travelled and estimated caloric expenditure, and physiological parameters, such as heart rate 
and breathing rate. Furthermore, these consumer trackers have a mobile application (mobile 
app) associated with them, which are used for self-monitoring, providing feedback, goal-
setting and monitoring of progression towards goals. Moreover, mobile phones and smart 
tablets are now a pervasive accessory to a majority of individuals and consumer trackers are a 
fast and rapidly growing area of consumer electronics. Traditionally, these consumer activity 
tracker measure areas related to physical activity; however, as already alluded to, sedentary 
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behaviour is the dominant daily behaviour; it is, therefore, worthy to investigate whether 
these devices can be an appropriate intervention tool to decrease levels of sedentary 
behaviour.  
 
1.2 General Aim  
Therefore the aim of this thesis is to identify and validate technology that can self-monitor 
sedentary behaviour and to determine its ability to reduce sedentary behaviour. 
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2.1 Sedentary Behaviour  
Sedentary behaviour (from the Latin ‘sedere’ which means ‘to sit’) is defined as any waking 
behaviour characterized by an energy expenditure ≤1.5 METs (Metabolic Equivalent and is 
equal to 3.5ml/kg/minute of oxygen consumption) while in a sitting or reclining posture 
(43,44). Therefore, sedentary behaviour would not include active sitting behaviours such as 
riding a bike, since it involves an energy expenditure of over 1.5 METs. Sedentary behaviour 
has been previously conceptualised as reflecting the low end of the physical activity 
continuum (i.e. being physically inactive). However, physical inactivity is now defined as an 
individual who does not meet physical activity guidelines (e.g. in adults not meeting 150 
minutes of MVPA per week in bouts of 10 minutes or more (18) would be defined as 
inactive). Evidence is now suggesting that sedentary behaviour has quantitatively different 
effects on human metabolism and health outcomes (44–48), with these effects largely 
occurring independent of MVPA (28).  
The movement continuum, (49) illustrated in Figure 2.1, helps to conceptualise the part 
sedentary behaviour plays in our daily physical activity, theorising sedentary behaviour as 
distinct from a lack of physical activity is important due to the unique nature of sedentary 
behaviour. Approaches needed to reduce sedentary behaviour may be different to those 
designed to increase physical activity. For example, Prince et al (35) in a meta-analysis of the 
effectiveness of controlled interventions with a focus on physical activity and/or sedentary 
behaviour for reducing time spent sedentary in adults, found consistent evidence that large 
meaningful reductions in time spent sedentary can be expected from interventions with a 
focus on reducing sedentary behaviour. Those interventions with a physical activity or a 
combined physical activity and sedentary behaviour component produced less consistent 
findings and generally resulted in modest reductions in sedentary time than sedentary 
behaviour intervention in isolation (35). Given that the majority of interventions included in 
the systematic review focused on increasing physical activity (e.g. increasing MVPA) and 
reductions in sedentary behaviour were a secondary outcome, there is a scientific rationale for 
why this might be occurring. A systematic review conducted by Mansoubi and colleagues (50) 
showed that, in studies conducted using objectively measured sedentary time and physical 
activity, there were small to medium inverse associations between sedentary time and MVPA 
and medium to large inverse associations between sedentary time and light intensity physical 
activity (50). Given that light physical activity typically involves standing and light 
ambulation; these incidental behaviours tend to be more prevalent when an individual is not 
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sedentary, as opposed to moderate to vigorously active, which is likely to occur through more 
structured activity in adults. (50).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1 - The Movement Continuum, illustrating the different aspects of physical 
behaviours throughout the day. Adapted from Tremblay et al (2010)  
 
2.2 Prevalence of Sedentary Behaviour 
Sedentary behaviours are a ubiquitous component of modern society. This has been 
exemplified in a study analysing five decades of energy expenditure data from the U.S. 
Bureau of Labor Statistics which found a steady shift towards more sedentary occupations 
since 1960 in the USA (51). The use of sophisticated physical activity monitors (that provides, 
valid and reliable, duration, amount, frequency and time of data on sedentary and activity 
time) in population-based studies has provided insights into how adults spend their day, and 
more specifically, the large contribution that sedentary behaviour makes to overall waking 
hours (52). For example, analysis of accelerometer data from over 600 participants (aged >20 
years) in the 2003-2006 US National Health Nutrition Examination Survey (NHANES) found 
that mean accelerometer-derived sedentary time across 10 year age categories ranged 
between 7.3 and 9.3 h/day, with older adults generally the most sedentary (31). In 
proportional terms, it can be estimated that 60-70% of adults total waking hours are spent 
sedentary (31,48). In contrast, MVPA accounted for only 5% of the total time across the 
sample, with the remainder being spent in light intensity physical activity (20). Further 
epidemiological data, using objective methods of measurement indicated that adults spend 
approximately 55-70% of their waking hours engaged in sedentary time (21,31,48,53), with 
one study reporting greater than 9 hours per day, on average, spent sedentary (54). However, 
these population studies have traditionally utilised accelerometers as their measurement 
Sleep Sedentary Behaviour  Light Activity  Moderate Physical Activity  Vigorous Physical activity  
METS - + 
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modality, which measure inactivity rather than posture. More recently, The Maastricht Study 
(55), measured the physical activity and sedentary behaviour levels of 2,449 participants 
between the ages 40-75 years using the activPAL (PAL technologies ltd, Glasgow, UK). This 
study revealed that participants spent between 58.7-63.0% of their day sitting and lying, 
providing similar prevalence levels to studies utilising accelerometers. 
Looking to the future, a study by Ng and Popkin (56) assessed time-use in physical activity 
and sedentary behaviour using detailed historical self-report data from 1965-2005 and used 
this to interpolate to 2020 and 2030. The results from their forecast suggest that time spent in 
leisure sedentary pursuits will increase to over 51 hour/week by 2030 (56). Given the high 
prevalence of this behaviour it is important to understand its relationship with health. 
 
2.3 Sedentary Behaviour and Health Outcomes 
While this is a relatively new area of health-behaviour research, compared to research 
investigating the effects of physical activity on health, the effects of prolonged sitting have 
been observed since the 1950’s. Jerry Morris’ London bus drivers and conductors study 
demonstrated that there was a two-fold increase in the risk of myocardial infarction in the 
sedentary bus drivers compared to their active conductor colleagues (57). Since its 
emergences as a distinct risk factor for chronic disease, there has been an increasing body of 
research describing the effect of sedentary behaviour on health outcomes in adults (58).  
Thorp and colleagues (59) systematically reviewed longitudinal studies (since 1996) 
reporting the relationship between self-reported sedentary behaviour and device-based 
measures of sedentary time with health-related outcomes in adults 18 years and older. The 
review identified 48 longitudinal studies; of these, 46 incorporated self-reported measures of 
total sitting time; TV viewing time only; TV viewing time and other screen-time behaviours; 
and TV viewing time plus other sedentary behaviours. The findings from this review 
indicated a consistent relationship of self-reported sedentary behaviour with mortality and 
with weight gain from childhood to the adult years. However, mixed findings were observed 
for associations with disease incidence, weight gain during adulthood, and cardio-metabolic 
risk. Of the three studies that used device based/objective measures of sedentary time, one 
study showed that markers of obesity predicted sedentary time whereas inconclusive findings 
have been observed for markers of insulin resistance (59), with similar findings being 
reported by Proper and colleagues (60) when systematically reviewing the literature on the 
relationship between sedentary behaviours and health outcomes. 
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Moreover, a systematic review and meta-analysis examining the association between 
sedentary behaviour and diabetes, cardiovascular disease and cardiovascular and all-cause 
mortality found eighteen studies (16 prospective, two cross-sectional; all self-reported 
sedentary behaviour). When comparing the greatest time spent sedentary to the lowest, there 
was a 112% increase in the relative risk (RR) of diabetes (RR: 2.12; 95%CI: 1.61, 2.78), a 
147% increase in the RR of cardiovascular events (RR: 2.47; 95% CI: 1.44, 4.24), a 90% 
increase in the risk of cardiovascular mortality (RR: 1.90; 95% CI: 1.36, 2.66) and a 49% 
increase in the risk of all-cause mortality (RR: 1.49; 95% CI: 1.14, 2.03). The effects reported 
were largely independent of MVPA, suggesting that the deleterious effects of higher levels of 
sedentary behaviour are not mediated through lower amounts of MVPA (28). Furthermore, an 
update of this systematic review published by Bauman and colleagues (29) corroborated these 
results and found that there is moderately consistent evidence for an association between total 
sitting time and all-cause mortality, even when adjusted for or stratified by self-reported 
leisure time physical activity (29). More recently, Biswas and colleagues (61) conducted a 
systematic review and meta-analysis to quantify the association between sedentary time and 
hospitalisations, all-cause mortality, cardiovascular disease, diabetes and cancer in adults 
independent of physical activity. The review found 47 articles (44 prospective designs, 46 
self-reported). Significant associations were found with all-cause mortality (HR, 1.240 [95% 
CI,1.090 to 1.410]), cardiovascular disease mortality (HR, 1.179 [CI, 1.106 to 1.257]), 
cardiovascular disease incidence (HR, 1.143 [CI, 1.002 to 1.729]), cancer mortality (HR, 
1.173 [CI, 1.108 to 1.242]), cancer incidence (HR, 1.130 [CI, 1.053 to 1.213]), and type 2 
diabetes incidence (HR, 1.910 [CI, 1.642 to 2.222]). Despite the marked heterogeneity in the 
research designs and the assessment of physical activity and sedentary time, the authors 
concluded that prolonged sedentary time was independently associated with deleterious 
health outcomes regardless of physical activity (61).  
Further research has been published on the relationship between high levels of sedentary 
behaviour and all-cause mortality. A meta-analysis looking only at the association between 
all-cause mortality and daily total sitting, it was reported that each hour of daily sitting is 
associated with an overall 2% increased risk of all-cause mortality. However, this relationship 
was nonlinear, with a 5% increased risk for each one-hour increment for adults sitting >7 
hours/day and dose response modelling suggesting a 34% higher mortality risk in adults 
sitting 10 hours/day, after taking levels of physical activity into account. The authors also 
calculated an overall weighted population attributable fraction (the proportional reduction in 
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population disease or mortality that would occur if exposure to a risk factor were reduced to 
an alternative ideal exposure scenario) for all-cause mortality for total daily sitting time of 
4.9%, after adjustment for physical activity (62). The results from these studies show 
increasing evidence of the detrimental effect of sedentary behaviour on all-cause mortality. 
Theoretically, prolonged sedentary behaviour should be related to a reduction in total energy 
expenditure, and hence might contribute to weight gain due to the energy imbalance. A 
number of cross-sectional (63–66) and large cohort (67–69) studies have shown significant 
increases in weight among those at the highest levels of sedentary behaviours. However, a 
more recent longitudinal study has shown a mixed pattern, suggesting that obesity was 
associated with subsequent sedentary behaviour, but that sitting did not show a prospective 
association with weight gain (70). Furthermore, a review into whether dietary intake is 
associated with sedentary behaviour in adults, indicated that there is a clear small-to-
moderate association with elements of a less healthy diet including lower fruit and vegetable 
consumption; higher consumption of energy-dense snacks, drinks and fast-foods; and higher 
total energy intake and sedentary behaviour (largely self-report measurement of TV viewing) 
(71), which may further contribute to the energy imbalance and subsequent weight gain.  
Sedentary behaviour has also been shown to have a relationship with various site specific 
cancers. A review of 18 articles evaluating the research on sedentary behaviour and cancer 
found a statistically significant, positive association with colorectal, endometrial, ovarian and 
prostate cancer risk (30). The review of the literature further comments on the potential 
biological pathways by which sedentary behaviour may influence site-specific cancer risk. It 
hypothesizes the role of adiposity and metabolic dysfunction as mechanisms operant in the 
association between sedentary behaviour and cancer. 
Research is further increasing concerning the possible links between sedentary behaviour and 
indices of psychological well-being. Typically, in addition to depression and cognitive 
function, these associations include generic measures of well-being, such as health-related 
quality of life. Teychenne and colleagues (13) conducted a systematic review on depression 
and sedentary behaviour in adults. Seven observational (five cross-sectional and two 
longitudinal) and four intervention studies were included. Of the observational studies, six 
out of the seven studies showed a positive association between sedentary behaviour and 
depression, showing that higher sedentary behaviour was associated with greater depression. 
The one of the seven observational studies also showed similar findings for time spent surfing 
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the internet, but reported negative associations for depression with hours spent emailing and 
using chat rooms. This suggests that the type of sedentary behaviour may be an important 
moderator of any association between sedentary behaviour and depression (13). 
A recent harmonised meta-analysis of data from more than 1 million men and women as part 
of the Lancet Physical Activity series however, found that high levels of physical activity 
(35.5 MET-h per week or approx. 60-75 of moderate intensity physical activity per day) seem 
to eliminate the increased risk of death associated with high sitting time (72). While this 
amount of physical activity is beyond the level of most physical activity recommendation, 60-
75 minutes of moderate intensity physical activity is congruent with the level of physical 
activity showing maximum mortality benefit in a large meta-analysis (73).  That said, large 
scale nationwide surveillance studies have indicated that small amounts of the population are 
meeting national physical activity guidelines (e.g. 4% women and 6% men meeting physical 
activity guidelines in England (19))  so using 60-75 minutes of moderate intensity physical 
activity per day as a public health message should be treated with caution.  
The majority of the evidence to date has focused on the link between total sedentary time 
and/or individual sedentary behaviours, in particular TV viewing, and health. However, 
emerging evidence is suggesting that the nature in which sedentary behaviour is accumulated 
may also be important. For example, it might be informative to know if periods of sitting are 
prolonged or whether they take place in a more sporadic form. Healy et al. (74) found that 
objectively assessed breaks in sedentary time were beneficially associated with waist 
circumference, BMI, triglycerides and 2-h plasma glucose, and these associations were 
independent of total sedentary time and MVPA (74). Similarly, Henson et al. (75), in a study 
of adults at risk of diabetes found that breaks in sedentary time were inversely associated 
with measures of adiposity but no other cardio-metabolic outcomes. Increasing the number of 
breaks from sedentary time may be important for health, independent of total sedentary time 
(75). Furthermore, a recent systematic review and meta-analysis aimed at investigating the 
relationship between breaks in sedentary time and cardio-metabolic health (13 studies 
included – seven observations [all objectively measured – six ActiGraph, one Actical], six 
experimental) found that breaks in sedentary time of at least light intensity physical activity 
may have a positive effect on glycaemia but not on lipidemia in adults. The results from this 
review suggests that breaking prolonged sitting with light intensity physical activity breaks 
may be adequate for counteracting some acute detrimental effects of sedentary behaviour on 
cardio-metabolic health. In contrast, the evidence from observational studies involved in this 
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review tends to suggest that there is no detrimental association of prolonged sitting on these 
same cardio-metabolic health markers. Furthermore, the observational studies found 
consistent associations were not found between breaks in sedentary behaviour and any of the 
cardio-metabolic markers other than with BMI (76). From this overview, there appears to be 
a growing wealth of evidence correlating prolonged sedentary behaviour with detrimental 
cardio-metabolic health markers, it is important therefore to have an understanding of what 
physiologically might be occurring to cause these detrimental cardio-metabolic effects. 
2.4 Physiology of Sedentary Behaviour 
There is increasing evidence surrounding the physiological mechanism underpinning the 
reasoning for sedentary behaviour being detrimental to one’s health. The current theory on 
sedentary behaviour physiology posits that the unloading of large skeletal muscles in the back, 
trunk and legs associated with sitting is thought to lead to a cascade of events, which 
consequently leads to metabolic deregulation (46). The biological plausibility for sitting and 
poor health outcomes has come from two key areas of research: bed rest studies in healthy 
human participants (77–86) and hind limb suspension in rats (45–47). 
Bed rest studies have consistently found that prolonged muscle inactivity (1-3 weeks) incurs 
a series of pathophysiological responses, including glucose intolerance and impaired lipid 
metabolism (77). Although, the physiological mechanisms remain unclear, analysis of 
skeletal muscle that have been biopsied pre and post exposure to prolonged sedentariness 
suggest a down regulation of key enzymes involved in glucose and lipid metabolism (29), in 
particular a reduced activity of GLUT4 [a glucose transporter (87,88)] and lipoprotein lipase 
[LPL – an enzyme that facilitates the uptake of free-fatty acids into skeletal muscle and 
adipose tissue (45,46)]. For example, studies in rats that have been immobilised (and not 
allowed to stand or ambulate) have shown a 22% decrease in plasma HDL cholesterol (so 
called ‘good cholesterol’ they act as cholesterol scavengers, picking up excess cholesterol in 
the blood stream and taking it to the liver where it is broken down. i.e. increased HDL = 
decreased “bad” cholesterol) on the first day of immobilisation. Furthermore, the rats’ 
quadriceps (used in postural support) lost more than 75% of their ability to siphon off the fat 
circulating in the lipoproteins from the bloodstream when incidental activity was reduced 
(47). One important factor to consider is that these studies involving bed rest and rodent 
models involved a large amount of unbroken time spent sedentary, far more than might be 
spent by healthy free-living adults, and therefore, these findings might not be wholly 
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generalisable to human physiology (29,77); however, it has been suggested that it may be a 
helpful short-term model to investigate the effects of sedentary living (78). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 2.2 - Theoretical model linking sedentary behaviour and health risks even in the 
presence of sufficient physical activity. Adapted from  Bauman et al (2013)  
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Figure 2.2 provides a theoretical model of how these physiological effects of 
decreasing/breaking up sitting time may happen even in the presence of meeting physical 
activity guidelines. As Figure 2.2 shows, sedentary behaviour increases muscle inactivity, 
which in turn leads to a deregulation in lipoprotein lipase activity and GLUT 4 activity 
leading to the biomarker profile of hyperglycaemia, hyperinsulinaemia and hyperlipidemia. 
As previously seen an increase in sedentary behaviour has been seen to increase the risk of 
weight gain or obesity. A study in adults conducted under the following conditions: 1) An 
active, no-sitting condition (energy intake matched to expenditure), 2) Low energy 
expenditure (sitting), with no reduction in energy intake (energy surplus) and; 3) Sitting with 
energy intake reduced to match low expenditure (energy balance), measured ghrelin (the so 
called appetite stimulating hormone) and leptin following a meal, and found ghrelin was 
lower in the sitting group compared to the standing group, with no change in appetite. When 
intake was reduced (i.e., the sitting but energy balanced group), the decrease in ghrelin when 
sitting was attenuated, hunger increased, and fullness decreased. Sitting but in energy balance 
led to an increase in ghrelin in the men but attenuated the leptin (the “satiety hormone,” used 
to help regulate energy balance by inhibiting hunger) response, reduced ghrelin, increased 
hunger, and decreased fullness in the participants. This led to the conclusion by the authors 
that prolonged sitting may promote excess energy intake through a hormonal response, 
leading to weight gain (89). 
 
Although there is some overlap in energy expenditure between sitting and standing activities, 
it is invariably true that standing activities have slightly higher energy expenditure than 
sitting activities. Indeed, when undertaking the same task, such as typing, standing will 
always have higher energy expenditure than sitting because of greater muscle activation, 
driven by posture controlling muscles (29,45,46,77). Therefore, it is plausible that over recent 
decades, the reduction in standing and light movement throughout daily living and 
occupational activities has contributed in some part to the modern obesity epidemic. It has 
been shown that the reduction in occupational energy expenditure over the last five decades 
directly maps onto the obesity epidemic in the United States (51). Others have also noted that 
the sales of energy-saving devices, which have helped facilitate increasing sedentary 
behaviour, correlated with increasing levels of obesity, whereas changes in energy intake do 
not (90). Even in today’s environment, differing occupational roles can have a substantial 
effect upon daily energy expenditure. For example, it has been hypothesised that compared 
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with a highly sedentary deskbound worker, a waiter or hospital nurse could expend up to 800 
kcal/day more (91). Even a fairly modest increase in energy expenditure of 200 kcal/day 
would equate to over 4kg of weight loss over the course of a year; assuming an unchanged 
energy intake [based on a 90kg man (92)]. 
More recently, experimental studies have begun to look at the acute physiological effects of 
sedentary behaviour in adults. One such study investigated the effects of 1 day sitting 
(17houts/day objectively assessed) on whole body insulin sensitivity with a strict diet. 
Fourteen young non-obese fit men and women completed three 24-hour conditions:  
1) An active, no-sitting condition (energy intake matched to expenditure).  
2) Low energy expenditure (sitting), with no reduction in energy intake (energy 
surplus).  
3) Sitting with energy intake reduced to match low expenditure (energy balance). 
Their findings showed that an acute bout of prolonged sitting resulted in a 31% reduction in 
insulin sensitivity. These findings were attenuated when participants undertook their 
subsequent experimental condition in which sitting was reduced and displaced with walking 
and standing (93). However, reducing energy intake to match energy expenditure during a 
prolonged bout of sedentary behaviour reduced the deleterious impact on insulin sensitivity 
by roughly 50%. 
As previously stated, the breaking up of sedentary behaviour has been shown to reduce the 
prolonged effects of sitting on cardio-metabolic health. Research into the physiological 
advantages of breaking up sitting time is now growing with studies showing that breaks in 
sedentary behaviour has beneficial cardio-metabolic effects. Dunstan et al. (58) examined the 
acute cardio-metabolic effects of breaking up sedentary behaviour; 19 middle-aged 
overweight and obese adults undertook 3 experimental conditions: 
1) Uninterrupted sitting (approximately 7 hours) 
2) Sitting interrupted with light-intensity walking every 20 minutes 
3) Sitting interrupted with moderate intensity walking every 20 minutes. 
Compared with uninterrupted sitting, plasma glucose was reduced by 23% in activity break 
conditions. Of note, there were no significant differences in plasma glucose between the light 
and moderate intensity conditions (58). These findings were corroborated in another small 
randomised controlled cross-over study (94). This study, conducted in healthy, normal weight 
adults, compared the effects of prolonged sitting (9 hours), continuous physical activity 
combined with prolonged sitting (1 × 30 minutes bout of walking) and regular light intensity 
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walking breaks on postprandial metabolism (walking for 1 minute 40 seconds every 30 
minutes). The results showed that regular activity breaks (with a 39% reduction in the 
glucose area under the postprandial curve) were more effective than continuous physical 
activity at decreasing postprandial glycaemia levels (94). This points to the added value of 
breaking up sedentary behaviour regularly throughout the day, rather than in a single bout, 
which has also been noted in other experimental (95) and epidemiological (74,75,96) studies. 
Further evidence suggests that increased standing, without walking, may have a significant 
effect on metabolic health. A randomised controlled trial examined the effect of 30 minute 
bouts of sitting and standing through the provision of sit-stand desks compared with 
prolonged sitting, on metabolic health in overweight/obese office workers during an 8-h 
working day. The glucose area under the postprandial curve was 11% lower in the sit-stand 
desk condition, although the difference in insulin failed to reach significance (97). This is 
consistent with a nonrandomised office-based study that found that glucose levels were 
reduced by 43% following an afternoon of standing compared with seated computer work 
(98). However, not all standing-based studies have yielded significant results, particularly in 
healthy, young adults (99,100).  
Saunders and colleagues (86) attempted to systematically review interventions which have 
examined the impact of uninterrupted sedentary behaviour lasting <7 days (operationally 
defined as an “acute” bout) on insulin sensitivity, glucose tolerance and lipid, glucose and 
insulin levels in adults (86). The results indicated moderate quality evidence suggesting the 
acute bouts of uninterrupted sedentary behaviour lasting 2 hours to 7 days results in rapid and 
deleterious change in triglyceride levels, insulin sensitivity, and glucose tolerance. However, 
of the 29 articles found, 21 were bed rest studies and all except one of the 29 studies had a 
study duration of less than a day. Despite the fact that prolonged period of bed rest are not 
generalisable to everyday life, the metabolic impact of prolonged bed rest has received more 
attention than the metabolic impact of prolonged sitting. Furthermore it is unclear whether 
prolonged sitting and prolonged bed rest have a comparable impact on markers of cardio-
metabolic risk (86). 
Breaks in sedentary time have further been examined in relation to a number of other 
physiological outcomes including C-reactive protein (inflammatory marker associated with 
increased risk of several major diseases, including coronary heart disease and vascular 
mortality (101,102). Inflammation may be an adjunct pathway, along with reduced muscular 
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contractions, through which prolonged sedentary time may impact on cardiovascular disease 
risk, depressive symptoms and skeletal muscle gene expression (101,102). 
More recently, a review of the prospective experimental studies regarding the beneficial 
effects of breaking up prolonged sitting time on cardiometabolic risk factors, found that 
breaking up sitting time and replacing it with light-intensity physical activity and standing 
may be a stimulus sufficient enough to induce acute favourable changes in the postprandial 
metabolic parameters in physically inactive and type 2 diabetic participants. The exact 
frequency, intensity and type of activity will differ according to different subject 
characteristics, especially with respect to subjects’ habitual physical activity with more 
intense breaks needed for healthy samples (103).  
Given these findings, it is highly likely that, accurate measurement and innovative solutions 
are needed to promote reduced sedentary behaviour, for the betterment of cardio-metabolic 
health. 
2.5 Measurement of Sedentary Behaviour  
Valid and objective measurement of sedentary behaviour is of vital importance to assess the 
interaction between sedentary behaviour and health outcomes, namely because of the inherent 
disadvantages associated with subjective forms of measurement, notably their moderate 
reliability and slight to moderate validity (104), and susceptibility to social desirability bias 
(105). Furthermore, objective measurements can be used to quantify precisely the magnitude 
of the association between behaviour and health, to describe dose-response relationships and 
to document patterns of, and changes in sedentary behaviour between individuals over time 
(104) allowing for causal associations with health outcomes to be recognised (32,106). 
However, the majority of the research on sedentary behaviour to date has largely used proxy 
or self-reported measures although an increasing number of researchers are using objective 
methods as they become more readily available. There are numerous methods used to 
measure sedentary behaviour. In order to avoid confusion, throughout this thesis sedentary 
time will be defined as measurement of time spent sedentary using accelerometers whilst 
traditionally using a cut-point of ≤100 count per minute (CPM) whereas sedentary behaviour 
will be used when measured using posture sensors and/or subjective self-reported 
assessments.  
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2.5.1 Subjective Measurement 
Questionnaires are historically the most commonly reported method of capturing sedentary 
behaviour, the majority of which are self-administered, although in-person, telephone 
interviews and diaries have also been used (107,108). To date, the majority of studies using 
self-report measures have centred on capturing daily TV viewing time as a proxy marker of 
overall sedentary behaviour (107,108). Many of the questionnaires used to capture TV 
viewing time have not reported reliability and validity data. Those that provided data in 
adults, showed that reliability coefficient were generally fair to high (test-retest r=0.32-0.93), 
but concurrent validity was highly variable (r=0.19-0.80) (107). In addition, the measurement 
of TV viewing time as an indicator of total sedentary behaviour is challenging, as this 
behaviour does not appear to be representative of overall time spent in sedentary behaviour 
(109,110). Consequently, the interpretation of overall sedentary behaviour from the 
assessment of TV viewing to make inferences should be interpreted with caution.  
 
Other self-report questionnaires have focused more on global measures of sedentary 
behaviour, such as total daily sitting time, but similarly, the measurement properties of many 
such instruments have not been adequately demonstrated (111). The international physical 
activity questionnaire (IPAQ) was designed to provide an internationally standardised method 
of measuring physical activity and sedentary behaviour in surveillance studies (112). The 
sedentary item in the IPAQ has been shown to have moderate reliability (Spearman p>0.7 for 
test –retest data) but poor to moderate convergent validity ([the extent of the agreement with 
another non-criterion measure that should assess the same physical activity or sedentary 
parameter based on face and content validity (113)] Spearman rho<0.5) when compared with 
objectively measured sedentary behaviour (112).  
 
Recent work has attempted to develop more refined measurement tools that assess multiple 
sedentary behaviours (e.g. TV viewing, reading, socializing) and/or domain-specific 
behaviours (e.g. sitting at work or at home and motorized transport) (111,114,115). These 
show promise, but further development and validation work is required. One study reported 
that when compared with accelerometer-assessed sedentary time, a single-item question 
significantly underestimated sitting time, whereas a domain-specific questionnaire, with 
multiple items, more accurately assessed average sedentary behaviour (116). However, the 
single item questionnaire had preferential limits of agreement, demonstrating smaller 
measurement error (both random and systematic), possibly because of fewer responses 
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required. This may suggest that more detailed questionnaires will be needed for sedentary 
behaviour prevalence and surveillance studies, whereas single item questionnaires may be 
more appropriate for health-related epidemiology research, where ease of use and the ability 
to rank behaviours of interest are the dominant requirements. 
 
The methodologies (e.g. recall period vs questionnaire response format) and mode of 
administration (e.g. interviewer vs self-administer) of existing self-report instruments are 
particularly diverse. Assessment of test-retest results in adults does not clearly demonstrate 
that one recall period is superior to another (104). There is evidence, however, that 
concurrent validity (assessment of convergent or criterion validity when measures taken at 
same time (113)) may be better in adults when participants recall a typical day compared with 
a 7-day recall period. However, these observations originate from studies in different 
populations and use different referent measures (107). In addition, adults appear better able to 
recall sedentary behaviour for weekdays than weekends, perhaps because of greater 
capriciousness in behavioural configurations at the weekend (111,116). 
 
The strengths of self-report questionnaires include being cost effective, readily accessible to 
the majority of the population and have a relatively low participant burden (104). Self-report 
tools can also be used to identify the type of behaviour and the context in which it occurs, 
information that may be used to inform intervention design. However, as technology 
continues to advance, global positioning systems when combined with accelerometry can 
determine where activity takes place outdoors (117), yet, as the majority of time is spent 
indoors (118,119), further technological developments such as Real Time Location Systems 
and Radio Frequency Identification can be used to provide objectively measured detailed data 
on the context (such as temporally patterned location information, which can be matched to 
objective measures of behaviour) in which behaviours occur indoors (120). 
 
An important limitation of self-report measures is that they consistently demonstrate poor 
validity (104,107). A major obstacle to establishing validity is the absence of an accepted 
‘gold standard’(i.e. most valid) reference measure of sedentary behaviour (106). The use of 
one form of self-report to validate another is inappropriate because of the problem of 
propagation of uncertainty, the hypothesis that the unique variances of the associated 
indicators overlap. In other words, the specific nature of the shared variables remains 
unknown when one self-report measure is used to validate another (104). A further limitation 
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of self-report is that they are susceptible to influence by cultural norms and perceived social 
desirability (104,105) for example, accomplishing linguistic and conceptual consistency in 
the translation of self-report tools is problematic, restricting the comparability of data 
collected in different populations who have different cultural and linguistic customs. Given 
the significant limitations of using subjective methods of quantifying sedentary behaviour, 
more accurate and objective methods have been sought (104).  
2.5.2 Objective Measurement of Sedentary Behaviour 
The use of objective measurement methods to determine levels of sedentary behaviour may 
be a relatively new area, however, the objective measurement of sitting time can be traced 
back to the late 1960’s. Bloom et al (121) used the 90PoP angle change at the knee that occurs 
with changes in position between sitting and standing to design a gravity-activated switch. 
The switch, after several modifications, was reduced in size making it possible to place it in a 
normal watch mechanism, which was then placed inside a watchcase. Since the switch works 
by gravity, and the position of the watch on the leg varies from person to person, an 
adjustable watch holder was made. This holder was pivot anchored to the strap band; 
therefore, once the clock is placed above the knee, the clock may be rotated in its holder to be 
certain that it stops on sitting down and starts on standing. The watch would be wound each 
time it was worn and set at 12:00. At the end of data collection, the watch was removed and 
its time would be recorded. A reading of 5:15 would indicate five hours and fifteen minutes 
of standing. Participants were fitted with the watch and readings were taken for various 
periods of time (2-35 days; 85% completed 6 days or longer). Results from the study found 
that obese participants spent 15% less time each day on their feet. The obese participants also 
spent significantly more time in bed and sitting than their lean counter-parts (121). Whilst 
this is a rudimentary method of measuring sedentary behaviour by not providing strong data 
on the temporality or intensity of behaviour, the clear advantage of using objective measures 
of behaviour should be apparent. With the advancements of technology over the last five 
decades since the Bloom and Eidex study, there are currently more novel objective measures 
of sedentary behaviour becoming available. 
2.5.2.1 - Pedometers 
Pedometers are a well-known and well-used method of physical activity measurement and 
behaviour change. Traditionally, pedometers have a lever arm that moves with each stride; 
making electrical contact compressing a piezoelectric crystal, with the electrical impulse 
generated recorded as a step. Pedometers have been used, sparingly, as a proxy measure of a 
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sedentary lifestyle, defined by Tudor-Locke and colleagues (122) as a pedometer step count 
below 5000 steps/day. However, there are a number of limitations with this method. Firstly, 
they fail to produce any information on the length of time spent sedentary. Secondly, an 
individual could be in a non-sedentary job (e.g. bar staff) and could stand for prolonged 
period of time without accruing 5000 steps a day. This could lead to a misconception as to 
whether an individual has a sedentary lifestyle or not (122). Therefore, this sedentary lifestyle 
index is more a measure of physical inactivity than sedentary behaviour, which is the main 
reason why pedometers have been used sparingly as a measure of sedentary behaviour. 
2.5.2.2 - Accelerometer 
Accelerometers are small lightweight technologies that are usually worn on an elasticated belt 
positioned on the hip or lower back, which measure the frequency and amplitude of 
acceleration at the body segment to which they are attached and often integrate this 
information in the form of movement ‘counts’ (123). They can be used to estimate the total 
amount of sedentary time through the accumulation of low movement counts at specified cut 
points. They can also be used to detect short incidental breaks in sedentary time, defined by 
periods where movement counts exceed the specified cut point threshold set for sedentary 
time, which may not be feasibly be recorded by self-report measures (74). In addition, as the 
collected information is time stamped, specific segments of the day or week can be extracted, 
such as time at work. 
 
Key issues in the use of accelerometry for the assessment of sedentary behaviour is that they 
do not measure posture, they only estimate sedentary time though lack of movement counts. 
Other issues include device initialization, post-processing, signal feature extraction and 
inference of specific outcome variables (124). There is a lack of consensus as to the most 
appropriate accelerometer data-processing protocol, restricting the comparability between 
studies and obstructing evidence synthesis. Nevertheless, accelerometers are now being used 
to assess sedentary time in research studies.  
 
Previously, it was necessary to specify the sampling frequency (epoch) during device 
initialization, but in newer accelerometer modes that record raw accelerometer data, the 
epoch is overlaid during post-processing. A significant effect of epoch length on 
accelerometer determined sedentary time has been reported, but findings are inconsistent and 
the most appropriate sampling frequency for determining sedentary time has yet to be 
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established (125,126). In general, however, it is beneficial for researchers to collect data in as 
short an epoch as possible, as this provides information on exposure at the highest possible 
resolution. Furthermore, data collected in shorter epochs can be summed into longer epochs, 
facilitating the process of directly comparing findings across studies. Importantly, data 
collected using longer epochs cannot be subdivided into short time frames. In the absence of 
a consensus regarding ideal epoch length, data collection using the smallest possible epoch, 
although potentially leading to the requirement of supplementary data processing procedures, 
allows for data to be re-integrated and compared between studies that would not otherwise be 
possible. 
 
The monitoring period for accelerometer-based assessments of sedentary time has typically 
been seven days (31,127,128) with participants included in subsequent analysis if they 
provided data for at least 3-5 days usually including at least one weekend day. However, 
Matthews et al. (129) recommend that at least 7 days of monitoring may be required to obtain 
reliable estimates of habitual time spent inactive by adults.(129).  
 
In studies with adults, a minimum of 10 hours of wear time has typically been required 
(31,127,130). Identification of non-wear time is typically conducted by selecting a period of 
consecutive zero counts about which it is deemed that the device must have been removed. 
These segments of zero counts are then removed from further analysis. In studies concerned 
with estimating sedentary time, non-wear criteria have varied from 10 to 60 minutes of 
consecutive counts (31). Using strings of zero counts to indicate non-wear time, however, this 
is problematic because a continuous zero reading may occur during periods of sedentary 
behaviour (131). Continuous zero counts may be recorded when a participant is sitting or 
lying still (while wearing the device), potentially resulting in the erroneous removal of 
sedentary time data because of misclassification as non-wear time. Improved methods of 
identifying non-wear time are therefore needed. One possible solution is to combine motion 
sensing with physiological assessments (such as heart rate (HR) (132), wherein the absence 
of physiological data may be used to signify non-wear time. Another potential solution is for 
devices to develop an electronic log of non-wear within the data stream.  
 
ActiGraph (ActiGraph LLC, Pensacola, FL) and Actical accelerometers [(Respironics, 
Philips, N.V.) (uniaxial models)] defined sedentary time commonly using a count threshold 
of <100 counts per minute (CPM) in adults (31,48,127,133). However, despite the 
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widespread use of this cut point, this value was not empirically derived, and studies reporting 
the validity of this cut point in adults are limited (31,134). Kozey-Keadle and colleagues (134) 
assessed the criterion validity (the extent of the agreement between a measure and another 
already held as being a standard) of a number of ActiGraph GT3X cut points (50, 100, 150, 
200 and 250 CPM) for defining sedentary time against direct observation in a small sample of 
adults (n=20). Findings indicated that the ActiGraph 100 CPM cut point underestimated 
sedentary time by 4.9%. The cut point with the lowest bias was 150 CPM, which 
overestimated sedentary time by 1.8%. Another study investigated sedentary behaviour cut 
points for the Actical accelerometer (hip mounted), using the activPAL (thigh mounted; PAL 
technologies Ltd, Glasgow, UK) device as the criterion measure. It was concluded that a 
threshold of 0 counts/15s epoch provided the most accurate estimates of sedentary time. 
However, recognising the potential difficulties a zero-count cut point would raise in terms of 
distinguishing non-wear time, the authors recommend a threshold of 0-5 counts/15s epoch 
during the period when the device can be deemed to have been worn (135). However, the 
most common method of determining sedentary time using accelerometers is still the <100 
CPM cut point. 
 
A key limitation of traditional (count based) accelerometers as a measure of sedentary 
behaviour is that they assess intensity of movement and thus are less able to distinguish 
between postures, such as sitting and lying or standing still. Consequently, periods of 
standing still may be misclassified as sedentary behaviour and vice versa (116,136). Newer 
models of the ActiGraph include an inclinometer function, which classifies participant’s 
posture into four categories (device removed, standing, lying, and sitting). Preliminary 
evidence, however, indicated that the validity of this function is limited and may be 
influenced by point of attachment (137). Furthermore, a recent study in adults reported 
excellent accuracy for the ActiGraph GT3X+ (attached to the thigh) when classifying sitting, 
standing and stepping (the majority of the activities were correctly classified more than 90% 
of the time for both monitors) during a laboratory-based protocol (138). In addition, the 
ActiGraph (attached to the thigh) provided similar estimates of sedentary time compared to 
the activPAL (64% versus 62%) under free-living conditions (138). Carr and Mahar (139) 
reported that the hip-based ActiGraph correctly classified 90% of time spent sedentary 
(defined as sitting and standing still) when using ≤150 CPM. However, the ActiGraph 
inclinometer function was less accurate in determining posture, classifying less than 70% of 
the time correctly as sitting, standing, or walking (139), providing further evidence of a point 
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of attachment influence on the validity of the inclinometer function in the ActiGraph. 
However, it may not be pragmatic to have participants wear the ActiGraph at the thigh for 
prolonged periods of time. 
2.5.2.3 – Heart Rate and Accelerometry 
The assessment HR  as a method for the studying of behaviour has a long history (140,141). 
Most epidemiological efforts, however, have concentrated on estimating total energy 
expenditure or time spent at moderate to vigorous intensity level, typically using the flex-
heart rate (flex-hr) method (142). The individually established flex-hr point (a discriminatory 
threshold between rest and exercise) determines when data from free-living behaviour are 
translated as energy expenditure at rest or according to an established regression line from an 
exercise test. In free-living conditions, it has been shown that most time is spent below the 
flex-hr point (143). Subsequently, time below flex-hr has been used to estimate sedentary 
time and furthermore it has been found to be associated with insulin resistance (144). This 
measure of sedentary time generally has high specificity but low sensitivity (104). 
 
Several studies have investigated the utility of combined HR and movement sensing to 
accurately assess physiological intensity across a wide range of behaviours (145–148). 
Defining sedentary behaviour in caloric terms (e.g. time spent at 1.5 METS or below) enables 
sedentary outcome variables to be derived from these methods. Combining accelerometry 
with heart-rate could be used to increase the accuracy of behavioural measurements above 
just accelerometry alone. This can be achieved by using the combination of the 
biomechanical and physiological information to determine whether the monitors have been 
worn. 
2.5.2.4 – Posture Sensors 
The activPAL is a small lightweight electronic device worn under clothing, attached directly 
to the skin on the midline of the anterior aspect of the thigh. The activPAL determines 
posture on the basis of thigh acceleration, including the gravitational component and uses 
proprietary algorithms to classify time as sitting/lying, standing or stepping. Information on 
cadence, number of steps taken, sit-to-stand and stand-to-sit transitions and estimates of 
energy expenditure are also provided (104).  
 
The activPAL has been shown to be a reliable and valid measure of step counts in adults 
(149–154). However, relatively few studies have explored the criterion validity of the 
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activPAL for measuring sedentary behaviour (134,136,155). In one validation study, a mean 
percentage difference of 0.19% (limits of agreement: -0.68% to 1.06%) between the 
activPAL monitor and direct observation for total time spent sitting was reported (155). More 
recently, Kozey-Keadle and colleagues (134) examined the validity of the activPAL in 
assessing sedentary behaviour and detecting reductions in sitting. The activPAL output was 
highly correlated with direct observation (rP2P=0.94) and accurately identified investigator 
manipulated reduction in sitting time. These studies provide promising preliminary evidence 
that the activPAL may be a valid tool for the assessment of sedentary behaviour in adults 
(134). Similar to other accelerometer-based methods, the activPAL does not provide 
information on the type of behaviour being undertaken or the social or environmental context 
in which it occurs. 
 
More recently, a new method of distinguishing posture is using a pressure sensor placed 
either in a foot-based monitor or in a seated cushion. The foot-based sensor typically utilises 
a combination of discrete resistive pressure sensors in combination with a triaxial 
accelerometer to provide raw sensor data to be analysed by proprietary algorithms and 
software. This software is used to identify specific postures and activities such as sitting, 
standing, walking, running, cycling and stair climbing, with an average of 98% accuracy. 
Energy expenditure was also determined with better than 95% accuracy (156–158). The 
technology can then be embedded in an insole of a shoe or even into the fabric of socks with 
a smartphone based biofeedback and coaching application also available. 
 
The seat-based sensor comprises a cushion containing a medical grade pressure sensor which 
acts as a switch to detect transitions of greater than three seconds to and from the seat and 
typically a microcontroller which records a time stamp for each transition. Data tends to be 
downloaded either using proprietary software packages or to a smartphone app for data-
analysis and feedback. For such a device like the one described here, the smallest mean 
difference, compared with direct observation, for sitting time and transitions was 0.30 ± 0.21 
minutes and –0.46 ± 0.78 respectfully. During free-living, both the cushion sensor compared 
to the activPAL (set to record events greater than 3 seconds) showed excellent levels of 
agreement with direct observation for sitting time (0.999 and 0.990 respectively) and 
transitions (0.997 and 0.928 respectively). (159). 
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Whilst these two methods to measuring sedentary time might be novel, their feasibility to be 
used to measure sedentary behaviour for prolonged periods in a free-living setting has yet to 
be tested. Logically, their utility as measures of sedentary behaviour is most certainly going 
to be hampered by the fact that when sitting in numerous different locales over the course of 
the day individuals will require several of the seat-based sensors to capture all the different 
seated areas. As for the foot-based pressure sensor, unless participants were willing to use the 
same pair of shoes or purchase numerous pairs, it is unlikely that the shoe-based method is an 
appropriate tool for sedentary behaviour for use across prolonged periods of time (e.g. weeks) 
2.5.2.5 – Multi-unit Sensors  
The utility of multi-site/multi-sensor devices has been examined widely in the clinical setting 
[e.g. mobility assessment in older adults (160)], but their potential in other study types (e.g. 
interventions and epidemiological studies) is largely unknown. Typically, these devices use 
multiple accelerometers, inclinometers or physiological sensors attached at various points on 
the body. Sensor signals are then integrated to enable classification of different postures and 
types of movement. A number of such devices have been developed and examined for their 
accuracy in detecting posture and activity (both activity type and energy expenditure) in 
controlled laboratory settings (161–166). However, the validity and feasibility of using these 
devices under free-living conditions has not been comprehensively tested. Limitations in 
battery and memory capacity and the computational and analytical complexity associated 
with processing multi-unit sensor data also limits their applicability in a free-living setting. 
Furthermore, wearing multi-site sensors will increase the level of participant burden. 
 
These devices may, however, be valuable as criterion measures in the validation of other 
sedentary behaviour measurement tools. For example, the Intelligent Device for energy 
Expenditure and Activity (IDEEA; MiniSun, Fresno, CA, USA) has demonstrated 98% 
accuracy in classifying 32 different types of activity and postures under laboratory conditions 
(161). Matthews et al (31) reported data from a small unpublished data set, which was 
conducted as part of their research in which the convergent validity of the ActiGraph 7164 
100 CPM cut point for sedentary behaviour was compared against the IDEEA monitor in 19 
free-living adults. The ActiGraph and IDEEA monitors displayed similar values for time 
spent sedentary (8.63 and 8.53 hours/day, respectively), there was a moderate association 
between the two devices (r=0.59) (31).  
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2.5.2.6 – New and Emerging Technologies 
Moore’s law (167) continues to predict with some accuracy that electronic devices will 
become smaller, more sophisticated and cheaper every 12-24 months. Technology for data 
capture, processing and storage often outpaces our ability to describe it in the scientific 
literature. It is also highly feasible that disposable omnidirectional accelerometers with 
inclinometric or gyroscopic capabilities will soon cost less than printing, sending, collecting 
and entering paper surveys (104). Because of this rapid innovation, new commercially 
available technologies to assess and track behaviour are proliferating. Corporations such as 
Fitbit (Fitbit, Inc, San Francisco, CA) , Jawbone (Jawbone, San Francisco, CA), and Misfit 
Shine (Misfit, Inc, San Francisco, CA) are at the forefront of this market, with wearable 
technology recognised as a leading technological trend in 2014/15 by many technological 
commentators and experts (168). 
 
A major decision made by commercial users will concern the accuracy of the device verses 
the interface and usability of the device. Researchers are often concerned with evaluating the 
accuracy of the device whereas users are often more interested in the perceived usefulness 
and ease of use of the technology. Both these components could be highly related to wear 
compliance. To date, there is limited scientific research regarding the reliability and validity 
of these commercially available activity monitors as a measure of physical activity and 
sedentary behaviour. Furthermore, the research is limited to their use as measures of time 
spent physically active and not time spent sedentary (169).  
 
To date, the Fitbit devices have received the majority of attention, with a number of studies 
scrutinising the validity of various outputs (170–179). Dannecker and colleagues (158) 
examined the ability of the original Fitbit (now superseded by a number of FitBit iterations) 
to measure active energy expenditure among 19 healthy young adults, and found that it 
underestimated 4-hour energy expenditure by 28% compared with indirect calorimetry (a 
criterion energy expenditure measure). More recently, Takacs and colleagues (170) examined 
the ability of the Fitbit “One” to count steps during treadmill walking among 30 healthy 
adults. Participants ambulated at five different speeds for five minutes at each speed, wearing 
three Fitbit devices (at each hip and in the front pocket of the dominant side). Using direct 
observation as the criterion, excellent validity (0.97-1.00) and inter-device reliability (99% 
agreement) were reported, regardless of walking speed or device wear site.  
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Given the large number of activity monitors now commercially available, methodologies 
which evaluate them simultaneously are required in order to determine the relative utility of 
these devices in comparison to both their commercial and research counterparts. A recent 
study compared the validity of the Fitbit Ultra (now superseded), Nike Fuelband and a 
traditional pedometer (Yamax SW-701) in people with stroke and traumatic brain injury (n = 
50) during a two minute walk test. It was found that the Fitbit Ultra was the most accurate 
device (95% agreement with direct observation), followed by the Yamax (85%), and the Nike 
Fuelband (66% accuracy), highlighting that validity in wearable technologies can vary widely 
(180). Lee, Kim and Welk (181) also examined the validity of eight consumer-level devices 
for estimating energy expenditure in healthy young adults (n = 60). During a 69 minute 
protocol in a laboratory setting, the consumer-level devices were compared against an 
indirect calorimetry criterion. The devices were ranked based on percent accuracy, as follows: 
BodyMedia FIT (90.7% accuracy), Fitbit Zip (89.9%), Fitbit One (89.6%), Jawbone UP 
(87.8%), ActiGraph GT3X (87.4%), DirectLife (87.2%), Nike Fuelband (87%) and Basis BI 
Band (76.5%). To date, it appears that no studies have scrutinised a large number of devices 
simultaneously for other variables provided by the devices (e.g. sleep time and MVPA), and 
very few studies thus far have examined the devices in free-living conditions. 
 
Many consumer-level devices have displays (usually LED/LCD) for immediate feedback and 
associated mobile and internet-based applications, providing users with feedback on a variety 
of metrics including (but not limited to) step count, calories burned, stairs climbed, distance 
travelled, active time and sleep. Some devices also offer the ability to interact with other 
users via online social networks and platforms which has been shown to have potential 
positive benefits for health behaviour change (182). Several manufacturers claim their 
devices accurately capture physical cactivity levels whilst worn on various body sites (e.g. 
Misfit Shine can be worn on a necklace, wrist band, bra or waist band). Furthermore, such 
devices typically cost 50-100 US dollars, making them considerably cheaper than research-
grade activity monitors Considering these features and their agile nature, consumer-level 
activity monitors, coupled with smartphone technology, have vast potential to enhance user 
experience and utility (183).  
 
These devices, however, have been created for the consumer market, battery life is a key 
component to allow for prolonged usage without the need to recharge. Because of this, 
compromises have needed to be made elsewhere, mainly in sampling frequency. 
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Traditionally, research grade accelerometers can measure acceleration at hertz level 
frequency, sometimes in excess of 100Hz. Whilst consumer activity trackers do also measure 
acceleration at hertz level frequencies, they do not make this readily available, as the data 
needs to be aggregated to minute level data to be transferred to the phone app via Bluetooth. 
This might have ramifications in terms of the level of acuity gained from higher resolution 
sampling frequency data. Furthermore, wearable technology traditionally connects to a 
mobile phone application for data feedback, which means that (depending on the device) the 
raw data are not available to the user.  
 
The current method of objectively measuring sedentary behaviour is utilising research grade 
accelerometers and posture sensors. However, the priorities of the manufacturer of these 
research devices is not participant comfort or providing immediate feedback, instead they 
prioritise high resolution data collection, therefore reducing their ability to be used as an 
effective behaviour change tool. The current consumer electronic realm has manufacturers 
attempting to reach a compromise between high resolution data collection and the ability to 
provide immediate feedback to the wearer (something that is important to the consumer). 
Furthermore, due to the inherent ability of these devices to self-monitor and provide feedback, 
they provide a unique opportunity to be deployed as intervention modalities for behaviour 
change in reducing sedentary behaviour. 
 
2.6 Health Behaviour Change 
Understanding how behaviours are effected by different behaviour change techniques is 
important in developing interventions (184–186). Altering the incidence of any particular 
behaviour requires a change in their capability, motivation or opportunity to engage in the 
behaviour (185,187,188). Capability refers to the psychological and physical abilities to 
perform behaviour, and includes knowledge and skills. Motivation involves all the processes 
that energise and direct behaviour, including not just goals, plans and beliefs but also 
‘automatic’ processes involving emotions, habits and impulses. And finally, opportunity 
involves all factors that are external to the individual that may influence engagement with an 
activity, ranging from the physical environments in which people spend time to the social 
cultural influences that dictates how we perceive and think about behaviour change 
interventions. It is important for designers of interventions to understand how these factors of 
capability, motivation and opportunity vary as a function of particular behaviours, target 
populations and contexts (185,189–191). 
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There is growing recognition that attempts to change behaviour should draw on theories of 
behaviour and behaviour change. In the United Kingdom, the Medical Research Council 
recommends beginning the development of any complex intervention by identifying relevant 
theories to advance an understanding of the likely process of change before conducting any 
exploratory piloting and formal testing (192–194). However, there is also a legitimate 
question as to how far explicit use of theory promotes the design of effective behaviour 
change interventions. In fact, interventions that have purportedly been informed by theory 
have not necessarily been found to be more effective than those that have not. Some reviews 
have found a positive association (191,195–198), but others have found no association, or, 
even a negative association (199). Some reviews have reported a mixture depending on the 
measure of effectiveness (200,201). 
 
One factor that may contribute to this mixed picture is the way the theory has been used as a 
stepping off point for ideas versus being used in a systematic manner to develop intervention 
content. Unfortunately, it has been found that the reported use of theory in intervention 
design is generally inadequate. Another crucial factor is the choice of appropriate theory. For 
example, if behaviour is fundamentally under influence of habitual or emotional factors then 
a theory that focuses exclusively on beliefs and reflective thought processes may not be 
appropriate when informing intervention design.  
 
2.6.1 Behaviour Change Techniques and Their Associated Theory 
In order to improve the effectiveness of interventions to change behaviour, such as physical 
activity and/or sedentary behaviour, it is necessary to replicate and accumulate evidence 
across empirical studies. This is not straightforward, as interventions to change health-related 
behaviours are usually complex, comprising many, often interacting components (194). 
Systematic reviews of the effects of physical activity interventions on behaviour or health 
outcomes often conclude that both the interventions as well as the effect sizes are extremely 
heterogeneous (202–204). While some interventions are indeed highly effective in changing 
behaviour and relevant health outcomes, others fail to achieve such effects. Replication, 
accumulation and application of evidence depend on the ability to reliably specify the details 
of intervention content both for primary research and for secondary evidence syntheses.  
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Michie and colleagues (205) believed that the current reporting of interventions in published 
evaluations fell short of the detail required for reliably identifying intervention content 
(42,206,207) and hence they limit the possibility of identifying the effective components 
within interventions (42). Reporting of intervention content is often brief and imprecise with 
interventions being broadly characterised as, for example, ‘behavioural counselling’, 
‘cognitive behavioural therapy’ or ‘motivational strategies’. In some cases, reporting does not 
mention content but, instead, describes mode of intervention delivery such as ‘face to face’ or 
‘telephone delivered’ or in terms of number of intervention sessions. Where details of 
intervention content is provided, such as in published intervention protocols, terminology is 
variable across intervention descriptions; the same label may be applied to different 
behaviour change techniques or different levels applied to the same technique. An example of 
the former is ‘behavioural counselling’ described both as ‘educating patients about the 
benefits of lifestyle change, encouraging them, and suggesting what change could be made’ 
and ‘feedback on self-monitoring record, reinforcement, recommendations for change, 
answers to questions, and general support’. Therefore, standardised definitions of techniques 
were required. In an attempt to improve the reporting of use of theory in intervention design, 
a 19 item ‘Theory Coding Scheme’ has been developed (208). The scheme assesses whether 
theory was mentioned, how theory was used in intervention development, whether theory had 
an indirect influence on an intervention, how theory was used to explain intervention effects 
on outcomes and the implications for future theory development. This initiative created the 
‘Taxonomy of Behaviour Change’ which describes 93 behaviour change techniques (209).   
 
Michie and colleagues (42) then applied this taxonomy of behaviour change techniques to 
assess the effectiveness of behaviour change interventions designed to promote physical 
activity and healthy eating and investigate whether theoretically-specified behaviour change 
techniques improve outcomes. Active behaviour change interventions were only included, 
instead of both active and/or passive intervention techniques because active behaviour change 
techniques have been found to be more effective than passive interventions in other areas and, 
because of the sustained behaviour change necessary to translate dietary and physical activity 
in health benefits, self-regulatory processes are likely to be central to health-enhancing 
change (42). Moderator analysis, using both univariate and multivariate meta-regression, 
revealed that the number of theoretically-derived self-regulation techniques, in particular self-
monitoring of behaviour was associated with improved effectiveness. Furthermore, 
interventions combining self-monitoring with one or more of four other self-regulation 
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techniques, namely, prompting intention formation or goal setting, specifying goals in 
relation to particular contextualized actions, providing feedback on performance and 
reviewing previously-set goals in light of that feedback were significantly more effective than 
interventions not including self-monitoring and one other self-regulatory techniques from 
Control theory (pooled effect sizes for healthy eating: 0.54 versus 0.24; physical activity: 
0.38 vs. 0.27; all interventions: 0.42 vs. 0.26) (42). Additionally, a further meta-regression 
investigating behavioural change interventions for obese adults with additional risk factors or 
co-morbidities, found self-monitoring to be a significant moderator of intervention 
effectiveness on weight (210). 
  
The most well-known objective measurement of self-monitoring physical activity is the use 
of the pedometer. A systematic review to evaluate the association of pedometer use with 
physical activity and health outcomes among outpatients revealed pedometer users increased 
their physical activity by 26.9% over baseline. Furthermore, when all studies were combined, 
pedometer users significantly decreased their body mass index by 0.38 kg/mP2P (95% CI, 0.05-
0.72; P = .03). Intervention participants also significantly decreased their systolic blood 
pressure by 3.8 mm Hg (95% CI, 1.7-5.9 mm Hg, P < .001) (211). The basic premise 
underlying the use of pedometers to increase physical activity is that the immediate visual 
feedback of cumulative step counts increases individual’s awareness of how their personal 
behavioural choice affects their physical activity. Used as part of a guide and repetitive self-
monitoring, feedback and goal-setting process, the pedometer is able to provide up-to-the-
minute information which can be used to adjust these behavioural choices to achieve physical 
activity objectives. 
 
The focus, however, of this thesis surrounds how sedentary behaviour can be influenced by 
self-monitoring. Gardner and colleagues (41) reviewed interventions to reduce sedentary 
behaviour and the behaviour change techniques that they used within the interventions. 
Interventions which used self-monitoring (n=15; of which n=13 used a self-reported measure 
of sedentary behaviour) were defined as “particularly promising” behaviour change 
techniques, with a promise ratio (metric devised as a measure of the behaviour change 
techniques contribution to the intervention promise) of 4.0, which was the highest promise 
ratio of all behaviour change techniques investigated (41). There is a logical basis for these 
findings. Interventions have been found to be more effective if they involve techniques that 
behaviour change theory predicts would act synergistically. Carver and Scheier’s Control 
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Theory (212) specifies action control processes underpinning behaviour regulation. The 
theory proposes that setting goals, monitoring behaviour, receiving feedback and reviewing 
relevant goals in the light of feedback are central to self-management and behavioural control. 
 
The accuracy with which self-monitoring is effective is dependent on the schedule of which 
the behaviour is monitored, the competitions from concurrent responses, and the valences of 
the target behaviour  (213–215). Thus there are restrictions on the use of self-monitoring 
when precise numerical data about target behaviour are required. However, if certain 
conditions are met, self-monitoring data can still be used to provide estimates of behaviour or 
to monitor relative change in behaviour over time. Self-monitoring also serves as a number of 
functions that do not require absolute accuracy in recording. Self-monitoring can be used to 
obtain qualitative information that is relevant to diagnosis and treatment planning. For 
example, participants might self-monitor the antecedents and consequences of a target 
behaviour or to record their emotional states while engaging in the behaviour. Self-
monitoring can also serve to increase participant’s motivation for change. Baseline data, 
collected before treatment implementation, can provide an incentive for future change. Later 
in the intervention, the achievement of a criterion can be graphically displayed and can 
provide a visual guide for the administration of reinforcement (216). Self-monitoring is 
closely related to two linked psychological theories: Control Theory and Self-Regulation 
Theory. These are discussed below and examples are provided with how these theories can be 
used.  
 
2.6.1.1 Control Theory 
Control theory aims to provide a model of human functioning and behavioural regulation, 
explaining people’s moment to moment actions, behaviour change and maintenance of 
physical health. The core component of the theory is a negative feedback loop, which 
functions to reduce or eliminate perceived discrepancies between current behaviour and a 
comparison value (such as a goal behaviour state). 
 
A person perceives their current condition via an input function (e.g. pedometer determined 
step count) and compares that perception against a particular standard (e.g. 10,000 steps goal) 
through a mechanism termed a comparator. If the person perceives a difference between their 
current condition and the reference value they attempt to reduce the discrepancy by 
performing a behaviour (termed output function – e.g. increase their step count). Performance 
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of the behaviour, in turn, has an impact on the environment, thus leading to changes in a 
person’s perceptions of their current condition, and a new comparison with the reference 
value, and so on. Behaviour is governed by a closed loop of control which continuously 
functions to minimise discrepancies between a person’s current situation and a particular 
standard of comparison. 
 
There are two further influences on behaviour that are external to this closed loop. The first is 
disturbance, which refers to factors external to the system affecting a person’s current 
condition. Disturbance does not affect the components of the model directly. However, it can 
modify perceptions entering the system via input function and lead to increased or decreased 
discrepancy from the standard. The second factor is the desired condition or comparison 
standard that is external to the closed loop, and is termed the reference value. The reference 
value arises from a hierarchy of systems of interconnected feedback loops. Each of these 
relates to superordinate (at the higher end of the hierarchy) or subordinate (at the lower end of 
the hierarchy) goals, where achievement of subordinate goals is necessary for the attainment 
of superordinate goal. The reference values for each level of control are set by the level above 
and at the highest level the reference value is derived from prior knowledge and experience. 
See Figure 2.3 for a diagrammatical representation of Control theory. 
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Figure 2.3 – Control theory’s negative feedback loop. Adapted from Carver and Scheier (1982) 
Comparator 
(e.g. Less 2,500 steps) 
Reference Value 
(e.g. 10,000 steps) 
Impact on Environment 
(e.g. Increase step count – to new Input Function) 
Output Function (Behaviour)  
(e.g. Decide to increase steps) 
Input Function (Perception) 
(e.g. 7,500 steps) 
Disturbance 
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2.6.1.2 Self-regulation theory 
Self-Regulation Theory proposes that behaviour is determined by three sources of control: a 
person’s immediate environment, their biological systems and cues (arising from the person’s 
cognitive and behavioural goals). These three factors interact to determine behaviour with the 
relative importance of each changing at different times and in different contexts [e.g. sitting 
behaviour might be primarily controlled by the biological system (need to sit for rest) at one 
point, but at another, environmental facts (such as the comfortable chair being in the vicinity) 
might become important]. According to the theory, adequate self-regulation can reduce the 
influence of fluctuations in biological and environmental factors upon behaviour, allowing 
for a more consistent pursuit of personally set goals over time and across contexts. 
 
The theory is based upon the assumption that everyday behaviour consists of chains of 
behavioural responses, where each response is cued by the preceding response until an 
activity (e.g. driving to work) is completed. Such behavioural sequences relate to a mode of 
cognitive processing termed automatic processing. Self-regulation processes apply other 
cases – such as where learned behaviour chains are not available, are interrupted or become 
ineffective, or where choices between alternative responses need to be made. These self-
regulation processes involve a qualitatively different mode of cognitive processing: 
controlled processing. Controlled processing requires continuous decision-making between 
response alternatives and attentional focus.  
 
The self-regulation process first involves a self-monitoring stage, in which a person closely 
and deliberately monitors their own behaviour. Through past experience, people will develop 
expectations about acceptable behaviour within the relevant domain (e.g. a person self-
monitoring their time spent sitting). These expectations form standards by which a person can 
judge their own behaviour. In the second stage, which is termed the self-evaluation stage, a 
person makes a comparison between the information about their own behaviour gathered 
during the self-monitoring stage and the standards for that behaviour. If self-monitoring has 
been insufficient or inaccurate, or if standards are unrealistic or poorly defined, effective self-
regulation will be undermined at this stage. The third stage of self-reinforcement involves a 
person’s reaction to the information gained during the self-evaluation stage, specifically their 
cognitive and emotional reactions of satisfaction or dissatisfaction thereby serving a 
motivational purpose. If a person notices no discrepancy between the standard and their own 
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behaviour (or if their behaviour exceeds the standard), they will not be motivated to change 
their behaviour. However, if their behaviour falls short of the standard, the resultant 
dissatisfaction will result in attempt to change behaviour. During these attempts the self-
regulation process is repeated until the standard is met or until efforts to change behaviour are 
abandoned. In cases where behaviour falls short of the standard and discrepancies are very 
large or are reacted to with self-punishment, the resultant emotions could lead to motivation 
to avoid rather than motivation to change behaviour (216). See Figure 2.4 for a 
diagrammatical representation of Self-regulation theory.  
 
 
Figure 2.4 – Self-Regulation Model Kanfer (1991) 
Note: Self-monitoring stage – person closely and deliberately monitors their own behaviours, self-evaluation 
stage where a person makes a comparison between the information about their own behaviour from the self-
monitoring phases and the self –reinforcement involves a person’s reaction to the information gathered in the 
self-evaluation stage; Perf = performance Kanfer (1991) 
 
The resemblance between these ideas should be evident. The processes themselves are nearly 
identical; the existence of a reference value, the self-reflective comparison between that value 
and one’s present state and the attempt to match the one with the other. Both these theories 
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discuss the process of self-regulation as involving self-imposition of behavioural standards, 
observations of one’s own actions (i.e. self-monitoring), and evaluation of the actions by 
comparing them with the standards. In addition, both discuss the importance of the person’s 
expectancies of being able or unable to alter behaviour in the direction of the standard, 
viewing them as critical determinants of whether the person continues to strive or gives up 
the attempt. The importance of expectancies in the behaviour change process has also been 
verified empirically (217,218). Whilst self-monitoring of sedentary behaviour is possible, 
there are no real standards [apart from the recent Canadian guidelines (219)] that can be 
employed. However, the use of prompts or cues to alert people to prolonged bouts of 
sedentary behaviour will help individuals to keep track of their behaviour and make the 
appropriate evaluations of their actions. 
 
2.7 Sedentary Behaviour Interventions in Adults 
The majority of previous sedentary behaviour interventions have focused on reducing the 
behaviour in children and adolescents (220). However, there is a growing breadth of literature 
on interventions attempting to reduce sedentary behaviour in adults (34,41),  but these are 
mostly small scale studies (221). Early interventions that have been suggested to change 
sedentary behaviour were most often physical activity interventions that assessed sedentary 
behaviour as a secondary outcome. For example, Chau et al. (222) conducted a systematic 
review on interventions to reduce sitting in the workplace. They included six studies in the 
review and found no evidence for intervention effectiveness as far as reducing sedentary 
behaviour was concerned. This finding is perhaps unsurprising given that all of the included 
studies were designed to increase physical activity and did not have a clear focus on 
sedentary behaviour reduction. In addition, the studies relied on self-reported measures of 
sedentary or sitting behaviour, of which only one specifically assessed occupational sitting 
(222).  
 
More recently, studies have used a variety of approaches to target sedentary behaviour more 
directly and these provide better evidence on whether changing sedentary behaviour is 
possible and, if so, what are likely to be effective strategies, with the majority of these studies 
having been focused on office workplaces. A pilot quasi-experimental control study 
conducted on 18 adult office workers (aged 20-65 years) in Australia aimed to examine the 
efficacy of an intervention to reduce office workers’ sitting time using commercially 
available sit-stand workstations. Intervention efficiacy was determined by change in time 
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spent sitting, standing, and stepping at the workplace and during all waking time from 
baseline to 1 week and 3 months. Sedentary behaviour was objectively measured using the 
activPAL. Changes in fasting cholesterol, high density lipoprotein, triglycerides, and glucose 
levels were also assessed from baseline to 3 months. The intervention group reduced sitting 
time following one week by 143 minutes/day at the workplace and 97 minutes/day during 
waking time and these effects were maintained over the three month period. The intervention 
group saw significantly increased HDL cholesterol, however, no significant difference were 
observed in other biomarkers (223).  
 
Another randomised controlled trial intervention, again in an office/workplace setting in the 
UK investigated the effects of point of choice prompting software on work computers, to 
reduce long uninterrupted sedentary periods and total sedentary time at work. The software 
reminded the participants to stand every 30 minutes during the 5-workday intervention period. 
An advice window reminding participants to take a break appeared on the monitor, for 1 
minute every 30 minutes from the time the PC was switched on. Sedentary behaviour was 
measured using the activPAL. The results indicated that there was a reduction in the number 
and duration of sedentary bouts at work during the intervention phase compared to that at 
baseline. However, there were no significant differences in total sedentary behaviour between 
the control and the intervention group (224), suggesting a compensatory effect happening 
outside the workplace. A limitation of this study is the lack of information on the time 
participants spent at their PC. For example, the software would prompt the participant to 
stand every 30 minutes. However, this would not take into account whether the person might 
have been standing under their own volition at or away from their desk.  
 
More recently Healy and colleagues (225) published data on reducing sitting time in office 
workers using a multicomponent intervention (225). The intervention emphasised three key 
messages: “Stand Up, Sit Less, Move More” and comprised organisational, environmental 
and individual elements. Relative to the controls, the intervention group significantly reduced 
workplace sitting time (mean change [95%CI]: −125 [−161, −89] min/8-h workday), with 
changes primarily driven by a reduction in prolonged sitting time (−73 [−108, −40] min/8-h 
workday). Workplace sitting was almost exclusively replaced by standing (+127 [+92, +162] 
min/8-h workday) (225). 
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Furthermore, a recent systematic review and meta-analysis into the evidence for activity 
permissive workstations on sedentary time, health-risk biomarkers, work performance and 
feasibility indicators in office workplaces found that the installation of workstations can lead 
to substantial reductions in sedentary time without impacting negatively on work-related 
outcomes; and that they are acceptable to workers. The study found no significant changes in 
health related outcomes; however, this was based on evidence from short-term studies with 
weak-to-moderate designs and/or insufficient statistical power, making it difficult to ascertain 
any conclusive findings (37). 
 
Other systematic reviews have been conducted into the effect of workplace interventions to 
reduce sitting time, with some findings showing effective interventions effects (34,222,226), 
while the others are not (37,227). Inconsistency in the findings can be explained by 
differences in inclusion criteria between the different studies (e.g. studies included in the 
Martin et al. (34) review were only randomised controlled trials), as well as differences in the 
study strategies and implementation. 
 
Very few interventions seeking to reduce sedentary behaviour in adults have been undertaken 
outside of the work place context. A novel randomised control trial (RCT) intervention 
examined the effects of a TV lock-out system to reduce TV viewing time on energy intake, 
energy expenditure, energy balance, body mass index and sleep in 36 overweight and obese 
adults (228). The lock-out system (BOB TV Time Manager; Hopscotch Technology, Boulder, 
Colorado) was attached by plugging the TV cord into the monitor and a four digit code was 
given to each household member to activate the system to turn on the TV. The system 
recorded total minutes per day of viewing per participant code. After the baseline 
measurement period, the intervention group had a weekly limit of 50% of their objectively 
measured TV viewing time form baseline placed on them. Activity behaviour was measured 
using the SenseWear Pro 3 Armband (BodyMedia Inc., Pittsburg, PA, USA). Although not 
statistically significant, both groups reduced their energy intake (-125kcal/day [95% CI. -303 
to 52] vs -38kcal/day [95% CI. -265 to 190] p=0.52) for intervention and control groups 
respectively. The intervention groups significantly increased energy expenditure 
(119kcal/day [95% CI. 23 to 215]) compared to the controls (-95kcal/day [95% CI. -254 to 65] 
p=0.02). Energy balance was negative in the intervention group between phases (-
244kcal/day [95% CI. -459 to -30]) but positive in controls (57 kcal/day [95% CI. -216 to 
330]) p=0.07. The intervention group showed a greater reduction in BMI (-0.25 [95% CI. -
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0.45 to -0.05] vs -0.06 [95% CI. -0.43 to 0.31] in controls) (p=0.33). There was no change in 
sleep (228). 
 
One published feasibility study, ‘Stand Up For Your Health’, has shown favourable results in 
adults aged 60 years and older (n=59; (229)). This trial used a 45 minute face to face meeting 
to assist participants to reduce sitting time and to increase breaks in sedentary behaviour. The 
intervention was informed by Social Cognitive Theory and behavioural choice theory, and 
focused on building self-efficacy (via goal setting), self-control (via self-monitoring and goal-
setting), outcome expectancies (via barriers and benefits), reinforcement (via rewarding 
behaviour change) and preference (via identifying enjoyable non-sedentary pursuits). During 
the intervention participants: 
1) reviewed their accelerometer-assessed sedentary time from the previous day; 
2) received normative feedback on their self-reported sedentary time, using 
graphs to compare to an average Australian of a similar age and gender; 
3) completed a goal-setting exercise to reduce sedentary time and increase the 
number of breaks in prolonged sedentary time, and  
4) formulated a behaviourally specific action plan. 
Generic strategies to reduce and break up sedentary time were suggested, and participants 
identified strategies specific to their circumstances. The participants were also encouraged to 
self-monitor their sitting behaviour using a tracker. Sedentary time was derived from the 
ActiGraph accelerometer and defined as <100 CPM. At the end of the first week of data 
collection participants received the intervention and were then monitored for another week. 
During the post-intervention week there was a small but significant reduction in sedentary 
time of 3.2% and an increase in the number of breaks from sedentary time. Participants 
reduced their sedentary time mainly during the day, and increased their breaks in sedentary 
time in the evening. This intervention is promising but full randomised trials with 
representative sample are required before a definitive conclusion about its effectiveness can 
be made (229).  
 
More recently, Martin et al. (34) systematically reviewed and meta-analysed the effect of 
interventions which included sedentary behaviour as an outcome measure in adults. The 
review found clear evidence that it is possible to intervene to reduce sedentary behaviour in 
adults by 22 mins/day in favour of the intervention group. Moderate to high quality evidence 
on the efficacy of lifestyle interventions for reducing sedentary behaviour suggests that this 
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may be a promising approach. Interventions focusing on sedentary behaviour only result in 
the greatest reduction in sedentary time (42 min/day), however this was based on only two 
studies of low to medium quality. Findings also suggests that intervention duration up to 3 
months and interventions targeting men and mixed genders can produce significant 
reductions in sedentary behaviour (34). 
 
The results from this systematic review are consistent with those of Prince et al. (35) in 
relation to the effect of physical activity and sedentary behaviour intervention and 
interventions focusing on sedentary behaviour only, despite there being no overlap of 
included studies in the latter. However, in contrast, the systematic review by Martin and 
colleagues (34) found no evidence of a beneficial effect on sedentary behaviour from 
interventions focused on increasing physical activity. This difference in findings could be 
attributed to the differences in the definitions of lifestyle interventions and physical activity 
interventions between the two systematic reviews (34,35). 
 
With the mixed picture of interventions effectiveness in reducing sedentary behaviour, the 
increasing amount of commercially available technology which inherently contains different 
behaviour change techniques, allows them to be potentially useful in interventions to reduce 
sedentary behaviour and increases physical activity. 
 
2.7.1. New and Emerging Technology and Behaviour Change 
The wearables market is a newly established digital health market segment. Whilst they are 
not as well adopted as mHealth apps (mobile health - a term used for the practice of medicine 
and public health supported by mobile devices; mHealth apps are often free), and their 
wearable counter-part come at a premium, which has helped sales in this new market grow at 
a fast rate. According to early estimates, health and fitness wearables account for just 30% of 
the total wearables market, at £1.5 billion in 2014, growing to £3.1 billion by 2018 (230). 
Over 3 million wrist-worn wearable devices such as fitness bands and smartwatches are 
estimated to have been sold in the UK in 2015, up 11% from unit sales in 2014. In 2015, 63% 
of wrist-worn wearable devices sold were fitness bands, compared to 37% which were 
smartwatches. Currently one in seven of the UK population own any kind of wearable device 
(231,232). Consumers age 16-34 years show the strongest interest in wearables, being about 
three times more likely than those aged 35+ years to own a fitness band. Indeed, 13% of 
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British people aged 16-34 years currently own a fitness band compared to 4% of those over 
age 35 years (232). 
 
Whilst wearable technology is increasing rapidly in popularity at the moment, wearable 
computers for personal advantage have been around for decades. The first documented 
occurrence of wearable technology is of Ed Thorpe’s and Claude Shannon’s cigarette pack-
sized pocket computer that was designed to predict roulette wheels in the early 1960’s. The 
computer itself consisted of 12 transistors that allowed its wearer to time the revolutions of 
the ball on the roulette wheel and determine where it would end up. Wires led down from the 
computer to switches in the toes of each shoe, which let the wearer covertly start time to the 
ball as it passed a reference mark. Another set of wires led up to an earpiece that provided 
audible feedback in the form of musical cues – eight different tones represented an octant in 
the roulette wheel. When everything was in sync, the last tone heard indicated where the 
person at the table should place their bet. The system provided the wearer with a 44% edge in 
roulette.  
 
Modern day consumer wearables can deliver personalised, immediate and goal orientated 
feedback on specific tracking data obtained via sensors and provide long lasting wear without 
requiring continual charging (e.g. > 7days battery life). Their small form factor makes them 
easier to wear continuously, and whilst smartphones are still required to process the incoming 
data for most consumer wearables, it is conceivable that in the near future all processing 
functionality will be self-contained. 
 
At present, wearables are more likely to be purchased by individuals who already lead a 
healthy lifestyle and want to quantify their progress (233). The majority of wearable 
manufacturers (e.g. FitBit, Jawbone, and Garmin) stress the potential of their devices to 
become an “all-in-one” platform for improving physical performance and positive habit 
formation. Wearable manufactures utilise a range of digital persuasive techniques and social 
influence strategies to increase user engagement, including the gamification of activity with 
competition and challenges, publication of visual feedback on performance utilising social 
influence principles, or reinforcements in the form of virtual rewards for achievement. 
 
The most successful vendors will likely be those that give consumers a clear path for action-
taking and behaviour change with their products and services (234). Consumers can be 
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directed through a road map designed to increase their engagement as the technology 
continues to benefit them. This road map could include the steps of getting the consumer to 
try quantified tracking with the solution, see the value provided by the solution, continued 
engagement, change behaviour, and maintain the behaviour change. Since even the simple act 
of tracking has been shown to have an impact, individuals can start with this light touch 
behaviour. Some of the benefits of self-tracking alone in affecting behaviour change have 
been seen in weight loss diary keeping (234,235) and home power consumptions. Electricity 
consumption was reduced when individuals could self-monitor and obtain feedback about 
their resource use: 7-10% reductions with smart meters and other feedback (236,237), and a 
32% reduction with feedback plus incentives (238). If wearable tracking can be made 
extremely easy (ideally automated), fun (with gamification and social engagement), and even 
remunerative (with rebates and cost-savings), then there could be significant growth in the 
types of things individuals are willing to track and wearable data streams as a result. 
 
But do wearables make people healthier through increasing physical activity? Currently 
empirical data in this area are lacking. Lewis et al. (239) systematically reviewed the 
literature on the efficacy and feasibility of interventions using electronic activity monitor 
systems within published physical activity literature. Of the 11 studies, four used 
commercially available devices for individuals to use (Gruve, PAM, Fitbit), the rest were 
only available through distributors and traditionally to researchers. Feedback from the 
electronic activity monitoring systems was administered for differing monitoring periods. 
Those interventions involving commercially available monitors showed significant pre-post 
intervention increases in physical activity, whilst also displaying significant pre-post 
decreases in sedentary behaviour although sedentary behaviour was not the main outcome. 
Encouragingly, the interventions involving the Gruve and Fitbit had an 80% or better 
retention rate potentially due to their better aesthetics and comfort of wear. 
 
Research projects using wearable technology that have integrated behaviour change–based 
text messages in their interventions have resulted in considerable increments in physical 
activity in adults (240). This is the case of interventions where participants who were 
provided with physical activity tracking and received feedback through automated and 
tailored text messages increased their daily step-count by 2,334 steps/day (25%) compared 
with those randomised to physical activity alone. Total physical activity time and aerobic 
time also increased in the text receiving group by 21 and 13 min/day, respectively when 
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compared to the blinded and unblinded – no text groups (240). In another study by 
Compernolle et al. (241), participants in the intervention arm were given information on how 
to increase steps, a digital pedometer with 7 day memory, and were granted access to tailored 
web-based step advice (241). A recommended 10,000 daily step goal was used. The 
intervention resulted in an increase of 1,056 daily steps in the intervention group compared 
with a reduction of 256 daily steps in the control group using only a blinded pedometer (241).  
 
The majority of interventions using wearable technology or consumer electronic devices have 
been aimed at increasing physical activity, in no small part, due to the fact that most 
consumer electronic devices track steps as their main tracking outcome. There is therefore a 
dearth of research examining the use of consumer electronic devices examining their ability 
to decrease sedentary behaviour which needs to be addressed in the future. 
 
2.8 General Summary 
Sedentary behaviour has a clear and established inverse relationship with markers of cardio-
metabolic and psychological health. Accurate measurement of sedentary behaviour is 
therefore of vital importance. The majority of measures of sedentary behaviour have been 
conducted using self-reported questionnaires however, these are open to a variety of biases. 
More objective measures have therefore been sought. In search of objective measures of 
sedentary behaviour; researchers are now using accelerometers to quantify sedentary time. 
However, accelerometers also have their own pitfalls. They assess intensity of movement and 
thus are less able to distinguish between postures (a key variable in the definition of 
sedentary behaviour) such as sitting and lying. In lieu of this limitation, posture sensors are 
being used to quantify sedentary behaviour. However, there is currently a paucity of sensors 
used in published research, which accurately measures sedentary behaviour to its current 
definition.  
Interventions aimed at reducing sedentary behaviour currently show a mixed picture. They 
are either interventions that aim to increase physical activity and measure sedentary 
behaviour as a secondary outcome, or these interventions tend to target office workers to 
reduce desk-based sedentary behaviour. However, it has been shown in the literature that 
utilising the self-regulatory behaviour change technique of self-monitoring could be a 
promising avenue to decreasing sedentary behaviour. The boom in commercially available 
behavioural trackers provides a unique opportunity to utilise these devices to both accurately 
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and objectively measure sedentary behaviour and also to utilise them as an intervention 
modality for reducing sedentary behaviour as they inherently allow their users to self-monitor 
and receive feedback on behaviour.  
2.9 Aims 
Therefore the aim of this thesis is to identify and validate technology that can self-monitor 
sedentary behaviour and to determine its ability to reduce sedentary behaviour. 
2.9.1 Aim of Study 1 
The purpose of this study was to, by way of a systematic review, scope the current 
technologies that could be used to self-monitor and provide feedback on time spent in 
physical activity and/or sedentary behaviours. Secondly, the study aimed to quantify the level 
of self-monitoring and feedback attributes of these technologies.  
2.9.2 Aim of Study 2 
From the systematic review, a technology was chosen based on its ability to self-monitor and 
provide feedback on sedentary behaviour. The purpose of this study, therefore, was to 
determine the validity and reliability of the LumoBack Posture Sensor (LumoBody Tech, Inc, 
Palo Alto, CA) as a measure of sedentary behaviour under both laboratory and free living 
conditions. 
2.9.3 Aim of Study 3 
Having determined the validity of the LumoBack in Study Two, the LumoBack was 
repurposed to be a device that provides feedback (in the form of prompts/cues) on time spent 
sedentary. The aims of this study therefore were: 
1. To determine whether a repurposed LumoBack Posture Sensor can reduce sedentary 
behaviour in a sample of healthy adults over the course of five weeks.  
2. To quantify the engagement of the participants with the technology determined by 
time engaging with the mobile application associated with the LumoBack.  
In an attempt to understand potentially why individuals engaged with the intervention, 
investigation of health outcome data was also determined to quantify to whether those with 
the “most to gain” (health-wise) were more engaged. 
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This study has been published as an original article in a peer-reviewed journal (Sanders, J. P., 
Loveday, A., Pearson, N., Edwardson, C., Yates, T., Biddle, S. J., & Esliger, D. W. (2016). 
Devices for Self-Monitoring Sedentary Time or Physical Activity: A Scoping Review. 
Journal of Medical Internet Research, 18(5), e90). With the exception of some minor wording 
and/or format changes, it is presented in its published form. The introduction section below 
may repeat aspects of the literature review directly pertinent to the purpose of the study. 
 
JPS was involved in concept and design, acquisition of data, analysis and interpretation of 
data. Additionally JPS drafted the manuscript. AL was involved in the acquisition of data by 
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3.1 Introduction 
Modern environments and technological advancements have radically altered the way we live 
our lives (25). The need to undertake purposeful physical activity has all but disappeared and 
sedentary behaviour, defined as ‘any waking behaviour in a sitting or reclining posture with 
an energy expenditure ≤1.5 metabolic equivalent’ (43) is the dominant behaviour. Low levels 
of moderate to vigorous physical activity (MVPA) have been consistently associated with the 
risk of developing chronic diseases, such as type 2 diabetes, cardiovascular disease, and some 
cancers (242). In addition, increasing the total level of daily movement, such as the number 
of steps taken, has also been strongly inversely associated with the risk of developing chronic 
diseases (203,243). There is also mounting evidence that the amount of time spent sedentary 
is an important determinant of health status independent of physical activity levels. For 
example, Wilmot and colleagues (28) found that when comparing those with the highest 
levels of sedentary behaviour with the lowest, independent of physical activity levels, there 
was a 112%, 147%, 90% and 49% increase in the relative risk of type 2 diabetes, 
cardiovascular disease, cardiovascular mortality and all-cause mortality, respectively (28). 
Moreover, how sedentary behaviour and physical activity are accumulated throughout the day 
may also be important, with frequent breaks to sedentary behaviour associated with a 
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healthier metabolic profile (74). This has necessitated a paradigm shift, which focuses on 
both the accumulation of MVPA (the traditional focus of lifestyle interventions), and the 
importance of postural allocation throughout the waking hours.  
 
Over the last decade, there has been a plethora of tools that have been developed to support 
sedentary behaviour and physical activity behaviour change, of which the greatest growth has 
been seen in self-monitoring tools. Self-monitoring, defined as ‘a person closely and 
deliberately monitors their own behaviour’ (209,216) and ‘allowing the modification of their 
behaviours to achieve predetermined goals or outcomes’ (244), for behaviour change has a 
strong theoretical foundation. Self-regulation theory posits that self-monitoring precedes self-
evaluation of progress made towards one’s goal and self-reinforcement for progress to be 
made (216)10T.10T Furthermore, Control Theory proposes that self-monitoring of behaviour, setting 
goals, receiving feedback, and reviewing relevant goals in the light of feedback work 
synergistically and are central to self-management and behavioural control (42,212). Self-
monitoring, therefore, can increase an individual’s personal responsibility, promote 
independence and, by taking an active rather than physical activity passive role, individuals 
can create their own pathways towards goal achievement (245). When included in behaviour 
change interventions, self-monitoring has proven to be an effective behaviour change strategy 
across a variety of behaviours including smoking, diet and physical activityP Pand as such is 
considered a foundation of lifestyle behaviour change interventions (42,246).  
 
Traditionally, self-monitoring of physical activity and sedentary behaviour occurred via paper 
based journal methods (246); however, more recently the pedometer became a popular 
method of self-monitoring for interventions designed to increase physical activity with 
individuals who used pedometers increasing their physical activity by 26.9% from baseline 
(211). Subsequently, advances in technology have led to an explosion of bodily worn 
electronic devices becoming available that go beyond simply measuring and providing 
feedback on the number of steps per day (e.g., Fitbit, Jawbone). Along with physical activity, 
electronic devices are also starting to measure sitting time, providing real-time feedback, as 
well as encouraging interruptions in prolonged sitting. It has been suggested that the use of 
these electronic approaches to self-monitor might lessen the burden of traditional methods 
and may improve adherence to self-monitoring and thus result in greater achievement 
towards behavioural goals (247).  
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This increased availability of electronic self-monitoring devices provides an opportunity for 
researchers to utilise these novel technologies as an aid for behaviour change in physical 
activity and sedentary behaviour on a large scale. Furthermore, wearable technologies are 
increasingly being integrated into healthcare systems. Recent reports from the National 
Information Board in a review of the National Health Service in the United Kingdom (UK) 
indicate the need for “citizens” to start playing a more active role in their healthcare, by 
accessing, entering and uploading data into their own online medical record. Under these new 
plans citizens will be able to access and download their detailed GP records as well as 
contributing to it with information held by their personal wearable technology or biosensors 
(248,249). In addition, as more health care providers in the United States move to a value-
based care system (i.e., “reward points” for positive lifestyle alterations which can be 
redeemed for discounts on a range of products and/or activities) mobile technologies that 
promote health and well-being by engaging in important health behaviours (e.g., increased 
MVPA) will continue to grow and have the potential to be an integral piece of future health 
care systems. In light of this, a review of the current tools used to self-monitor physical 
activity and/or sedentary time has the potential to be a valuable resource to researchers, 
clinicians, healthcare providers and the general public. 
 
Therefore, it seems timely to review the characteristics and measurement properties (e.g., 
wear location, integrated sensors, outcomes measured), of currently available self-monitoring 
devices, both consumer marketed and those used in research settings, that have been (or could 
be) utilised in, or developed for, real time self-monitoring of sedentary behaviour and/or 
physical activity.  
3.2 Methods 
3.2.1 Searches 
The search strategy was built around three groups of key words: behaviour (i.e. physical 
activity and sedentary behaviour), measurement, and population. A detailed description of the 
keywords used and method of combination can be found in Appendix 1.1 (page 211). For the 
purposes of this study, tools were deemed to measure sedentary behaviour if they could 
measure the users sitting and/or reclining posture. Scopus, MedLINE, Web of Science and 
Institute of Electrical and Electronic Engineers (IEEE) databases were searched using these 
key terms from the inception of the databases to October 1, 2015. In addition, manual 
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searches of personal files were conducted as were screening of reference lists of primary 
studies. 
 
3.2.2 Internet Search Engines 
Due to the rapid release of technology in the consumer electronic (CE) area, a grey literature 
search of relevant websites was conducted for technologies that allow the self-monitoring of 
physical activity and sedentary behaviour but may not have made it into the published 
research to date. Keywords based on the same groups as the database searches were used to 
search the internet engines Google, Bing and Yahoo. Searches were extracted for later review 
using a specialised browser plug-in [SEOquake (35TUwww.seoquake.co.ukU35T) a browser plugin 
software providing the search engine optimisation metrics]. The first 200 search results from 
each search engine were extracted for further review; this was a pragmatic approach as it was 
deemed that results after the first 200 were either not relevant (i.e. did not meet 
inclusion/exclusion criteria) or were repetitive. This ensured that the results were unaffected 
by the changing algorithms of web search engines. Searches were completed on October 1, 
2015. 
3.2.3 Study Inclusion and Exclusion criteria 
Two sets of inclusion criteria were developed for research articles and websites. For inclusion 
in the review, studies were required to i) include adults aged ≥ 18 years; ii) be published in 
English; iii) describe a device that objectively self-monitors physical activity, physical 
inactivity and/or sedentary behaviour/sitting and can, or has the potential to, provide feedback 
to the user. Traditionally, there would also be a criteria based around study type; however, in 
order to obtain the widest variety of device, this wasn't included. 
  
For inclusion in the review, i) websites from manufacturers were included only, therefore 
blogs or consumer review pertaining to technologies of interest were excluded and ii) devices 
that had the ability to self-monitor and were available to purchase at the time of the review 
were included.  
3.2.4 Data Extraction 
Potentially relevant articles were selected by i) screening titles, ii) screening abstracts, and iii) 
if abstracts were not available or did not provide sufficient data, the entire article was sought 
and screened to determine whether it met the inclusion criteria. Relevant websites were 
selected by i) screening web page titles and ii) screening devices on relevant web pages to 
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determine whether it met the inclusion criteria. Data were extracted on standardised forms 
developed for this review. 
 
Information on the devices was extracted from papers and cross-referenced with device 
manufacturer information. Validity data on each device was not extracted, instead papers 
with relevant validity data, where available (151,153,158,168,170,171,176,177,181,250–260), 
have been referenced in the data table as the authors chose to focus this review on the 
characteristics of the devices to allow the reader to make a judgement about their efficacy as 
self-monitoring tools. 
 
A 10% sub-sample of potentially relevant articles retrieved for full paper screening were 
extracted by a second author (AL) to determine inter-rater agreement. Inter-rater agreement 
was high (Cohen’s Kappa = 0.81). If any discrepancies arose, these were resolved by 
discussion between authors. 
3.2.5 Self-monitor Scoring  
Each device was designated a self-monitoring code;  
• YRPA R: Yes – Self-monitors Physical Activity; 
• YRPIR: Yes – Self-monitors Physical Activity/Physical Inactivity (i.e self-monitoring 
and feedback on lack of movement); 
• YRSBR: Yes – Self-monitors Sedentary behaviour. 
The different attributes of the self-monitoring devices were based on Control Theory (212), 
specifically the ability to receive feedback (defined as the provision of informative and 
actionable insights on the performance of the behaviour) and the ability to set goals (defined 
as agreeing on a goal/target defined in terms of the behaviour to be achieved, (209). Aspects 
included the different types of feedback; vibratory, auditory, omnipresent - in the form of 
colours or lights - or potentially via push notifications. Also included, was the timing of the 
feedback (i.e., immediate or delayed). Other features included the way in which the data are 
portrayed (e.g., numeric data/graphical representation of the data). Additionally the platform 
pervasiveness was also included (i.e., how many different devices can the data be viewed on 
and on what operating systems). Each of these aspects were broken in to what feedback 
attributes were available on either the device or the backend platform (defined as the smart 
device/software that the technology connects to). Other attributes included were goal setting 
capability of the device and whether the device or associated software could be customised  
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by the end user via some method, usually an application programming interface or software 
development kits. Table 3.1 provides a detailed description of each self-monitoring attribute. 
Each attribute is split into whether the attribute is present on the device itself (denoted as a 
D_ ) or whether it is present on the backend platform (i.e. smartphone/tablet etc; denoted with 
BP_). 
 
Each device was given a score between 1 and 6 for each attribute of behaviour change. This 
score was used to describe two factors i) whether or not that device contains that behaviour 
change attribute and ii) to what extent it does or does not contain the attribute. Below is the 
self-monitoring scoring system that has been used for each attribute; 
1) Yes  
2) Yes – Difficulties (e.g. proximity to computer) 
3) Yes – Lack of evidence to suggest this 
4) No – But present in future iterations  
5) No – But possible (with Application Programming Interface or Software 
Development Kit) 
6) Not described/Not featured 
This scoring system is meant to be a descriptive tally of the behaviour change attributes and 
not a judgement on the effectiveness of the various features.  
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Table 3.1 - Description of the self-monitoring attributes coded 
Self-
monitoring 
Attribute 
Description 
Auditory Feedback on behaviour provided verbally from device (e.g. via Sensoria – 
voice over feedback regarding ground contact from smartphone/smart 
mp3). 
Vibratory Haptic feedback on pre-determined behavioural thresholds provided using 
vibrations (e.g. LumoBack) 
Omnipresent Feedback that is visible all the time, usually in the form of a changing 
progression bar which changes with advancement towards pre-determined 
goals (e.g. FitBit Flower) 
Push 
Notification 
The delivery of information regarding behavioural goals from a software 
application to a computing device without a specific request from the user. 
Immediate Whether the data/feedback are immediate in its return to the user (e.g. 
LumoBack). 
Delayed Whether the data/feedback are delayed in its return to the user (e.g. 
ActiGraph). 
Numeric Data are returned in the form of numbers/figures or statistics.  
Graph Data are returned in the form of graphical representation. 
Written/Text 
Feedback 
Data are returned in the form of textual feedback. 
‘Ometer  Data are returned in the form of a growing or shrinking picture/image 
based upon completion towards a pre-determined goal (e.g. UbiFit 
Garden). 
Application What Operating System the mobile application can it be accessed on for 
viewing the data/feedback. 
Software If a piece of computing software is present for use at viewing the data – 
what operating system can it be accessed on.  
Website Can the data/feedback be view on a website? 
Goal Setting 
Capability  
Can pre-determined goals be set by the user? 
3.3 Results  
3.3.1 Review Statistics 
Database searches identified 49,956 articles (Figure 3.1), of which 462 were deemed to be 
potentially relevant and thus retrieved for full text analysis. Papers (n=337) were excluded for 
a number of reasons: 
1) Pedometer Studies: Pedometer studies were excluded if no evidence could be found 
that the pedometer in question provided temporally stamped data;  
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2) Prototypes: that were not commercially available or where no data currently existed 
for the prototype and only proof of concept information was available;  
3) Health Outcome: papers were excluded if they examined the relationship between 
behaviour (e.g. sedentary behaviour and/or physical activity) and a particular health 
outcome (e.g. blood pressure, lipid profile) and the measurement tool of choice was 
not the main focus of the paper; 
4) Miscellaneous: articles were excluded if the purpose of the study was to examine a 
new algorithm or data processing procedure for device analysis. 
The remaining 125 studies (on 46 devices) and 90 websites yielded 146 devices (see 
supplementary table 1 http://www.jmir.org/2016/5/e90/) that were then selected for detailed 
scrutiny. Of these 64 were further removed because there was no evidence that they were 
designed for, have been used in, or could readily be modified for real-time self-monitoring 
purposes or that they are not currently available for purchase (see supplementary Table 2 
http://www.jmir.org/2016/5/e90/). 
 
The remaining 82 (261–341) technologies were included in this review. Seventy three (261–
332) technologies measured/self-monitored physical activity, of which 16 
(265,267,277,278,280,284–288,303,308,312,313,316,325,329–331) provided some measure 
of physical inactivity (see Table 3.2 and 3.4). Nine (333–341) technologies measured self-
monitored sedentary behaviour. (see Table 3.3 and 3.5), 8 (333,334,336–341) of which 
measured both physical activity and sedentary behaviour. Figure 3.2 (page 78) displays the 
number of self-monitoring attributes apparent in each of the devices found to measure/self-
monitor physical activity. Figure 3.3 (page 79) documents the popularity of the self-
monitoring attribute. Figure 3.4 (page 80) displays the number of self-monitoring attributes 
apparent in each of the devices found to measure/self-monitor sedentary behaviour. Figure 
3.5 (page 80) documents the popularity of the self-monitoring attributes with sedentary time 
self-monitoring devices. 
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Figure 3.1 – Study/website selection 
 
Database searches yielded articles (n=49,956) 
1. MedLINE = 17,840 
2. Scopus = 22,923 
3. Web of Science = 4,971 
4. Institute of Electrical and Electronics Engineers = 4,222 
 
Identified articles from database search (n=2,159) 
Excluded based on abstract 
(n=1,697) 
Full text articles retrieved for eligibility (n=462) 
Excluded – did not fulfil the 
inclusion criteria (n=337) 
1. Pedometers (n=48) 
2. Prototypes (n=35) 
3. Health Outcomes (n=48) 
4. Miscellaneous (New 
algorithm etc.; (n=206) 
Articles in systematic review (n=125) 
Included website (n= 90) 
Total papers/websites included in systematic review (n=215) 
Removed based on title eligibility 
(n=47,797) 
Duplicates (n= 2374) 
 
Yielding 146 unique devices 
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Name Manufacturer Size Weight Battery Life 
Placemen
t 
Sampling 
rate / 
Epoch 
Length 
Data 
Storage Sensor Interface Wireless 
Software 
for Data 
Processing  
SDK Outcome (Calculated) 
Self-
Monitoring Cost* Reference  
ActiGraph 
Link  
ActiGraph 
LLC, 
Pensacola, FL 
3.5 x 3.5 x 
1cm 14g 
14 days 
(wireless 
disabled, 
30Hz 
sample 
rate, gyro 
disabled, 
sleep 
mode) 
wrist, 
waist 
30-
100Hz 
240 
days/ 
4GB 
Triaxial 
Accelerometer, 
Gyroscope, 
Magnetometer 
USB Yes, BLE 
Actilife 
Software/ 
ActiLife 
Mobile 
Application 
No 
Energy 
Expenditure, 
activity 
intensity level, 
body position 
and amount of 
sleep 
YPA $275 (261) 
ActiGraph 
wGT3X+ 
BT 
ActiGraph 
LLC, 
Pensacola, FL 
4.6 x 3.3 x 
1.5cm 19g 
25 days 
(wireless 
disabled, 
30 Hz 
sample 
rate) 
Ankle, 
Waist, 
thigh or 
wrist 
30-
100Hz 
120 
days at 
30Hz 
Triaxial 
Accelerometer, 
Ambient Light 
Photodiode 
and 
inclinometer 
USB Yes, BLE 
Actilife 
Software/ 
ActiLife 
Mobile 
Application 
No 
Energy 
Expenditure, 
activity 
intensity level, 
body position 
and amount of 
sleep 
YPA $225. (262) 
Adidas Fit 
Smart  
Adidas 
International 
Trading  
3.4 x 1.2 x 
(1.8 or 2.0)cm  
47 - 
50g 5 days Wrist ? 
up to 10 
hours 
workout 
data  
Accelerometer, 
Mio 
Continuous 
optical heart 
rate  
USB  Yes, BLE 
Adidas 
MiCoach 
train and 
run app 
No 
Heart rate, 
calories, 
pace/speed, 
distance and 
stride rate 
YPA £145 (263) 
Amiigo Amiigo, Inc. 
One size – 
Micro 
Adjustable 
? 3 days Wrist and  shoe clip ? 6 days 
Triaxial 
Accelerometer, 
pulse oximeter, 
temperature 
sensor 
BLE  Yes, BLE Amiigo App No 
Activity 
Recognition, 
resting heart 
rate, calories 
burned, step 
counting, 
exercise 
tracking, sleep 
tracking. 
YPA $179 (264) 
                 
Table 3.2 - Devices that self-monitor physical activity 
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Apple 
Watch  
Apple Inc., 
Cupertino, 
CA, USA 
two case sizes 
heights 3.8 or 
4.2 cm  
? ? Wrist  ? ? 
Triaxial 
Accelerometer, 
GPS, Heart 
Rate Sensor 
Lightening 
USB Yes, BLE Apple iOS No 
Total Body 
Activity, step 
counting, 
calories burned, 
numbers of 
times stand up 
YPI £215 (265) 
Archos 
Activity 
Monitor 
ARCHOS  5.9 x 2.9 x 1.0 8g 7 days Wrist 1 Min 7 days 
Triaxial 
Accelerometer USB Yes, BLE 
ARCHOS 
Connected 
Self App 
No 
Steps, calories 
burned, walking 
distance  
YPA £50 (266) 
Basis Peak  
BASIS 
Science, Inc., 
San 
Francisco, 
CA 
? ? 4 days  Wrist  ? ? 
Triaxial 
Accelerometer, 
Optical Heart 
Rate Sensor, 
Galvanic Skin 
Response, and 
Skin 
Temperature 
Wireless 
sync Yes, BLE 
Basis - 
Fitness, 
Sleep and 
Stress 
tracker 
No 
Steps, Calories 
Burned, Heart 
Rate, 
Perspiration, 
Skin 
Temperature 
YPI $200 (267) 
Bowflex 
Boost 
Nautilus, Inc. 
Vancouver 
WA 
? ? 11 days Wrist ? 11 days Triaxial Accelerometer No Yes, BLE 
Bowflex 
Boost App No 
Activity Level, 
Calories, 
distance, steps 
and sleep 
YPA £83 (268) 
Epson 
Pulsense 
100 
Wristband  
Epson 
America, Inc. ? ? ? Wrist ? 20 days  
Triaxial 
Accelerometer, 
Heart rate 
Monitor 
USB Yes, BLE 
Pulsense 
Mobile 
App and 
Website 
Yes 
Heart rate zone, 
steps, calories 
burned, sleep 
patterns  
YPA $129 (269) 
Epson 
Pulsense 
500 watch  
Epson 
America, Inc. ? ? ? Wrist ? ? 
Accelerometer, 
Heart rate 
Monitor 
? Yes, BLE 
Pulsense 
Mobile 
App and 
Website 
Yes 
Heart rate zone, 
steps, calories 
burned, sleep 
patterns  
YPA $199 (269) 
Fitbit 
Charge Fitbit UK 
14 - 23.1 cm 
in 
circumference 
? 7 days  Wrist 60 seconds 7 days 
Triaxial 
Accelerometer ? Yes, BLE Fitbit App No 
Steps taken, 
distance 
travelled, 
calories burned, 
floors climbed 
and active 
minutes. 
YPA £100 (270) 
Fitbit Flex  
Fitbit, Inc. 
San 
Francisco, 
CA 
14 - 20.9 cm 
circumference 
- 1.3cm width  
? 5 days Wrist  60 seconds 30 days  
Triaxial 
Accelerometer 
Wireless 
Sync 
Dongle 
Yes, BLE 
Fitbit Flex 
App  and 
Fitbit 
Website  
No  
Calories 
Burned, 
distance travels, 
steps, and sleep 
quality. 
YPA £80 
(146,159,1
64,165, 
169,252) 
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Fitbit One 
Fitbit, Inc. 
San 
Francisco, 
CA 
4.8 x 1.9 x 
9.6cm  8g 
10-14 
days 
Waist, 
wrist 
60 
seconds 
7 Days 
@1min 
epoch                                                            
23 days  
overall 
data 
Triaxial 
Accelerometer 
and Altimeter 
USB Yes, BLE Fitbit App No 
Steps, Distance, 
Calories 
Burned, and 
Floors Climbed. 
YPA £80 (156,158, 163,253) 
Fitbit 
Surge  Fitbit UK 
15 - 23.1 cm 
in 
circumference 
? 7 days Wrist 60 seconds 7 days 
Triaxial 
accelerometer, 
Triaxial 
gyroscope, 
Optical Heart 
rate monitor, 
digital 
compass, 
altimeter, 
ambient light 
sensor, 
vibration 
motor  
? Yes, BLE Fitbit App No 
Steps taken, 
distance 
travelled, 
calories burned, 
floors climbed 
and active 
minutes, heart 
rate, GPS 
tracking, multi-
sport tracking, 
sleep tracking 
YPA £200 (273) 
Fitbug 
Orb  Fitbug Ltd  5 x 5 x 5 cm ? 4 months  
Anywher
e ? ? Accelerometer 
Wireless 
Sync  Yes, BLE 
Fitbug 
Activity 
App and 
Fitbug 
website 
No 
Calories burned, 
total activity, 
total steps, 
aerobic steps  
YPA $50 (274) 
FlyFit  FlyFit, Inc.  2.9 x 1.7 x 1.0cm <100g 
5-7 days 
with off-
sync 
mode or 
8 hours 
with real-
time sync 
Ankle ? ? Triaxial Accelerometer ? Yes, BLE 
FlyFit 
Mobile 
App 
No 
Steps, step 
speed, step 
distance, stairs 
climbed, 
calories burned, 
bike distance, 
bike speed,  
YPA 
$199 - 
pre order 
price 
(275) 
Free Wavz  Free Wavz ? 16g 6-8 hours 
Ear-
phone/pl
ug 
? ? 
Triaxial 
Accelerometer, 
Infra-red and 
red pulse 
oximeter 
? Yes, BLE 
Free Wavz 
Mobile 
App 
No 
Step, Heart 
Rate, O2 
saturation, 
average speed, 
distance, and 
calories burned. 
YPA $219 (276) 
Garmin 
VivoFit Garmin Ltd 12-21cm 25.5g 
1 year or 
greater Wrist ? 1Month ? USB Yes, BLE 
Garmin 
Connect 
App 
No 
Daily Step 
Count, goal 
countdown, 
distance, 
calories, heart 
rate and heart 
rate zone. 
YPI £100 (277) 
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Garmin 
Vivo 
Smart 
Garmin Ltd 12.7 to 22.1 circumference 
18.7 - 
19.0g 7 days Wrist ? 
3 weeks 
of 24/7 
activity 
data or 2 
weeks if 
heart 
rate 
monitor 
is used 1 
hour per 
day  
Accelerometer 
and Heart Rate 
Monitor 
(optional) 
Wireless 
Sync  Yes, BLE 
Garmin 
Connect 
App and 
Garmin on 
Computer 
No 
Step Counts, 
calories and 
distance  
YPI $170-200 (278) 
GoBe 
Activity 
Monitor 
HealBe 
GoBE ? ? 3 days  Wrist  ? ? 
Triaxial 
Accelerometer, 
heart rate 
sensor, and 
impedance 
sensor 
Wireless 
Sync Yes, BLE 
GoBe Body 
Manager 
Mobile 
App 
No 
Calorie Intake, 
Calories 
Burned, 
Hydration 
Levels, Heart 
Rate, Blood 
Pressure, Stress 
Levels, 
Distance 
Travelled. 
YPA $300 (279) 
GOQii 
Band  GOQii ? ? 4-5 days Wrist ? ? Accelerometer 
Wireless 
Sync  Yes, BLE 
GOQii 
Mobile 
App 
No 
Steps, distance 
travelled, 
calories burned, 
time spent 
active, sleep 
quality  
YPI £70 (280) 
Hexoskin 
Hexoskin, 
Montreal, 
Quebec. 
Shirt Size 41g 14 hours Shirt 64Hz 157 hours 
3 x heart rate 
sensor, 2 x 
breathing rate 
sensors, 
Triaxial 
accelerometer 
USB Yes, BLE Hexoskin App No 
Heart rate, 
Heart Rate 
Variability, 
Breathing Rate, 
Breathing 
Volume, Steps, 
cadence and 
calories burned, 
sleep. 
YPA $400 (281) 
iBitz GeoPalz, LLC, CO 
4.8 x 3.0 x 
2.0cm ? ? 
Waist or 
shoe 60sec 30 days 
Triaxial 
Accelerometer BLE  Yes, BLE 
iBitz Unity 
App No 
Steps, calorie 
burned, 
distance, 
average speed 
YPA £20 (282) 
iHealth 
Wireless 
Activity 
and Sleep 
Tracker 
iHealth Lab 
Inc. ? ? 5-7 days  
Wrist, 
Waist 
60 
seconds 14 days Accelerometer 
Wireless 
Sync Yes, BLE 
iHealth 
MyVitals 
App 
No 
Steps, calories 
burned and 
distance 
travelled  
YPA $60 (283) 
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Jawbone 
UP 
JAWBONE, 
San 
Francisco, 
CA 
14 – 20cm in 
circumference  19-23g 10 days Wrist ? 10 Days 
Triaxial 
Accelerometer 
3.5mm 
headphone 
port 
No 
UP by 
Jawbone 
App 
No 
Distance, 
calories burned, 
active time, and 
active intensity 
YPI £65 (156,163, 265) 
Jawbone 
UP2 
JAWBONE, 
San 
Francisco, 
CA 
22 x 1.15 x 
0.3-0.85 cm  25g 10 days  Wrist ? 
9 
Months 
Triaxial 
Accelerometer USB Yes, BLE 
UP by 
Jawbone 
App 
No 
Steps, exercise 
and calories 
burned, sleep 
tracking, food 
logging 
YPI £90 (285) 
Jawbone 
UP24 
JAWBONE, 
San 
Francisco, 
CA 
small - 5.2 x 
3.5cm, 
Medium - 6.3 
x 4.0, Large - 
6.9 x 4.3 
19g, 
22g, or 
23g 
14 days Wrist ? ? Triaxial Accelerometer USB Yes, BLE 
UP by 
Jawbone 
App 
No 
Steps, Activity 
Classification, 
Calories 
Burned. 
YPA £130 (164,165, 267) 
Jawbone 
UP3 
JAWBONE, 
San 
Francisco, 
CA 
22 x 1.15 x 
0.3-0.85 cm  29g 7 days  Wrist ? 
9 
Months 
Triaxial 
Accelerometer, 
heart rate 
sensor, 
respiration and 
galvanic skin 
response 
sensors 
Magnetic 
USB Yes, BLE 
UP by 
Jawbone 
App 
No 
Steps, exercise 
and calories 
burned, sleep 
tracking, food 
logging, heart 
rate.   
YPI £130 (287) 
Jawbone 
UP4 
JAWBONE, 
San 
Francisco, 
CA 
22 x 1.15 x 
0.3-0.85 cm  29g 7 days  Wrist ? 
9 
Months 
Triaxial 
Accelerometer, 
heart rate 
sensor, 
respiration and 
galvanic skin 
response 
sensors 
Magnetic 
USB Yes, BLE 
UP by 
Jawbone 
App 
No 
Steps, exercise 
and calories 
burned, sleep 
tracking, food 
logging, heart 
rate.   
YPI $200 (288) 
Ki Fit  Ki Performance  
6.2 x 5.5 x 
1.3cm unit + 
4 cm diameter 
Ki Fit Display 
45.5g 5-7 days 
Upper 
Arm 
Armband 
+ Wrist  
? 14 days 
Triaxial 
Accelerometer, 
Heat Flux 
sensor, Skin 
Temperature 
sensor,  
Galvanic skin 
response 
sensor 
USB Yes, BLE  
BodyMedia 
App and 
Online 
Activity 
Manager 
No  
Tracks calories 
burned, 
moderate and 
vigorous 
activity, steps, 
sleep, and goals 
YPA 
£269 + 
£60 for 
display 
(289) 
LEO  Gesture Logic  3.7cm in diameter ? ? Thigh ? 
2GB of 
flash 
memory  
Triaxial 
Accelerometer, 
Bioimpedence, 
Heart Rate 
Sensor, Muscle 
Tracking 
sensor 
Wireless 
Sync Yes, BLE 
LeoHelps 
Mobile 
App 
No 
Steps, Calories 
Burned, Heart 
Rate, Activity 
Recognition, 
Cadence, 
Muscle 
Monitoring, 
Hydration 
Levels, Lactic 
YPA $299 (290) 
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Acid Levels. 
LG 
Activity 
Tracker 
LG 
Electronics, 
18 x 1.7 x 
1.0cm 45g 2-3 days Wrist ? ? 
Triaxial 
Accelerometer, 
Altimeter 
? Yes, BLE LG Fitness App No 
Steps, Distance, 
Speed, Calories, 
pace and 
elevation.  
YPA $150 (291) 
LifeBeam 
Hat LifeBEAM ? ? ? Head  ? ? 
Triaxial 
Accelerometer, 
optical Heart 
rate sensor 
Wireless 
Sync 
Yes, BLE 
& ANT+ 
Compatible 
with a 
number of 
Health and 
Fitness 
Apps 
No 
Calories 
Burned, 
Cadence and 
steps, Heart 
Rate 
measurement  
YPA $99 (292) 
LifeTrak 
Core C200 Salutron Inc.,  
Watch head 
size - 5.3 x 
2.8, Strap 
length - 
21.7cm 
? 1 year  Wrist ? 
7 days 
of 
hourly 
data 
Accelerometer 
and Heart Rate 
Monitor 
(optional) 
? ? ? No 
Steps, heart 
rate, calories 
burned, 
distance. 
YPA $59.99 (293) 
LifeTrak 
Core C210 Salutron Inc.,  
Watch head 
size - 5.3 x 
2.8, Strap 
length - 
21.7cm 
? 1 year Wrist ? 
7 days 
of 
hourly 
data 
Accelerometer 
and Heart Rate 
Monitor 
(optional) 
? ? ? No 
Steps, heart 
rate, calories 
burned, 
distance, sleep 
tracking 
YPA $70 (294) 
LifeTrak 
Move 
C300 
Salutron Inc.,  ? ? 1 year Wrist ? 7 days 
Triaxial 
Accelerometer 
and Optical 
Heart Rate 
Sensor 
USB Yes, BLE 
LifeTrak 
App and 
Compatible 
with many 
different 
Health and 
Fitness 
Apps 
No 
Steps, calories 
distance and 
heart rate 
YPA $80 (295) 
LifeTrak 
Zone C410 Salutron Inc.,  
Watch head 
size - 5.3 x 
3.0, Strap 
length - 
21.7cm 
? 1 year Wrist ? 
7 days 
of 
hourly 
data 
Accelerometer 
and Heart Rate 
Monitor 
(optional) 
? Yes, BLE LifeTrak App No 
Steps, heart 
rate, calories 
burned, 
distance, sleep 
tracking 
YPA $100 (296) 
LUMOlift  
LUMO Body 
Tech, Inc., 
Palo Alto, Ca 
4.45 x 2.5 x 
1.2cm 11.5g 5 days  Chest ? 4 weeks 
Triaxial 
Accelerometer 
Wireless 
Sync  Yes, BLE 
LUMOlift 
App No 
Calories 
Burned, Steps, 
Sitting and 
Standing 
Postures  
YPI $100 (297) 
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Magellan 
EchoFit 
MiTac Int 
Corp 
4.6 x 4.9 x 
1.3cm  44g 
6 - 11 
months Wrist ? ? 
Accelerometer 
and Heart Rate 
Monitor 
(Optional) 
? Yes, BLE 
Echo 
Utility 
App, 
Compatible 
with a 
number of 
Health and 
Fitness 
Apps 
No 
Steps, distance , 
calories burned, 
sleep, elevation 
YPA $100 (298) 
Microsoft 
Band Microsoft  1.1 x 3.3cm ? 48 hours  Wrist  ? ? 
Optical Heart 
rate sensor, 
triaxial 
accelerometer, 
triaxial 
gyroscope, 
GPS, Ambient 
light sensor, 
Skin 
Temperature 
sensor, UV 
sensor, 
Capacitive 
sensor, 
Galvanic skin 
response. 
Magnetic 
USB Yes, BLE 
Microsoft 
Health No 
Heart Rate 
Monitor, steps, 
pace, calorie 
tracking, sleep 
tracking. 
YPA $200 (299) 
Misfit 
Flash 
Misfit 
Wearables 
San 
Francisco, 
CA 
2.85 x 0.8 x 
2.85 cm  6.0g 6 months  
Necklace
, Wrist, 
Waist, 
Shoe 
? 30 days Triaxial Accelerometer BLE  Yes, BLE Shine App No 
Step count, 
distance moved, 
calories 
expended, sleep 
quality and 
duration  
YPA $50 (300) 
Misfit 
Shine 
Misfit 
Wearables 
San 
Francisco, 
CA 
2.75 x 0.33 x 
2.75 cm 9.4g 6 months  
Necklace
, Wrist, 
Waist, 
Shoe 
? 30 days Triaxial Accelerometer BLE  Yes, BT Shine App No 
Step count, 
distance moved, 
calories 
expended, sleep 
quality and 
duration  
YPA $100 (156,164, 165,282) 
Moto 360  Motorola Mobility  
4.6 diameter 
x 1.1 height 
cm 
? 1 day  Wrist ? 
4GB 
internal 
storage 
+ 
512MB 
RAM 
Triaxial 
Accelerometer 
and Optical 
Heart Rate 
Sensor 
? Yes, BLE ? No Heart rate and steps YPA $250 (302) 
My 
Wellness 
Key 
Technogym 
Gambettola 
Italy 
8.5 x 2.0 x 
0.7cm 18.7g ? Waist 16Hz 30 days  
Uniaxial 
Accelerometer 
USB as part 
of the 
device 
No 
Online 
Activity 
Manager 
No 
Energy 
Expenditure and 
Activity 
intensity level 
YPI 
Price 
available 
on 
Request 
(252–
254,303) 
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New 
Balance 
Body 
TRNr 
New Balance,   ? ? ? Wrist  ? 30 days  Triaxial Accelerometer 
Wireless 
Sync Yes, BLE 
New 
Balance 
SmartTRNr 
No  Steps, distance, calories burned  YPA $60 (304) 
New 
Balance 
Life TRNr 
New Balance  ? ? ? Wrist  ? 7 days  
Triaxial 
accelerometer 
and Heart Rate 
Monitor 
Wireless 
Sync Yes, BLE 
New 
Balance 
SmartTRNr 
No  
Steps, distance, 
calories burned, 
heart rate 
YPA $80 (305) 
Nike+ 
Fuelband 
SE 
Nike  14.7 - 19.7cm 27 - 32g 4 days  Wrist ? ? 
Triaxial 
Accelerometer 
and ambient 
light sensor. 
USB Yes, BLE 
Nike+ 
Fuelband 
App 
No 
Nike fuel, steps, 
calories, 
distances, and 
time  
YPA £89 
(156,163–
165,241, 
287) 
Omate X Omate 4.5 x 4.1 x 1.12cm ? 7 days  Wrist ? 
128MB 
Internal 
Storage 
+ 32MB 
RAM 
Triaxial 
Accelerometer 
and Triaxial 
Gyroscopes 
USB Yes, BLE 
Compatible 
with a 
number of 
Health and 
Fitness 
Apps 
No Steps YPA $149 (307) 
PAM 
AM200 
Doorwerth, 
Netherlands 
5.8 x 4.2 x 
1.3cm 28g >1 year Waist 
1 second 
to 1 
minute 
3 
Months 
Uniaxial 
Accelerometer  
Micro -
USB No 
PAM 
Coach 
Computer 
Application 
No PAM Points YPI €79 (308) 
PAM 
AM300 
Doorwerth, 
Netherlands 
6.8 x 3.3 x 
1.0cm 20g >1 year Waist ? ? 
Triaxial 
Accelerometer 
Micro -
USB No 
PAM 
Coach 
computer 
and Mobile 
Application 
No 
physical activity 
score per day, 
number of 
minutes in three 
different 
intensity zones 
YPA €99 (309) 
Pavlok 
Behavioral 
Technology 
Group 
? few Oz 4 days Wrist  ? ? ? Micro -USB Yes, BLE 
Pavlok 
Mobile 
App 
No Activity and Sleep Tracking YPA $175 (310) 
Pebble Pebble Technology 
5.03 x 3.2 x 
0.8 cm 38g 7 days  
Wrist/ 
Bike 
handlebar 
? 7 Days 
Triaxial 
accelerometer 
and light 
sensor 
USB Yes, BLE Pebble App - 
Speed, Distance 
and Pace data, 
walking, 
running, biking 
and sleep.  
YPA $99 (311) 
Polar 
Loop  Polar Electro,  ? ? ? Wrist ? ? Accelerometer USB Yes, BLE 
Polar Flow 
app and 
Polar Flow 
Web 
Service  
No 
daily activity, 
calories burned, 
steps taken, 
YPI £85 (176,312) 
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Polar 
V800 Polar Electro,  ? ? ? Wrist ? ? 
Accelerometer 
and Heart Rate 
Monitor 
(optional), 
altimeter, 
barometer, 
GPS 
Custom 
USB Yes, BLE 
Polar Flow 
app a and 
Polar Flow 
Web 
Service  
No 
daily activity, 
calories burned, 
steps taken, 
distance and 
heart rate 
YPI £400 (313) 
Razer 
Nabu Razer. Inc. ? ? 7 days  Wrist ? ? 
Accelerometer 
and Altimeter USB Yes, BLE 
Fitness for 
Nabu app Yes 
Calories Burnt, 
Step Taken, 
Floors climb, 
distance 
travelled, hours 
slept 
YPA ? (314) 
Razr 
Nabu X Razer. Inc. ? ? 7 days  Wrist ? ? 
Accelerometer 
and Altimeter USB Yes, BLE 
Fitness for 
Nabu app Yes 
Calories Burnt, 
Step Taken, 
Floors climb, 
distance 
travelled, hours 
slept 
YPA ? (315) 
RT6 Stayhealthy  5.1 x 5.1 x 1.3cm 51g 
48hours 
@ 10Hz Waist 5-20Hz 
25-103 
hours 
Triaxial 
Accelerometer 
and Triaxial 
Gyroscopes 
USB No 
Stay 
Healthy 
Assist 
Software 
No Energy Expenditure YPI 
Price 
available 
on 
Request 
(316) 
Samsung 
Gear Fit  SAMSUNG 
2.3 x 5.7 x 
1.2cm 27g 3-5days  Wrist ? ? 
Accelerometer, 
Heart rate 
sensor, 
gyroscope 
? Yes, BLE 
On-board 
Samsung 
OS 
No  
Pedometer; 
Exercise; Sleep; 
Heart Rate;  
YPA $150 (317) 
Spree 
Hothead 
Technologies, 
Inc. 
? ? 
8 Hours 
@ non-
stop use 
Head  ? ? 
Triaxial 
Accelerometer, 
Optical Heart 
Rate sensor 
and 
temperature 
sensor 
? Yes, BLE Spree Apps No 
Body 
Temperature, 
Heart Rate, 
Movement  
YPA $199 (318) 
Stay 
healthy 
Activity 
Monitor  
StayHealthy  5.1 cm x 5.1 cm x 1.3 cm 51g 
14-20 
Days Waist  
10Hz 
6mins 
3.6 
years 
Triaxial 
Accelerometer USB  No 
Stay 
Healthy 
Assist 
Software 
No Energy Expenditure YPA 
Price 
available 
on 
Request 
(319) 
Striiv 
Band  Striiv, Inc.  ? ? 7 days  Wrist  ? ? Accelerometer  ? Yes, BLE Striiv App No 
Steps, Miles, 
Calories, 
Minutes of 
Activity 
YPA $70 (320) 
Striiv 
Fusion Striiv, Inc.  ? ? 5 days Wrist  ? ? 
Triaxial 
Accelerometer Micro USB BLE Striiv App No Steps, Calories Burned, sleep 
YPA $60 (321) 
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monitor 
Striiv 
Fusion Bio Striiv, Inc.  ? ? 5 days Wrist  ? ? 
Triaxial 
Accelerometer 
and optical 
heart rate 
monitor 
Micro USB BLE Striiv App  No 
Steps, Calories 
Burned, sleep 
monitor 
YPA $80  (322) 
Striiv 
Fusion 
Lite 
Striiv, Inc.  ? ? 5 days Wrist  ? ? Triaxial Accelerometer Micro USB BLE Striiv App No 
Steps, Calories 
Burned, sleep 
monitor 
YPA $100 (323) 
Striiv 
Touch  Striiv, Inc.  ? ? 5 days Wrist  ? ? Accelerometer ? Yes, BLE Striiv App No 
Steps, Miles, 
Calories, 
Minutes of 
Activity 
YPA $100 (168,324) 
Suunto 
Ambit3 
Amer Sports 
Company 
5.0 x 5.0 x 
1.7cm 92g 
2-3 days 
with GPS 
- 30 days 
in time 
mode 
Wrist  
Heart 
rate 10 
seconds, 
GPS 10 
seconds 
? Accelerometer, GPS USB Yes, BLE  
Suunto 
Moves 
count App 
No  
Steps, Heart 
rate, speed, pace 
and distance/ 
YPI £450 (325) 
Sync Burn  SYNC ? ? 1 year  Wrist  ? 7 days  Accelerometer Wireless Sync  Yes, BLE  
Map My 
Fitness 
Mobile 
App 
No  
Calories 
Burned, Heart 
Rate, % of Max 
HR, distance 
tracking, steps,  
YPA $38 (326) 
Sync Elite  SYNC ? ? 1 year  Wrist ? 30 days Accelerometer Wireless sync  
Head 
Phone 
Jack  
Map My 
Walk No 
Step tracking, 
distance, 
calories burned, 
activity time 
and fat burning, 
pace tracking, 
speed, auto 
stride length 
YPA $18 (327) 
Sync Fit  SYNC ? ? 1 year  Wrist  ? 7 days  Accelerometer ? ? ? No 
Calories 
Burned, Heart 
Rate, % of Max 
HR, distance 
tracking, steps,  
YPA £70 (328) 
TracmorD
/ Philips 
DirectLife 
Philips New 
Wellness 
Solutions 
3.2 x 3.2 x 
0.5cm 12.5g 3 weeks 
Lower 
Back or 
in pocket 
? 22 Weeks Triaxial USB No 
The 
DirectLife 
Program 
No 
Energy 
Expenditure, 
minutes spent 
walking, 
minutes spent 
running. 
YPI $199 (146,231, 232,310) 
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? = Unknown, Hz = Hertz, ANT+ - A proprietary wireless technology, Oz = Ounces, GPS = Global Positioning System, @ = at, SpO2 = Arterial Oxygen Saturation, BLE = Bluetooth low energy, 
USB = Universal Serial Bus YPAR R: Yes = Self-monitors Physical Activity. YPI: Yes = Self-monitors Physical Activity/Physical Inactivity (i.e self-monitoring and feedback on lack of movement). 
YSB: Yes = Self-monitors Sedentary behaviour. *Price has been rounded to the nearest Great British Pound, US Dollar or Euro. 
 
 
 
 
 
 
 
 
 
 
Vivago Vivago Wellness ? ? ? Wrist 
40Hz / 
1min ? 
Triaxial 
accelerometer USB ? ? No 
Energy 
Expenditure YPI €439 (258,330) 
Wello 
graph 
Wellograph 
Co., Ltd 
4.2 x 3.2 x 
1.25cm 55g 7 days  Wrist ? 
4 
months 
@ non-
stop use 
Tri-LED heart 
rate sensor, 9-
axis motion 
sensor 
Micro USB Yes, BLE 
The 
Wellograph 
App 
No 
Activity, BPM, 
Exercise, 
Fitness, Steps  
YPI $349 (331) 
Withings 
Pulse Withings, Fr 
4.3 x 2.2 x 
0.8cm 8g 2 weeks 
Waist, 
Wrist ? ? 
Triaxial 
Accelerometer 
and Optical 
Heart Rate 
Sensor and 
SpO2 sensor  
Micro-USB Yes, BT 
Withings 
Health 
Mate App 
No 
Steps taken, 
Floors Climbed, 
Distance 
travelled, 
Calories 
Burned, HR, 
Blood Oxygen 
level, Sleep 
quality and 
duration 
YPA £100 (156,165, 313) 
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3.3.2 Physical Activity Self-monitoring Technologies 
The device with the highest number of feedback attributes was the MicroSoft Band (299) 
with 18 of the 28 feedback possibilities that were coded. The most common feedback 
attribute used in the devices found was joint numeric and graphical data feedback on the 
associated backend platform, with 94% of the devices that self-monitor physical activity 
displaying these attributes. The least common form of feedback attribute was auditory 
feedback from the device (D_Auditory). This particular type of feedback was only present in 
2% of cases (Figure 2.4). 
3.3.3 Sedentary Time Self-monitoring Technologies 
The device with the highest number of feedback attributes was the LumoBack posture sensor 
and feedback coach (338) with 13 of the 28 feedback possibilities that were coded. The most 
common feedback attribute used in the devices found was joint numeric and graphical data 
feedback on the associated backend platform, with 81% of the devices that self-monitor 
sedentary time displaying these attributes. The least common form of feedback attribute was 
push notification of feedback from the device of sedentary time on the device. This particular 
type of feedback was present in none of the devices found. 
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Table 3.3 - Devices that self-monitor sedentary behaviour 
 
Name Manufacturer Size Weight Battery Life Placement 
Sampli
ng rate / 
Epoch 
Length 
Data 
Storage Sensor Interface Wireless 
Software 
for Data 
Processing  
SDK Outcome (Calculated) 
Self-
Monitoring *Cost  Reference 
Activ8 
VitaMove, 
Veldhoven, 
Netherlands 
3.4 x 
3.0 x 
1.0cm 
20g 50days 
Trouser 
Pocket or 
thigh 
using 
elastic 
strap 
12.5Hz 1-5days  Triaxial accelerometer USB No 
PC 
Application No 
Posture and 
movement 
recognition 
(lying, sitting, 
standing, 
walking, 
cycling, 
running) and 
energy 
expenditure 
YSB € 99 (333) 
ActivPAL 
VT 
PAL 
Technologies 
Ltd, Glasgow, 
UK 
5 x 
3.5 x 
0.7cm 
15g 10days 
Midline of 
the 
anterior 
aspect of 
the thigh 
20Hz (1 
second 
to 1 
min) 
16MB 
(10days) 
Triaxial 
accelerometer 
Micro 
USB No 
activPAL 
Software No 
Time spent in 
sitting/lying, 
upright and 
stepping 
activities, step 
counts, stepping 
cadence, 
activity score 
YSB £380 (139,141, 236–238,315) 
Darma Darma Inc. 
40 x 
40 x 
3cm 
? One Month  Seat ? 128MB 
Patented fibre 
optic sensors ? Yes, BLE 
Darma 
Mobile 
App 
No 
Posture, Time 
spent sitting 
Heart Beat, 
Respiration, 
Stress Level 
YSB $149 (342) 
Foot 
Logger  3L Labs  ? ? 
24 
hours Insole  ? 
50,000 
footprints 
Triaxial 
Accelerometer, 
pressure 
sensor, 
optional 
sensors 
available 
USB Yes, BLE  
LASIS - 
Life Log 
Acquisition 
and 
Analysis 
Service 
using 
Insole 
Sensor 
No  
Activity 
tracking, 
balancing 
assessment, 
failing accident, 
time spent, 
walking running 
sitting standing.  
YSB 
Price 
Available 
on Request 
(336) 
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Gruve 
Gruve 
Technologies, 
Inc., Anoka, 
MN. 
? ? ? Waist ? ? NEAT Activities 
Micro-
USB No 
Interactive 
Gruve 
Website 
No 
Sedentary Time 
(calculated from 
lack of 
movement), 
light intensity 
and moderate 
intensity 
physical activity 
and Energy 
Conservation 
Point 
YSB $180 (337) 
LumoBack 
LUMO Body 
Tech, Inc., 
Palo Alto, Ca 
4.15 x 
10 x 
0.8cm 
25g 5-7days 
Lower 
Back ? 
One 
month 
Posture 
Sensors and 
Triaxial 
accelerometer 
USB  Yes, BLE LumoBack App Yes 
Slouch vs. 
straight 
tracking, sit 
time vs. active 
tracking, stand 
up tracking, 
sleep position 
tracking 
YSB $70 (163,165, 324) 
Moticon 
OpenGo Moticon 
Shoe 
Insole  ? ? Insole  100Hz ? 
13 Pressure 
sensors, 
Triaxial 
Accelerometer, 
Temperature 
Sensor 
USB Yes, ANT  
Beaker 
Software  Yes  
Current 
Applications - 
Gait Analysis, 
motion analysis  
YSB 
Price 
Available 
on Request 
(344) 
OM 
Everyday OM Signal 
Under
Shirt ? 
2-3 
days  Shirt ? ? ? ? Yes, BLE 
OM Mobile 
App No 
Heart Rate, 
Breathing Rate, 
activity 
intensity, steps 
walked, calories 
burned and 
posture  
YSB $199 (340) 
Sensoria 
Fitness 
Heapsylon, 
Redmond, 
WA 
Sock 
of 
shoe 
size 
and 
anklet 
? ? Sock and Ankle ? 18 days 
Pressure 
Sensors (Sock) 
and Triaxial 
Accelerometer 
(Anklet) 
USB and 
BLE Yes, BT 
Sensoria 
App Yes 
Steps, speed, 
calories, 
altitude, 
distance, 
cadences, foot 
landing 
technique, and 
weight 
distribution of 
the foot 
YSB $199 (345) 
? = Unknown, Hz = Hertz, ANT+ - A proprietary wireless technology, Oz = Ounces, GPS = Global Positioning System, @ = at, SpO2 = Arterial Oxygen Saturation, BLE = Bluetooth low energy, 
USB = Universal Serial Bus YPAR R: Yes = Self-monitors Physical Activity. YPI: Yes = Self-monitors Physical Activity/Physical Inactivity (i.e self-monitoring and feedback on lack of movement). 
YSB: Yes = Self-monitors Sedentary behaviour. *Price has been rounded to the nearest Great British Pound, US Dollar or Euro. 
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Table 3.4 – Self-monitoring attributes of devices that measure physical activity 
 
Name Type Timing Feedback in Backend Platform Goal 
Setting 
Capabilities 
Device Backend platform Device Backend 
Platform 
Device Backend Platform 
A
ud
ito
ry
 
V
ib
ra
to
ry
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pr
es
en
t 
Pu
sh
 N
ot
ifi
ca
tio
n 
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ry
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t 
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sh
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Im
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n/
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‘O
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er
  
N
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G
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ph
 
W
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n/
Te
xt
 
Fe
ed
ba
ck
 
‘O
m
et
er
 
Application Software Website 
iO
S 
A
nd
ro
id
 
W
in
do
w
s 
M
ac
 
PC
 
ActiGraph 
Link 
6 6 1 6 6 6 2 6 1 6 1 1 1 6 6 6 1 1 6 6 6 6 6 1 1 6 6 
ActiGraph 
wGT3X+BT 
6 6 6 6 6 6 2 6 6 6 1 1 6 6 6 6 1 1 6 6 6 6 6 1 1 6 6 
Adidas Fit 
Smart 
6 6 1 6 6 6 1 6 1 1 1 1 1 6 6 6 1 1 6 6 1 1 6 6 6 1 1 
Amiigo 6 6 6 5 6 6 1 6 6 1 1 1 6 6 6 6 1 1 5 5 1 1 1 6 6 6 1 
Apple Watch 6 1 1 1 6 6 1 1 1 6 1 1 1 1 6 1 1 1 1 6 1 6 6 1 6 6 1 
Archos 
Activity 
Monitor 
6 6 1 6 6 6 1 6 1 1 1 1 1 6 6 6 1 1 6 6 1 1 6 6 6 6 1 
Basis Peak 6 6 1 4 6 6 1 4 1 6 1 1 1 1 1 6 1 1 1 6 1 1 6 6 6 6 1 
Bowflex 
Boost 
6 6 1 6 6 6 1 6 1 6 1 1 6 6 6 1 1 1 6 6 1 1 6 6 6 1 1 
Epson 
Pulsense 100 
Wristband 
6 6 1 1 6 6 1 6 1 6 1 1 6 6 6 1 1 1 6 6 1 4 6 6 6 1 1 
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Epson 
Pulsense 500 
watch 
6 6 1 6 6 6 1 6 1 6 1 1 6 6 6 1 1 1 6 6 1 4 6 6 6 1 1 
Fitbit Charge 6 6 1 6 6 6 1 6 1 6 1 1 6 6 6 1 1 1 6 6 1 1 6 6 6 1 1 
Fitbit Flex 6 6 1 6 6 6 1 6 1 6 1 1 6 6 6 1 1 1 6 6 1 1 6 6 6 1 1 
Fitbit One 6 6 1 6 6 6 1 6 1 1 1 1 1 6 6 1 1 1 6 6 1 1 6 6 6 1 1 
Fitbit Surge 6 6 1 6 6 6 1 6 1 6 1 1 1 1 6 6 1 1 6 6 1 1 1 6 6 1 1 
Fitbug Orb 6 6 6 6 6 6 1 6 6 6 1 1 6 6 6 6 1 1 6 1 1 1 6 6 6 1 1 
FlyFit 6 6 6 6 6 6 1 6 6 6 1 1 6 6 6 6 1 1 6 1 1 1 6 6 6 1 1 
Free Wavz 1 6 6 6 6 6 1 6 1 6 1 1 6 6 6 6 1 1 6 6 4 4 6 6 6 6 1 
Garmin 
VivoFit 
6 6 1 6 6 6 1 6 1 1 1 1 1 6 6 1 1 1 6 6 1 1 6 6 6 1 1 
Garmin 
VivoSmart 
6 6 1 6 6 6 1 6 1 1 1 1 1 6 6 1 1 1 6 6 1 1 6 6 6 1 1 
GoBe 
Activity 
Monitor 
6 6 6 6 6 6 6 6 6 6 1 1 6 6 6 6 1 1 6 6 1 1 6 1 1 6 1 
GOQii Band 6 1 1 1 6 6 1 6 1 1 1 1 1 6 1 6 1 1 1 6 1 1 6 6 6 6 1 
Hexoskin 6 6 6 6 6 6 1 5 6 6 1 1 6 6 6 6 1 1 6 6 1 1 1 6 6 6 1 
iBitz 6 6 6 6 6 6 6 5 6 6 1 1 6 6 6 6 1 1 6 1 1 6 6 6 6 6 1 
iHealth 
Wireless 
Activity and 
Sleep 
6 6 1 6 6 6 1 6 1 1 1 1 1 6 6 6 1 1 6 6 1 1 6 6 6 6 1 
73 
 
Tracker 
Jawbone UP 6 1 6 6 6 6 1 5 6 6 1 1 6 6 6 6 1 1 5 5 1 1 1 6 6 6 1 
Jawbone 
UP2 
6 1 1 6 6 6 1 1 1 1 1 1 6 6 6 1 1 1 6 6 1 1 1 6 6 6 1 
Jawbone 
UP24 
6 1 6 6 6 6 1 5 6 6 1 1 6 6 6 6 1 1 5 5 1 1 1 6 6 6 1 
Jawbone 
UP3 
6 1 1 6 6 6 1 1 1 1 1 1 6 6 6 1 1 1 6 6 1 1 1 6 6 6 1 
Jawbone 
UP4 
6 1 1 6 6 6 1 1 1 1 1 1 6 6 6 1 1 1 6 6 1 1 1 6 6 6 1 
Ki Fit 6 6 6 6 6 6 1 6 6 6 1 1 6 6 6 6 1 1 6 6 1 1 6 1 1 1 1 
LEO 6 6 6 6 6 6 1 6 6 6 1 1 6 6 6 6 1 1 6 6 1 1 6 1 1 6 1 
LG Activity 
Tracker 
6 1 1 6 6 6 1 6 1 1 1 1 1 6 6 6 1 1 6 6 1 1 6 6 6 6 1 
LifeBeam 
Hat 
6 6 6 6 6 6 1 6 6 6 1 1 6 6 6 6 1 1 6 6 1 1 6 6 6 6 1 
LifeTrak 
Core C200 
6 6 1 6 6 6 6 1 1 1 1 1 1 6 6 6 1 1 6 6 1 1 6 6 6 6 1 
LifeTrak 
Core C210 
6 6 1 6 6 6 6 1 1 1 1 1 1 6 6 6 1 1 6 6 1 1 6 6 6 6 1 
LifeTrak 
Move C300 
6 6 1 6 6 6 1 5 1 1 1 1 1 1 6 6 1 1 6 6 1 1 6 6 6 6 1 
LifeTrak 
Zone C410 
6 6 1 6 6 6 1 5 1 1 1 1 1 1 6 6 1 1 5 5 1 1 6 6 6 6 1 
LUMOlift 6 5 6 7 6 6 1 1 1 1 1 1 6 6 6 6 1 1 6 6 1 1 6 4 4 6 1 
Magellan 
EchoFit 
6 6 1 6 6 6 1 6 1 1 1 1 1 6 6 6 1 1 6 6 1 1 6 6 6 6 1 
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Microsoft 
Band 
1 1 1 1 6 6 1 1 1 1 1 1 1 6 1 6 1 1 6 6 1 1 1 6 6 6 1 
Misfit Flash 6 6 1 6 6 6 1 5 1 1 1 1 6 6 6 1 1 1 6 1 1 4 6 1 6 6 1 
Misfit Shine 6 6 1 6 6 6 1 5 1 1 1 1 6 6 6 1 1 1 6 1 1 4 6 1 6 6 1 
Moto 360 6 6 1 6 6 6 6 6 1 1 6 6 1 1 6 6 6 6 6 6 6 1 6 6 6 6 1 
MyWellness 
Key 
6 6 1 6 6 6 1 6 1 1 1 1 6 6 6 1 1 1 6 6 6 6 6 1 1 6 1 
New Balance 
Body TRNr 
6 6 1 6 6 6 1 6 1 1 1 1 1 6 6 6 1 1 6 6 1 1 6 6 6 6 1 
New Balance 
Life TRNr 
6 6 1 6 6 6 1 6 1 1 1 1 1 6 6 6 1 1 6 6 1 1 6 6 6 6 1 
Nike+ 
Fuelband SE 
6 6 1 6 6 6 1 6 1 1 1 1 1 6 6 6 1 1 6 6 1 1 6 6 6 6 1 
Omate X 6 6 1 1 6 6 1 1 1 1 1 1 1 1 6 6 1 1 6 6 6 6 6 6 6 6 6 
PAM AM200 6 6 1 6 6 6 1 6 1 1 1 1 1 6 6 6 1 1 6 6 6 6 6 6 1 6 1 
PAM AM300 6 6 1 6 6 6 1 6 1 1 1 1 1 6 6 6 1 1 6 6 6 6 6 6 1 6 1 
Pavlok 6 1 6 6 6 6 1 1 1 1 1 1 6 6 6 6 1 1 6 6 1 1 6 6 6 1 1 
Pebble 4 4 1 6 6 6 6 6 1 1 6 6 1 1 6 6 6 6 6 6 1 1 5 5 5 6 1 
Polar Loop 6 6 1 6 6 6 1 6 1 1 1 1 1 1 6 6 1 1 1 6 1 1 6 6 6 1 1 
Polar V800 6 6 1 6 6 6 1 6 1 1 1 1 1 1 6 6 1 1 1 6 1 1 6 6 6 1 1 
Razer Nabu 6 1 1 1 6 6 1 1 1 1 1 1 1 6 1 6 1 1 6 6 1 1 6 6 6 6 1 
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Razr Nabu X 6 1 1 6 6 6 1 1 1 6 1 6 1 6 6 6 1 1 6 6 4 1 6 6 6 6 1 
RT6 6 6 1 6 6 6 6 6 1 1 2 1 1 6 6 6 1 1 6 6 6 6 6 6 1 6 6 
Samsung 
Gear Fit 
6 6 1 1 6 6 1 6 1 6 1 1 1 6 6 6 1 1 6 6 6 1 6 6 6 6 1 
Spree 6 6 6 6 6 6 1 6 6 6 1 1 6 6 6 6 1 1 6 6 1 1 6 6 6 6 1 
Stayhealthy 
Activity 
Monitor 
6 6 1 6 6 6 6 6 1 1 2 1 1 6 6 6 1 1 6 6 6 6 6 6 1 6 6 
Striiv Band 6 6 1 6 6 6 1 6 1 6 1 1 6 6 6 1 1 1 6 6 1 1 6 6 6 6 1 
Striiv Fusion 6 6 1 1 6 6 1 6 1 1 1 1 1 6 6 6 1 1 6 6 1 1 4 6 6 6 1 
Striiv Fusion 
Bio 
6 6 1 1 6 6 1 6 1 1 1 1 1 6 6 6 1 1 6 6 1 1 4 6 6 6 1 
Striiv Fusion 
Lite 
6 6 1 6 6 6 1 6 1 1 1 1 1 6 6 6 1 1 6 6 1 1 4 6 6 6 1 
Striiv Touch 6 6 1 6 6 6 1 6 1 6 1 1 6 6 6 1 1 1 6 6 1 1 6 6 6 6 1 
Suunto 
Ambit3 
6 6 1 6 6 6 1 6 1 6 1 1 1 6 6 6 1 1 6 6 1 1 6 6 6 6 1 
Sync Burn 6 6 1 6 6 6 1 6 1 6 1 1 1 1 6 6 1 1 6 6 1 1 6 6 6 6 1 
Sync Elite 6 6 1 6 6 6 1 6 1 6 1 1 1 6 6 6 1 1 6 6 1 1 6 6 6 6 1 
Sync Fit 6 6 1 6 6 6 6 6 1 6 6 6 1 1 6 6 6 6 6 6 1 1 6 6 6 6 1 
TracmorD 
(Philips 
DirectLife) 
6 6 1 6 6 6 6 6 1 1 6 1 6 6 6 6 1 1 6 6 6 6 6 1 1 6 1 
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Vivago 6 6 1 6 6 6 6 6 1 6 6 6 1 1 6 6 6 6 6 6 6 6 6 1 6 6 6 
Wellograph 6 6 1 1 6 6 1 1 1 1 1 1 1 1 6 6 1 1 6 6 1 1 6 6 6 6 1 
Withings 
Pulse 
6 6 1 6 6 6 1 6 1 1 1 1 1 6 6 6 1 1 6 6 1 1 6 6 6 6 1 
1=Yes, 2 = Yes – Difficulties (e.g. proximity to computer) 3 = Yes – Lack of evidence to suggest this 4=No – But present in future iterations 5 = No – But possible (with Application Programming 
Interface or Software Development Kit) 6= Not described/Not featured 
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Table 3.5 – Self-monitoring attributes of devices that measure sedentary behaviour 
Name Type of Feedback Timing Of 
Feedback 
Feedback in Backend Platform Goal Setting 
Capabilities 
Device Backend Platform Device Backend 
Platform 
Device Backend Platform 
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Application Software Website 
iO
S 
A
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ro
id
 
W
in
do
w
s 
M
ac
 
PC
 
Activ8 6 1 1 6 6 1 1 5 1 1 6 1 6 6 6 1 1 1 6 5 6 5 6 6 6 1 1 
ActivPAL VT 6 1 6 6 6 6 6 6 1 6 6 1 6 6 6 6 1 1 6 5 6 5 6 6 1 6 6 
Darma 6 6 6 6 1 6 1 1 6 6 1 6 6 6 6 6 1 1 1 0 1 0 6 6 6 6 1 
FootLogger 6 6 6 6 5 5 5 5 6 6 5 5 6 6 6 6 5 5 5 4 1 0 6 6 6 6 5 
Gruve 6 1 1 6 6 6 6 6 1 6 6 1 6 6 6 1 1 1 6 5 6 5 6 6 1 1 1 
LumoBack 6 3 6 6 6 6 1 1 1 6 1 1 6 6 6 6 1 1 1 1 1 1 3 6 6 6 1 
Moticon 
OpenGo 
6 6 6 6 5 5 5 5 6 6 5 5 6 6 6 6 5 5 5 4 5 4 5 4 5 5 5 
OM Everyday 6 6 6 6 6 6 1 1 6 6 1 6 6 6 6 6 1 1 6 5 1 0 6 5 6 6 1 
Sensoria 
Fitness 
1 6 6 6 6 6 6 1 1 1 1 1 6 6 6 6 1 1 5 4 1 0 6 5 6 6 1 
1=Yes, 2 = Yes – Difficulties (e.g. proximity to computer) 3 = Yes – Lack of evidence to suggest this 4=No – But present in future iterations 5 = No – But possible (with Application Programming 
Interface or Software Development Kit) 6= Not described/Not featured 
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Figure 3.2 - Technologies found that can be used to self-monitor and provide feedback 
on physical activity ordered by number of self-monitoring attributes that were found 
to be present in the technologies 
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Figure 3.3 - Proportion of devices that can be used to self-monitor and provide 
feedback on physical activity which have the specific self-monitoring attributes 
Each attribute is split into whether the attribute is present on the device itself (denoted is a 
D ) or whether it is present on the backend platform (i.e. smartphone/tablet etc; denoted with 
BP ) 
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Figure 3.4 - Technologies found that can be used to self-monitor and provide feedback on sedentary time 
ordered by number of feedback elements that were found to be present in the technologies 
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Figure 3.5 - Proportion of sedentary behaviour devices that can be used to self-monitor and provide 
feedback on sedentary time which have the specific self-monitoring attributes   
Each attribute is split into whether the attribute is present on the device itself (denoted is a D ) or whether it 
is present on the backend platform (i.e. smartphone/tablet etc; denoted with BP ) 
81 
 
3.4 Discussion 
The present systematic review sought to identify current measurement technologies available 
that could be used for real time self-monitoring of sedentary behaviour and/or physical 
activity. The review identified 125 papers on 46 devices and 90 websites, giving a combined 
total of 146 technologies that monitor sedentary behaviour and/or physical activity. Of these, 
82 devices were considered capable of self-monitoring sedentary behaviour and/or physical 
activity. These devices can be used by researchers, clinicians and the general public.   
 
Technologies that self-monitor physical activity mainly come from the consumer health and 
fitness market. In general, these devices consist of an accelerometer for activity measurement 
(steps, calories burned, distance travelled) with varying secondary sensors including, 
gyroscope, inclinometer, lux sensors, skin sweat sensors and many more that will provide 
additional pieces of information. However, these devices will provide feedback only on 
physical activity, and increases in physical activity do not automatically lead to decreases in 
sedentary time (35). Additionally, more and more of these devices are providing feedback on 
not only the amount of physical activity, but the length of time spent inactive.  
 
There are devices from both the commercial and research sectors that self-monitor sedentary 
behaviour. These devices tend to measure sedentary behaviour in two differing ways. Firstly, 
posture sensors measure sedentary behaviour either through accelerometry in conjunction 
with gravitational components and proprietary algorithms (e.g. activPAL) or through the 
alignment of the area of the body surrounding the pelvic area (i.e., pelvic alignment is 
different depending on standing sitting and lying). The other way in which technologies tend 
to measure sedentary behaviour is via pressure sensors. These pressure sensors are either 
located in a sock, shoe or chair. When placed in a sock or shoe the pressure can determine 
standing when there is pressure on the sensor and when there is less pressure the wearer is 
sitting or lying. Located on the chair, there is a simple binary outcome that suggest when the 
pressure sensor is active the user is sitting and when inactive there is no sitting behaviour at 
that site. 
 
Both physical activity and sedentary behaviour devices usually provide either via vibratory 
feedback (e.g. Jawbone UP) or via an omnipresent display on the device (e.g. Garmin 
Vivofit). These devices tend to, but not exclusively, connect to a mobile application for 
feedback on the nature of the physical activity and sedentary behaviour. For physical activity, 
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this usually takes the form of energy expenditure or proprietary company points (e.g. Nike 
Fuel). For sedentary behaviour, this usually takes the form of time spent sitting (e.g. 
LumoBack). These mobile applications allow the wearer to receive real time continuous 
feedback along with goal-setting capabilities and customisation of type and timing of 
feedback, an aspect not traditionally offered by research devices.  
 
With the plethora of devices now available, with differing attributes and cost, it is 
unsurprising that these devices are growing in popularity. However, and perhaps 
paradoxically, there are a small number of devices specifically designed to measure sitting 
time. Furthermore, the small number of devices that do provide feedback on sitting were 
either not originally designed for its measurement (e.g. LumoBack) or are still mainly 
research tools to be used in scientific studies (e.g. activPAL VT). 
 
Self-monitoring technologies need to provide real-time feedback on aspects of physical 
activity and sitting that are personalised and relevant to the individual (i.e., the attributes of 
real-time feedback must resonate with the individual and not simply information that has 
been presupposed for them). Additionally, the immediate feedback should be of a low 
cognitive load so that it can resonate immediately with the end user (346,347). For example, 
the Fitbit One has a growing flower as a feedback indication of progression towards a user 
defined goal. Using a pictorial representation of this nature will resonate easier with the user 
(348,349). However, more detailed information on, for example, the temporal patterning of 
the behaviour should be accessible from a mobile application, website or software. 
The likelihood of the feedback being acted upon could be increased if it is provided in a 
manner that is context aware. In other words, the feedback must be given at a time when it 
can be acted upon by the user. For example, to reduce sitting provide feedback whilst 
watching television rather than sitting in an exam or during a prolonged dental procedure. If 
these attributes could be integrated into a single device it would help facilitate its use by 
differing populations regardless of technological ability. These devices need to have a 
substantial battery life and memory capacity, as well as keeping the costs reasonable. For this 
to occur there is a need for co-operative work across different research disciplines and 
commercial fields, to develop these context-aware, personalised feedback devices. Not every 
user will have the same needs, and the presentation of actionable information will need to be 
tailored to fit individual needs. In addition, simply providing more medical data to patients 
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not only fails to guarantee improved outcomes but also could potentially lead to negative 
consequences (350). Activity trackers have had a poor evidence of prolonged use, with a 
conservatively estimated one-third discontinuing use by 6 months after initiation (351). A 
recent study of several tools to encourage medication adherence in older adults, a major area 
of focus of mHealth developers, found that the most common descriptors participants used to 
describe their experience with the devices were “frustrating” and “challenging” (352). In 
another study of the usage of a dietary app to promote healthy eating, investigators found that 
fewer than 3% used the app for at least one week and fewer than 10% of these individuals 
made positive changes in their diet (353). Users require consumer-friendly devices and apps 
that are self-reinforcing and enjoyable to use. These goals might be accomplished with the 
use of incentives, gamification, and social networks to promote managed competition among 
peers or family members. This review demonstrates that there are a plethora of feedback 
attributes enabling users to customise their experience by choosing the device with best 
works for them.  
 
In order for the promise of wearable technology to be fully realised, consumers, providers, 
and health care systems must be able to trust the reliability, privacy and security of their data 
as well as the devices that collect and share it. Although regulatory oversight is often 
considered to be an impediment to the rapid dissemination of innovative technologies, the 
existence of potential scams which could harm the end user necessitates some level of 
oversight. Globally, there is a great deal of uncertainty around wearable technology 
regulation; there are numerous countries that have no regulatory framework, whereas the 
others that do have a framework are still in their infancy and being actively refined (354,355).  
 
Wearable technology users are also concerned about the privacy and ownership of their 
health data. In the era of big data, it is critical that the terms of ownership of personal data, 
most especially medical data, be unambiguously stated – not buried in the universally unread 
and then accepted terms of use agreements – with users required to explicitly consent 
whenever their data are sold or transmitted to others (356).  
 
One of the benefits of mHealth is easier accessibility to pertinent health care data, but this 
increased availability to both consumers and providers creates the potential for substantial 
security risks. Because of the small size of the device it becomes easier to inadvertently lose 
or be easier to steal, which may mean that the information stored on the device becomes 
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accessible to others. As consumer demand for wearable sensors increase, health care 
providers will face the possibility of being inundated by a torrent of patient data. This will 
create a number of difficult challenges, including the potential requirement for 24/7 oversight, 
the need to summarize multi-parameter, continuously collected data into a usable and 
clinically meaningful format, and liability challenges (357).  
 
The strengths of this review are the systematic approach taken and the comprehensive range 
of technologies that have been found. However, there are some limitations. Due to the nature 
of papers included, it was not possible to present data on the validity and reliability of the 
devices in their ability to measure sedentary behaviour. Similarly, due to the fact that 
objectively self-monitoring is in its infancy, there are gaps in the literature as to whether these 
devices truly work as self-monitors, consequently, we cannot comment on how useful or 
valid they are in these settings. However, validity data are important. Users of self-
monitoring technologies must be able to trust in the feedback that is being returned to them; 
otherwise they may become disenfranchised with the tool and the behaviour change tool. 
Therefore, incorporating important valid data with the feedback tools means additional value 
can be added to the consumers and potentially more potent behaviour change.  
3.5 Conclusion 
In conclusion, the authors believe that this review is the first of its kind to systematically 
describe the wide plethora of devices that self-monitor and provide feedback on physical 
activity and sedentary behaviour. There has been an explosion in the number of devices that 
measure physical activity and there is a greater need for the development of tools that 
specifically measure sitting time. Co-operative work between engineers, computer scientists 
and academics in relevant fields is needed to develop these technologies that provide real 
time, personalised, context aware feedback to aid in the reduction in sitting time, and its 
detrimental effect on cardio-metabolic health independent of physical activity. This could 
potentially lead to the use of these devices in a healthcare setting; both as part of the 
increasing value-based care systems that are starting to arise in the United States or as a 
diagnostic tool in which is beginning to be implemented in the National Health Service in the 
UK. 
 
The plethora of devices and differing feedback attributes allows the user to choose which 
device and which attribute works best for them. However, there is not currently a “one size 
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fits all devices” which means individuals may have to choose more than one device to 
measure different parameters of the behaviour or to determine the most resonating feedback 
attribute for them.  
 
This scoping review provides a record of a large breadth of devices with information on their 
capabilities both in terms of their ability to measure behaviour and to provide feedback to the 
user, therefore providing a foundation for clinical, research, and public health use. These self-
monitoring tools are becoming ever more present in daily life as well as becoming integrated 
into health systems throughout the world. Future studies are needed to further investigate the 
validity of these devices and their feasibility to in increasing physical activity and/or 
decreasing sedentary behaviour and the public health impact this may produce.  
 
From this review, it was determined that the LumoBack was the device which contained the 
highest volume of attributes as well as the ability to measure sedentary behaviour to the 
definition. Therefore in chapter 4, the LumoBack will be validated for measuring sedentary 
behaviour. 
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Chapter 4 - The validity of the 
LumoBack Posture Sensor as an 
objective measure of sedentary 
behaviour in adults 
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4.1 Introduction 
Sedentary behaviour (measured by posture sensors and questionnaires), is a distinct risk 
factor for cardio-metabolic health, which may be additional to the risks associated with lack 
of moderate-vigorous physical activity (MVPA (28,29,59,60,358). However, the optimal 
amount, frequency and distribution of sedentary behaviour are still a matter for debate. 
Reliable and valid measurements of sedentary behaviour are therefore essential to draw 
appropriate conclusions about their influences on health. Early studies measuring sedentary 
behaviour predominantly used self-report tools (52,59,104). However, self-reported 
measurement tools are prone to recall and response bias, social desirability, and under- or 
over-reporting (104). Additionally the reproducibility and validity of self-reported sedentary 
behaviour are variable (107,359). 
Accelerometry has been proposed as a method to objectively quantify sedentary time 
(measured by accelerometry) in addition to physical activity (360). Briefly, activity 
monitoring using accelerometers measures the intensity of the behaviour based on 
acceleration at the point the accelerometer is attached to the body. Accelerometers, which 
measure activity using accelerometric counts determine sedentary time as less than 100 CPM 
(48); however, the most accurate cut-point is yet to be universally agreed upon and may vary 
between different population groups (361). A problem with this approach is the inability to 
discriminate between differing postures (a key component of the sedentary behaviour 
definition (43)). In other words, if a person is sitting or standing still, these could both be 
interpreted as sedentary time using the accelerometer cut-point method. This will cause 
measurement problems for interventions where participants are encouraged to replace sitting 
with standing (134).  
In one study (52), 86 participants (87% women; mean age 52.7 years, SD 8.6 years) 
simultaneously wore an ActiGraph (ActiGraph, LLC, Pensacola, FL, USA) activity monitor 
and activPAL (PAL Technologies Ltd, Glasgow, UK) for 7 consecutive days (52). For this 
analysis, only valid days that had similar estimated wear times for both devices (±30 minutes) 
were considered. Sedentary time derived from the ActiGraph activity monitor (<100 CPM) 
was compared to sedentary behaviour from the activPAL (sitting and lying down) over an 
average of 4.5 observed days per person, and an average wear time of 14.3 ± 1.5 hours per 
day for each device. On average, recorded sedentary time was lower for the ActiGraph 
activity monitor (8.7 [SD=1.6] hours/day, or 60.9%) than for the activPAL (99 [SD=1.8] 
hours/day, or 63.4%; both p=0.01), but the correlation between the measures was relatively 
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high (ρ = 0.76, p<0.01). Interestingly, Bland-Altman analysis showed a small mean 
difference (-0.34 hours) and wide 95% limits of agreement (2.11 to -2.79 hours (52). In 
another study, 32 participants wore an ActiGraph GT1M and activPAL for one day (136). For 
similar amount of wear time (15.1 ± 1.9 vs 15.0 ± 2.0 for ActiGraph and activPAL 
respectively) the ActiGraph (sedentary time defined as <100 CPM) had statistically higher 
levels of sedentary time (650.6 ± 111.8 minutes/day) compared to the activPAL (518.5 ± 
147.8 minutes/day). This indicates that the ActiGraph activity monitor has minimal bias 
overall, but can both substantially over- and under-estimate sedentary time compared with the 
activPAL (136). These two validity studies imply that ActiGraph activity monitors provide 
useful estimates of sedentary time and that are sufficiently accurate to rank individuals by 
their level of sedentary time. However, given the limitations of accelerometry, development 
and testing of new measures of sedentary behaviour are required. The activPAL, an 
inclinometer enabled monitor, is able to measure different postures, such as lying, sitting, and 
upright postures, which has been shown to be a valid measure of behaviour in both laboratory 
and free-living settings (151–153,255,256,362,363). Additionally, posture sensors are 
emerging in the commercial market aimed at measuring various behaviours, some of which 
have the ability to measure posture, one such device is the LumoBack posture sensor (338). 
The LumoBack (LumoBody Tech, Inc, Palo Alto, CA) is a small (4.15 x 10 x 0.8cm, 25g) 
and flexible posture sensor, worn on the lower back. The LumoBack and other newer 
consumer electronic (CE) technologies in this area, has the ability to empower the wearer to 
self-monitor their behaviour. Furthermore, the systematic scoping review in Chapter Three 
(page 46) identified that there is currently a lack of sedentary behaviour self-monitoring 
devices compared to their physical activity self-monitoring counterparts. Of the nine 
sedentary behaviour self-monitoring devices, the LumoBack was seen as one of the more 
promising tools with its ability to measure body posture (as opposed to the absence of activity 
like accelerometers, or being seat based), to provide real-time feedback of behaviour to a 
mobile application, to utilise a vibratory functionality to provide prompt/cues for immediate 
feedback, and open source Software Development Kit (SDK) and Application Programming 
Interfaces (API), along with being relatively inexpensive compared to its research grade 
counterparts, makes the LumoBack worthy of validating for use as a sedentary behaviour 
measurement self-monitoring tool.  
Therefore the aim of this study was to examine the criterion and convergent validity of the 
LumoBack in measuring sedentary behaviour, by comparing the validity of the LumoBack to 
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direct observation, the ActiGraph wGT3X+ and the activPAL under laboratory conditions as 
well as examining the convergent validity of sitting time, standing time and stepping time of 
the LumoBack compared to the activPAL3 and ActiGraph wGT3X+ in a sub-sample of 
healthy adults in a free-living setting. 
4.2 Methods 
4.2.1 Design 
Data were collected in a controlled, laboratory environment. Data from the LumoBack were 
compared to direct observation (as the gold standard) as well as activPAL (worn on the thigh: 
hereafter referred to as activPAL) and ActiGraph wGT3X+ (worn on the waist: hereafter 
referred to as ActiGraph). In the laboratory measurement, the participants were instructed to 
follow a strict activity and posture protocol in a fixed setting. A sub-sample of participants 
wore the LumoBack, activPAL and ActiGraph for a period of seven days as part of the free-
living component of this study. 
4.2.2 Participants 
A convenience sample of 34 apparently healthy adults (45% male, mean age 27.1 ± 5.5 years, 
mean BMI = 23.8 ± 3.5 kg/mP2P) participated in the laboratory study. A sub-sample of 12 
healthy adults who participated in the laboratory study participated in the free-living study 
(58.3% male, mean age 26.8 ± 4.6 years old, mean BMI = 24.2 ± 3.2 kg/mP2P). This sub-
sample was chosen based on which of the individuals in the laboratory study had an iOS 
compatible device. The participants read an information sheet and completed a Health 
Screening Questionnaire, and Informed Consent form before measurements took place. Study 
documentation can be found in Appendix 2 (page 213).  
4.2.3 Procedures 
In the laboratory experiment, preliminary data were collected from the participants including 
their age, weight, standing height (enabling BMI to be calculated), and sex. For standing 
height, the participants were asked to stand upright, barefoot, with their back to the vertical 
backboard of the stadiometer (Leicester Portable health measure). The heels of the feet were 
placed together with both heels touching the back of the vertical board. The participant’s feet 
were pointed slightly outward at approximately a 60 degree angle. The participants head was 
maintained in the Frankfort Horizontal Plane position (the head is in the Frankfort plane 
when the horizontal line from the ear canal to the lower border of the orbit of the eye is 
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parallel to the floor and perpendicular to the vertical backboard) while the investigator 
lowered the horizontal bar snugly to the crown of the head with sufficient pressure to 
compress the hair. The participants were asked to inhale deeply and to stand fully upright 
without altering the position of their heels. The act of taking a deep breath helps straighten 
the spine to yield a more consistent and reproducible stature measurement. The measurement 
was recorded to the nearest 0.1 cm (364). For measurement relating to weight and BMI, the 
Tanita Body Composition Analyser BC-418 (Tanita, West Drayton, UK) was used. 
Participants were asked to remove all footwear and any extra weight (heavy jumpers, coins in 
pockets, belts etc.). Participants were asked to step on the weight platform, making sure to 
place their heels on the posterior electrodes, and the front part of their feet in contact with the 
anterior electrodes. The participants were then asked to hold onto the grips of the analyser 
until the measuring process had completed. Body weight was measured to the nearest 0.1kg. 
Following these anthropometric measurements, the devices were fitted to the participants. 
The activPAL was fitted on the midline anterior aspect of the participant’s right thigh affixed 
with medical dressing, whilst the ActiGraph was worn on the right hip. The LumoBack was 
fitted to the lower back with the Lumo logo facing outward, and in the centre of the back. 
Exact position was not necessary due to the calibration feature of the LumoBack. As such, 
each participant was asked to go through this calibration process before the commencement 
of the study protocol. The LumoBack was connected to the mobile application (app) via low 
energy Bluetooth (BLE). The mobile application possesses an avatar which assumes the 
posture of the wearer. Calibration of the device takes place by having the participant assume 
the posture shown by the avatar. Participants would hold this position while the mobile 
application calibration functions were enabled, signified by five mild vibrations from the 
LumoBack. Calibration was indicated to be completed by a push notification (see Table 3.3 
and 3.5) as part of the app. Once calibration was complete, the participant was asked to walk 
for a distance of approximately 20 metres and then to sit down on a chair (which was used for 
all sitting activities) so as to ascertain whether the calibration process had been performed 
correctly. This was determined by the avatar on the mobile application displaying in real time 
the postures and activities of the participants. Due to the lack of download feature from the 
device or the mobile application at the time of testing, data were recorded during the 
laboratory experiment on customised data recording sheets (See Appendix 2.4 page 221). 
Once the device had been fitted and the LumoBack had been calibrated, the participants were 
instructed to undergo seven different seated activities (Table 4.1). Each of these activities 
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lasted for five minutes with between 30-60 seconds in between activities. Time spent in each 
activity was recorded on the activity log sheet. At the time of data collection, study 
investigators were not aware of a method to download LumoBack data; therefore, a 
methodology of direct observation of the sitting time minimum card (min card; see Chapter 5 
page 120) on the LumoBack app via a secondary investigator was used to record the data 
from the LumoBack. A sub sample of this group was asked to wear the LumoBack, 
ActiGraph and activPAL for a period of seven days. Traditionally, in validation studies, 
participants would be provided with a diary log for participants to document when they 
removed the ActiGraph and activPAL so as to remove non-wear time from the analysis. 
However, when a LumoBack is removed and placed on charge or laid horizontally on a flat 
surface with the Lumo logo facing up, this is recorded in the data as non-wear. Therefore, 
participants were instructed to remove all devices at the same time and place the LumoBack 
on charge to create an electronic log of wear time. 
4.2.4 Activity Monitors 
The LumoBack is a small (4.15 x 10 x 0.8cm, 25g) and flexible posture sensor, worn on the 
lower back. Designed to measure an individual’s posture, the LumoBack has personalised 
built in calibration algorithms which adapt to each person’s body shape and movement 
behaviour. These are used to create a recommended optimal back posture model. The 
embedded posture sensors feed data to machine learning algorithms that continuously track 
the amount of time spent lying (used to infer sleeping), sitting, standing and stepping. The 
monitor connects wirelessly via BLE to an app, which includes an avatar that mimics the 
postures and daily activities of the wearer in real time. The LumoBack was worn on the lower 
back just above the waist using an elastic belt. The LumoBack measures posture based on the 
waist angle of the wearer, the device must be calibrated to each individual before use as the 
tilt is different from individual to individual.  
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Table 4.1 - A description of the sitting activities carried out 
Activity Picture Description  
1. Sitting on chair with feet flat 
on floor 
 
Sitting upright in a chair with trunk at approximate right angles to upper legs as well as approximate 90º right angles at 
the knees, with hands placed on the anterior aspect of the upper legs. Feet flat on floor. 
2. Sitting on chair with legs 
crossed (right over left) 
 
Sitting upright with trunk at approximate right angles to upper legs with knee of the right leg resting on the anterior aspect 
of the left knee, with hands resting on top of right knee. Left foot flat on floor. 
3. Sitting on chair with right foot 
resting on left thigh 
 
Sitting upright with trunk at approximate right angles to upper legs with the left knee at a right angle, with the lateral side 
of the right ankle resting on the left knee with the anterior aspect of the hands resting on the anterior aspect of the left leg 
and the medial aspect of the right thigh. 
4. Sitting on chair with legs 
stretched out forwards 
 
Sitting upright at the edge of a chair with legs stretched out straight, and feet flat on floor with the anterior aspect of the 
hands resting on the anterior aspect of the upper leg. 
5. Sitting with feet backwards 
underneath chair 
 
Sitting upright in a chair with trunk at approximate right angles to upper legs as well as approximate acute angle of less 
than 90º at the knees, with hands placed on the anterior aspect of the upper legs. 
6. Sitting with upper body 
movement (computer) 
 
Sitting upright in a chair with trunk at approximate right angles to upper legs as well as approximate right angles at the 
knees whilst typing on a computer, copying from a passage. 
7. Sitting playing games on a 
phone 
 
Sitting upright in a chair with trunk at approximate right angles to upper legs as well as approximate right angles at the 
knees whilst playing the same mobile game application. 
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Table 4.2 - Characteristics of the activity monitors used 
 LumoBack ActiGraph activPAL3 
Manufacturer LUMObody Tech Inc, ActiGraph LLC PAL Technologies Ltd 
Size (cm) 4.15 x 10 x 0.8 4.6 x 3.3 x 1.5 5 x 3.5 x 0.7 
Weight (g) 25 19 15 
Placement Lower Back  Wrist, Waist, Thigh One third down 
midline of the anterior 
aspect of the thigh 
Sample Frequency  
(Hz) *  
25  100 20 
Epoch Length P+ 5minutes 15 seconds 15 seconds 
Sensor Posture Sensors, 
Triaxial 
Accelerometers  
Triaxial 
Accelerometer, 
Ambient Light 
Photodiode 
Capacitative 
Accelerometer 
Waterproof Unknown 1m, 30mins Splash ProofP++ 
Interface Bluetooth Low Energy  USB Micro USB 
Software LumoBack App ActiLife ActivPAL3 7.2.32 
Outcomes – Measured Lying, Sit time, 
Standing time, 
Stepping time Number 
of Stand up, Step 
counts 
Counts, Inclinometer 
determined posture 
Time Spent in 
Sedentary, Upright, 
and stepping activities 
Price $69.99 £225 £380 
*sample frequency – the number of times the raw acceleration is sampled. Hz is a measure of frequency – 
defined as one cycle per second. (i.e. 100Hz = 100 samples per second) P+PDevice offers more options; the 
options selected in this study is presentedP  ++PCan be fully water proofed using supplementary materials. 
 
The ActiGraph (ActiGraph, LLC, Pensacola, FL, USA) is a small lightweight and 
rechargeable activity monitor. It uses a triaxial accelerometer to collect motion data on three 
axes. The ActiGraph measures and records time-varying acceleration in the range of 0.05-
2.5Gs. The accelerometer output is digitised by a twelve-bit analog to digital converter at a 
rate of 100Hz. Once digitised, the signal passes through a digital filter that band-limit the 
accelerometer to the frequency range of 0.25–2.5Hz. Each sample is summed over an ‘epoch’, 
that is, a specific interval of time which typically corresponds to 60s, however, in the case of 
this study it was 15s. The output of the ActiGraph is given in ‘counts’. The counts obtained in 
a given time period are linearly related to the intensity of the participants physical activity 
during a given period. The ActiGraph was worn on the right in line with midline of the thigh, 
were initialised to measure acceleration at 100Hz, and the data were processed using ActiLife 
Software (version 6.11.8). A cut point of less than 100 CPM was used as a measure of 
sedentary time.  
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Figure 4 1- Anterior view of how the devices were worn. 
*LumoBack worn on the lower back the waist using an elastic belt.  
The activPAL is a lightweight activity monitor that is worn on the thigh, attached by medical 
dressing. The activPAL uses a triaxial accelerometer sampling at 20Hz to produce signals 
* 
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reflecting thigh inclination and movement. The activPAL software uses proprietary 
algorithms to classify an individual’s free-living activity into periods spent lying/sitting, 
standing and walking. This information can be used to estimate daily energy expenditure and 
changes in free-living activity. The activPAL was taped to the anterior aspect of the thigh, 
approximately a third of the way down from the waist. It was attached using the medical 
dressing ((PAL Technologies Ltd, Glasgow, UK). See Table 4.2 for summary of the 
characteristics of the activity monitors and Figure 4.1 for wear sites of each of the devices. 
4.2.5 Statistical Analysis 
Data from the activity log sheet was transcribed into both Microsoft Excel 2010 (Microsoft 
Excel, Redmond, Washington) and SPSS version 22 (IBM SPSS Inc, Chicago, IL) for data 
analysis. Total sitting time was computed from the sum of the seven individual sitting 
conditions. Total Sitting Time (minus sitting with feet under chair) was also computed. Total 
sitting time (minus sitting with feet under chair) was calculated because the LumoBack 
measures sitting time via, pelvic tilt/waist angle and alignment, therefore when sitting with 
feet under chair the waist angle is closer to 180º, similar to that of standing. This will lead to 
a systematic under-estimation of sitting time by the LumoBack during this condition and 
consequently has been removed from a selection of analyses. 
Validity was calculated using Bland-Altman plots to test for criterion validity of the 
LumoBack, ActiGraph and activPAL against direct observation, as well as convergent 
validity of the LumoBack against ActiGraph and activPAL. Bland Altman plots are 
conducted by plotting the difference (Y axis) between the methods calculated by: 
𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷 = 𝑅𝑅𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷 𝑀𝑀𝐷𝐷𝑀𝑀ℎ𝑜𝑜𝑜𝑜 𝑀𝑀𝐷𝐷𝑀𝑀𝐷𝐷 − 𝑁𝑁𝐷𝐷𝑁𝑁 𝑀𝑀𝐷𝐷𝑀𝑀ℎ𝑜𝑜𝑜𝑜 𝑀𝑀𝐷𝐷𝑀𝑀𝐷𝐷  
plotted against (X axis) the mean of both methods calculated by: 
𝑀𝑀𝐷𝐷𝑀𝑀𝐷𝐷 =  𝑅𝑅𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷 𝑀𝑀𝐷𝐷𝑀𝑀ℎ𝑜𝑜𝑜𝑜 𝑀𝑀𝐷𝐷𝑀𝑀𝐷𝐷 + 𝑁𝑁𝐷𝐷𝑁𝑁 𝑀𝑀𝐷𝐷𝑀𝑀ℎ𝑜𝑜𝑜𝑜 𝑀𝑀𝐷𝐷𝑀𝑀𝐷𝐷 2  
Limits of agreement were calculated as: 95% 𝐿𝐿𝐷𝐷𝐿𝐿𝐷𝐷𝑀𝑀𝐿𝐿 𝑜𝑜𝐷𝐷 𝑀𝑀𝑎𝑎𝐷𝐷𝐷𝐷𝐷𝐷𝐿𝐿𝐷𝐷𝐷𝐷𝑀𝑀 = 𝑀𝑀𝐷𝐷𝑀𝑀𝐷𝐷 𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷 ± (1.96 × 𝑆𝑆𝐷𝐷 𝑜𝑜𝐷𝐷 𝑀𝑀ℎ𝐷𝐷 𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷) 
Reproducibility was assessed using Two-Way Mixed Intraclass Correlation (ICC). There was 
a lack of sufficient spread of data when performing interclass correlations on the individual 
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activities and direct observation therefore interclass correlations were only performed on the 
total sitting time measured by the LumoBack, ActiGraph and activPAL during the lab study.  
In addition mean absolute percentage error (MAPE), a measure of reproducibility of a 
method by comparing to a standardised method was calculated using the following equation: 
MAPE = |𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅 𝑀𝑀𝑅𝑅𝑀𝑀ℎ𝑜𝑜𝑜𝑜  𝑀𝑀𝑅𝑅𝑀𝑀𝑅𝑅−𝑁𝑁𝑅𝑅𝑁𝑁 𝑀𝑀𝑅𝑅𝑀𝑀ℎ𝑜𝑜𝑜𝑜 𝑀𝑀𝑅𝑅𝑀𝑀𝑅𝑅  |
𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅 𝑀𝑀𝑅𝑅𝑀𝑀ℎ𝑜𝑜𝑜𝑜  × 100 
Repeated Measures Analysis of Variance (ANOVA) with pairwise comparisons were used to 
determine whether there were any statistical differences in the amount of sitting time 
recorded by the LumoBack and direct observation. It was also used to determine any 
differences between the amounts of time spent sitting measured by the LumoBack and the 
ActiGraph and activPAL. Statistical significance level was set at 0.05.  
4.3 Results 
A convenience sample of 34 healthy adults participated in the laboratory study. A sub-sample 
of 12 healthy adults who participated in the laboratory study participated in the free-living 
study. Descriptive statistics of both samples can be found in table 4.3. Thirty one out of the 
34 participants who took part in the laboratory study were included in the analyses with three 
participant’s data were removed from the analysis, due to preliminary data mining suggesting 
a systematic device malfunction of one of the three devices.  
Table 4.3- Laboratory and Free-living Participants descriptive statistics* 
 Laboratory Mean 
(SD) – N=31 
Free-Living Mean 
(SD) N=12 
   
Age (Years) 27.1 (5.5) 26.8 (4.6) 
Male (%) 45.2 58.3 
Height (m) 1.7 (0.1) 1.8 (0.1) 
Weight (Kg) 69.2 (15.4) 76.1 (10.3) 
BMI (kg/mP2P) 23.8 (3.5) 24.2 (3.2) 
% Body Fat 28.0 (8.2) 28.2 (7.9) 
*There were no significant differences in participant characteristics between those taking part in the Laboratory validation 
only and those participants in both study components (P>0.05) 
4.3.1 Laboratory Assessment: Criterion- and Convergent- Validity  
Table 4.4 and Appendix figures 4.2-4.10 shows the Bland-Altman data and plots respectively 
for the LumoBack, ActiGraph and activPAL against direct observation to assess criterion 
validity. During the first three conditions (feet flat on floor, legs crossed (right over left) and 
right foot resting on left thigh) the LumoBack, ActiGraph and activPAL undercounted by 
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<1.1 seconds per five minute condition, with 95% CI of <±11 seconds compared to direct 
observation. 
During the legs stretched out forward condition, the LumoBack and ActiGraph under-
reported sitting time compared to direct observation. The activPAL also under-reported 
sitting time but to a greater extent than the LumoBack and ActiGraph.  
The LumoBack, ActiGraph and activPAL all under reported sitting time during the Sitting 
with Feet Back Under the Chair condition, with the LumoBack having the greatest mean 
difference of the three measurements. Furthermore, during the Sitting with Upper Body 
Movement (Computer) the LumoBack, ActiGraph and activPAL under reported sitting time. 
And finally, the LumoBack, ActiGraph and activPAL under reported sitting time during the 
Sitting Playing a Game on a Phone condition. 
Grouping all sitting activities together into a total sitting time condition, the LumoBack, 
ActiGraph and activPAL under-reported total sitting time. When the sitting with feet back 
under the chair was removed from the analysis, the LumoBack ActiGraph and activPAL all 
under-reported sitting time. 
Table 4.5 and appendix 4.7-4.14 shows the Bland-Altman data and plots respectively for the 
LumoBack vs ActiGraph and activPAL In general, during the first three conditions (feet flat 
on floor, legs crossed (right over left) and right foot resting on left thigh) the LumoBack had 
a mean difference of <1 seconds per five minute condition, with 95% CI of <±11.1 seconds 
compared to ActiGraph and activPAL. 
During the legs stretched out forward condition the LumoBack has a mean difference of 5.0 
(SD 17.3) seconds per 5 minute condition with upper limits of 39 seconds and lower limits of 
-29 seconds when comparing the LumoBack to the ActiGraph during this condition. However, 
compared to the activPAL the LumoBack has a mean difference of -153.54 with 95% CI of -
448.8, 141.7. Additionally, the LumoBack had a mean difference of 61.8 seconds compared 
to the ActiGraph, and mean difference of 54.2 seconds in the Sitting with Feet Back under 
chair condition. Furthermore, the LumoBack had a mean difference of 40.5 seconds 
compared to the ActiGraph, and mean difference of 43.4 seconds in the Sitting with Upper 
Body Movement (Computer) condition. In the final task, the LumoBack had a mean 
difference of 11.1 seconds compared to the ActiGraph, and mean difference of 0.7 seconds in 
the Sitting with Playing a Game on Phone. Finally, the LumoBack in total when accounting 
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for all activities had a mean difference 133.9 seconds when compared to the ActiGraph and 
mean difference of -38.1 seconds. However, when feet underneath chair was removed from 
the analysis the mean difference reduced to 72.1 seconds when compared to the ActiGraph, 
and a mean difference of -92.3 when compared to the activPAL. 
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Table 4.4 - Bland-Altman data assessing the criterion validity of the LumoBack, ActiGraph and activPAL to direct observation 
Sitting Posture 
(Seconds) 
LumoBack ActiGraph  activPAL 
Mean 
Difference 
Standard 
Deviation 
95% Limits of 
Agreement 
Mean 
Difference 
Standard 
Deviation 
95% Limits of 
Agreement 
Mean 
Difference 
Standard 
Deviation 
95% Limits of 
Agreement 
Lower 
Limit 
Upper 
Limit 
Lower 
Limit 
Upper 
Limit 
Lower 
Limit 
Upper 
Limit 
Feet Flat on Floor 
(300) 
0.86 4.1 -7.2 8.9 1.1 3.9 -6.6 8.8 0.0 0.0 0.0 0.0 
Legs Crossed (Right 
over Left) (300) 
0.1 3.08 -5.9 6.1 0.6 2.9 -5.1 6.2 0.0 0.0 0.0 0.0 
Right Foot Resting on 
Left Thigh (300) 
0.9 4.9 -9.51 10.4 0.0 0.0 0.0 0.0 0.5 1.8 -3.0 3.9 
Legs Stretched out 
Forward (300) 
5.5 17.8 -29.4 40.4 0.5 2.8 -4.9 6.0 159.3 151.1 -136.9 455.4 
Feet Underneath Chair 
(300) 
60.9 130.5 -194.8 316.6 1.0 3.9 -6.5 8.6 10.9 56.7 -100.2 122.0 
Upper Body Movement 
(Computer) (300) 
42.1 100.2 -154.3 238.4 1.6 6.1 -10.5 13.6 0.2 1.1 -2.0 2.4 
Playing game on phone 
(300) 
10.9 51.0 -89.1 110.9 0.5 2.8 -4.9 6.0 11.3 56.6 -99.7 122.3 
Total Sitting Time 
(2100) 
139.0 208.0 -268.7 546.8 5.3 9.2 -12.7 23.4 180.1 206.2 -222.0 586.2 
Total Sitting Time (- 
Feet Underneath Chair) 
(1800) 
76.2 138.3 -194.9 347.3 4.1 8.9 -13.2 21.5 171.2 172.0 -165.9 508.4 
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Table 4.5 - Bland-Altman data assessing the convergent validity of the LumoBack, to the ActiGraph and activPAL  
Sitting Posture (Seconds) ActiGraph activPAL 
Mean 
Difference 
Standard 
Deviation 
95% Limits of 
Agreement 
Mean 
Difference 
Standard 
Deviation 
95% Limits of 
Agreement 
Lower 
Limit 
Upper 
Limit 
Lower 
Limit 
Upper 
Limit 
Feet Flat on Floor (300) 0.2 5.6 -11.1 10.7 0.9 4.2 -7.2 9.1 
Legs Crossed (Right over Left) (300) -0.4 3.65 -7.6 6.7 0.1 3.1 -6.0 6.3 
Right Foot Resting on Left Thigh (300) 0.9 4.9 -8.6 10.4 0.5 3.8 -6.9 7.9 
Legs Stretched out Forward (300) 5.0 17.3 -29.0 39.0 -153.5 150.6 -448.8 141.7 
Feet Underneath Chair (300) 61.8 131.0 -195.0 318.6 54.2 126.0 -192.7 301.1 
Upper Body Movement (Computer) (300) 40.5 99.4 -154.3 235.4 43.4 101.8 -156.1 242.8 
Playing game on phone (300) 11.1 53.0 -92.7 114.9 0.7 79.8 -155.7 155.1 
Total Sitting Time (2100) 133.9 209.2 -276.2 543.9 -38.1 280.4 -587.6 511.4 
Total Sitting Time (- Feet Underneath 
Chair) (1800) 
72.1 137.1 -196.5 340.8 -92.3 222.2 -527.8 343.2 
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Table 4.6 provides the mean time and ICC from the laboratory experiment. Intraclass 
correlations comparing the total sitting time of the LumoBack and ActiGraph was 0.82 (95% 
CI: 0.63, 0.91) and 0.73 (95% CI: 0.47, 0.87) for the activPAL.  
Table 4.6 - Mean time measured by each device for Total Sitting time and the Intraclass 
Correlation Coefficients (ICC) 
Task LumoBack 
Seconds 
Mean(SD) 
ActiGraph 
Seconds 
Mean(SD) 
activPAL 
Seconds 
Mean(SD) 
ICC (Lower Bound, 
Upper Bound) 
LumoBack  
and 
ActiGraph  
LumoBack 
and 
activPAL 
Total Sitting 
Time 
1721.7(139.6) 1794.2(10.7) 1776.6(111.3) 0.82 
(0.63,0.91) 
0.73 
(0.47,0.87) 
Total Sitting Time is the sum of all seven sitting conditions in the laboratory setting of the validation.  
The mean absolute percentage errors of the LumoBack, relative to the actual time spent 
sitting, at each of the conditions during the laboratory study are shown in table 4.7. The 
MAPE was <4% for all conditions except for, feet underneath chair (MAPE: 24.3) and upper 
body movement (MAPE: 16.3). The MAPE for total sitting time was 7.0 and when the feet 
underneath the chair condition was removed the MAPE decreased to 4.3. The MAPE for the 
ActiGraph and activPAL are also presented in Table 4.7. 
 
Table 4.7 - Mean Absolute Percent Error of the LumoBack during each condition 
compared to direct observation, Mean (SD) 
Sitting Condition Mean Absolute 
Percentage Error of the 
LumoBack 
Mean Absolute 
Percentage Error of 
the ActiGraph 
Mean Absolute 
Percentage 
Error of the 
activPAL 
Feet Flat on Floor 1.0 (0.9) 0.4 (1.3) 0.0(0.0) 
Legs Crossed (Right over 
Left) 
0.6 (0.8) 0.2 (0.9) 0.0(0.0) 
Right Foot Resting on 
Left Thigh 
0.7 (1.5) 0.0 (0.0) 0.2 (0.6) 
Legs Stretched out 
Forward 
2.3 (5.6) 0.2 (0.9) 53.1 (50.4) 
Feet Underneath Chair 24.3 (40.7) 0.3 (1.3) 3.6 (18.9) 
Upper Body Movement 
(Computer) 
16.3 (35.5) 0.5 (2.0) 0.1 (0.4) 
Playing game on phone 3.8 (17) 0.2 (0.9) 3.5 (18.2) 
Total Sitting Time 7.0 (9.7) 0.3 (0.4) 12.0 (18.9) 
Total Sitting Time (minus 
Feet Underneath Chair) 
4.3 (7.7) 0.2 (0.5) 10.0 (9.4) 
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Repeated measures ANOVA were conducted to determine if there were any statistical 
differences in LumoBack measured time spent in sitting and the activPAL and ActiGraph 
during the laboratory conditions. The assumptions of sphericity were violated therefore this 
was corrected using the Greenhouse-Geisser estimates of sphericity. The results shows that 
there were no significant differences between sitting time measured by the LumoBack 
compared to the actual time spent sitting, ActiGraph and activPAL during the following 
conditions; Sitting on a Chair with Feet Flat on Floor, (FR(1.84,47.72)R = 1.16 p = 0.32), Sitting on 
a Chair with Legs Crossed (Right over Left), (FR(1.78,49.80) R= 0.50 p = 0.589), Sitting on a Chair 
with Right Foot resting on Left Thigh, (FR(1.03,28.95) R= 0.92 p = 0.35), Sitting playing on game 
on phone, (FR(1.59, 47.75)R = 1.338, p = 0.27).  
A one way within measure ANOVA indicated that measured sitting time was different during 
Sitting on Chair with Legs stretched out in front, (FR(1.02,29.69) R= 36.613, p <0.0005). Post-hoc 
Bonferroni analysis revealed that sitting time measured by the LumoBack was significantly 
higher than that of the activPAL (p<0.0005; 294.8 vs 141.4 seconds). There was also a 
significant difference in measured sitting time during the sitting with feet back under the 
chair, (FR(1.58,45.912) R= 4.52 p = 0.02). Post-hoc analysis revealed that sitting time measured by 
LumoBack was significantly lower than actual sitting time (p=0.02 239.1 vs 300.0 seconds) 
and ActiGraph measured time (p=0.02 239.1 vs 298.5 seconds respectively). In addition, the 
ANOVA analysis of the sitting with upper body movement conditions showed a significant 
difference in measured sitting time (FR(1.38,41.49) R= 4.45 p = 0.03). Post-hoc analysis indicated 
that sitting time measured by the LumoBack was significantly lower than the actual sitting (p 
= 0.02 257.9 vs 300.0 seconds respectively) and sitting time measured by the ActiGraph (p = 
0.02, 257.9 vs 297.58 seconds respectively).  
4.3.2 Free-Living Assessment: Convergent- Validity  
Table 4.8 displays the mean time and intraclass correlations from the free living experiment. 
Intraclass correlations comparing behaviours measured by the LumoBack and activPAL were 
0.87 (95 CI: 0.55, 0.96), 0.91 (95% CI: 0.70, 0.98), and 0.78 (95% CI: 0.24, 0.94) for 
sedentary behaviour, standing behaviour and stepping behaviour respectively. Furthermore, 
ICC comparing sedentary behaviour measured by the LumoBack and sedentary time 
measured by the ActiGraph were 0.80 (95%CI: 0.11, 0.95). 
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Table 4.8 - Mean time, Standard Deviation (SD) and Intra-class Correlations 
Coefficients (ICC) for Sedentary, Standing, and Stepping time and steps for the 
LumoBack compared to the activPAL and ActiGraph  
Behaviour  LumoBack 
Minutes 
Mean/ SD 
activPAL 
Minutes 
Mean/ SD 
ActiGraph Minutes 
Mean/ SD 
ICC (95% CI) 
LumoBack and 
activPAL 
LumoBack 
and 
ActiGraph 
Sedentary  524.1 
(70.4) 
530.5 
(54.2) 
562.6 (57.1) 0.87 (0.55, 0.96) 0.80 (0.11, 
0.95) 
Standing  232.2 
(85.3) 
229.7 
(63.6) 
N/A 0.91 (0.70, 0.98) N/A 
Stepping  83.3 (29.1) 79.6 (22.9) N/A 0.78 (0.24, 0.94) N/A 
Steps 8780.3 
(1096.6) 
8179.0 
(951.1) 
N/A 0.84 (0.44, 0.95) N/A 
N/A – ActiGraph does not measure these variables therefore they were not included in these analyses.  
Table 4.9 shows the results of the mean absolute percent error for the LumoBack as a 
measure of sedentary behaviour, standing, stepping and steps taken compared to the 
activPAL and ActiGraph during the free-living study. The MAPE for all condition ranged 
between 2.38 and 8.08 when comparing the LumoBack to the activPAL and was 5.07 when 
comparing the LumoBack and the ActiGraph. 
Table 4.9 - Mean Absolute Percent Error of the LumoBack compared to activPAL for 
each measurable behaviour, Mean(SD) 
Behaviour Mean Absolute Percentage Error 
LumoBack and activPAL LumoBack and ActiGraph 
Sedentary 2.38(3.23) 5.07 (1.81) 
Standing  6.88(12.32) N/A 
Stepping  8.54(14.81) N/A 
Steps Taken  8.08(15.33) N/A 
N/A – ActiGraph does not measure these variables therefore they were not included in these analyses.  
Repeated measures ANOVA was conducted to determine any significant differences in 
measured behaviours between the LumoBack, ActiGraph and activPAL for sedentary 
behaviour. The assumption of sphrecity was violated, therefore this was corrected using the 
Greenhouse Geisser estimates of sphercity. The results showed that there were significant 
differences between sedentary behaviour measured by the three devices, (FR(2,12.109)R = 8.0, 
p=0.014). Follow up bonferroni pairwise comparison indicated that the differences occurred 
when comparing the LumoBack to the ActiGraph (524.1 vs 562.6 mins, p=0.03) and the 
ActiGraph and the activPAL (562.6 vs 530.5mins p<0.005). In both comparisons, the 
ActiGraph over reported time spent sedentary in compared to the LumoBack and activPAL. 
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There were no significant differences in time spent sedentary when measured by the 
LumoBack and activPAL (524.1 vs 530.5mins, p>0.05). Paired sample T-test comparing 
behaviours measured by the LumoBack and activPAL in the free-living setting showed that 
there were non-significant difference in upright time [232.2 vs 229.7mins, tR(11)R = 0.2, p=0.85], 
stepping time [83.3, 79.55 mins, tR(11)R = 0.57, p=0.58] and steps taken [8780 vs 8179 steps, 
tR(11)R = 0.77, p=0.46]. 
Table 4.10 and Figures 4.11-4.12 are the Bland-Altman data and plots for the LumoBack and 
activPAL during the free-living component of the study. On average the LumoBack over 
reported sitting time by 4.6 mins (SD 21.8 95% CI; - 47.7, 38.4), under reported standing 
time by 8.9 mins (SD 20.3; 95% CI; -31.3, 49.1) and under reported stepping time by 2.3 
mins. Additionally the LumoBack under reported steps taken by 153 steps (SD 712; 95% CI -
1258, 1564). Furthermore, compared to the ActiGraph, the LumoBack under-reported 
sedentary time by 38.4 minutes (95% CI: -46.0, 122.7). 
.  
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Figure 4.1 - Bland-Altman plot comparing the LumoBack and the activPAL as a measure of Sedentary, Standing and Stepping time and Steps Taken 
Note: A: Bland-Altman of LumoBack vs activPAL for Total Sedentary Behaviour, B: Bland-Altman of LumoBack vs activPAL for Total Standing time, C: Bland-Altman plot of LumoBack vs 
activPAL fot Total Stepping time; D: Bland-Altman plot of LumoBack vs activPAL for Steps Takens, Black solid line shows the mean difference, Red lines denotes the upper and lower 95% 
Limits of Agreement. 
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Figure 4.2 - Bland-Altman plot of total sedentary time of the LumoBack compared to 
the ActiGraph  
Note: Black solid line shows the mean difference, Red lines denotes the upper and lower 95% Limits of 
Agreement. 
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Behaviour (Seconds) activPAL ActiGraph 
Mean Difference Standard Deviation 95% Limits of Agreement Mean Difference Standard Deviation 95% Limits of Agreement 
Lower Limit Upper Limit Lower Limit Upper Limit 
Sedentary  -4.6 21.8 -47.7 38.4 38.4 42.6 -46.0 122.7 
Standing 8.9 20.3 -31.3 49.1     
Stepping 2.3 8.8 -15.0 19.7     
Steps 152.9 712.8 -1258.6 1564.4     
Table 4.10 - Bland-Altman plots data comparing measured behaviour in minutes of the LumoBack to, ActiGraph and the activPAL in 
the free-Living setting 
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4.4 Discussion 
The aim of this study was to investigate the criterion- (direct observation) and convergent- 
(ActiGraph and activPAL) validity of the LumoBack as a measure of sedentary behaviour in 
a laboratory and free-living setting. The results from the laboratory study suggests that during 
the first four conditions, the LumoBack has acceptable criterion validity, with mean bias of 
<6 seconds per five minute condition. The tight confidence intervals of these conditions 
indicate that the LumoBack may be a reliable measure of sedentary behaviours during these 
conditions. The LumoBack, however, did significantly under-reported the time spent sitting 
during the feet underneath the chair condition and the upper body movement condition, by 
nearly 60 seconds. The feet underneath the chair condition discrepancy can be explained by 
the way in which the LumoBack measures postures. Briefly, the LumoBack measures posture 
by measuring the lower back (anterior pelvic tilt) angle of the wearer. This could be related to 
the participants anterior pelvic tilt angle deviating greater than 25 degrees from the calibrated 
seated angle therefore the LumoBack decision algorithms decided that the participant is 
standing (365). There is also a significant under-reporting occurring during the conditions 
following on from sitting with upper body movement which, could be a result of, anecdotally, 
participants tending to sit whilst typing on the computer with their legs behind the chair. This 
might be a result of there not being a ‘wash-out’ non-sedentary activity after the sitting with 
feet back under the chair condition. This would lead to the erroneous results for similar 
reasons as the previous condition. It is important to acknowledge that the extent to which this 
would affect misclassification of sitting time during a typical seven day period would depend 
on the prevalence of this type of sitting posture in daily life.  
The total sitting time mean bias showed that the LumoBack under reported across all the 
conditions by over 2 minutes when assessing its criterion validity. However, this is perhaps 
unsurprising because of the two conditions previously discussed. When the condition that had 
the most error was removed from the analysis (i.e. feet behind the chair), the mean bias 
decreased by almost a minute. However, the 95% confidence interval indicates that there is 
still variability in the measurements.  
When assessing convergent validity of the LumoBack compared to the ActiGraph, apart from 
the two conditions already discussed (sitting with feet back under the chair and upper body 
movement) the LumoBack showed acceptable convergent validity. When assessing the 
convergent validity of the LumoBack compared to the activPAL, during the condition of 
sitting with legs stretched out forward, the LumoBack over-reported compared to the 
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activPAL. However, the results of assessing the criterion validity of the activPAL suggest 
that it was the activPAL which was the erroneous measurement during this condition. Indeed, 
during this sitting position the angle of the thigh changes slightly (i.e. knee angle increases 
above 90 degrees and the front of the thigh dips), which causes a misclassification by the 
activPAL suggesting that the activPAL proprietary angular parameters for the classification 
of sitting require the thigh to be close to being parallel to the ground (138). It can be 
considered, therefore, that the activPAL was the device that was erroneous in this condition 
not the LumoBack. 
Apart from the two conditions previously discussed, there is MAPE, of less than 10%. Within 
the field of pedometry and accelerometry a MAPE of <10% is an acceptable cut off point for 
determining the accuracy of a device (366–369), and in the current laboratory study, when 
comparing the LumoBack as a measure of sedentary behaviour compared to the activPAL 
and the ActiGraph the LumoBack had a MAPE <10%.  
The LumoBack had acceptable convergent validity in the Free-Living component of the study, 
with a mean bias of -4.6mins for sedentary time, 8.9mins for standing time, and 2.3mins for 
stepping time, with a mean bias of 152 steps compared to the activPAL. Furthermore the 
MAPE for the LumoBack for all behaviours were <10% indicating acceptable agreement 
between the LumoBack and the activPAL as measures of sedentary, standing and stepping. 
The ICC further corroborate the agreement between the  LumoBack compared to the other 
devices by displaying good to excellent (as defined in (370)) correlations coefficients (ICC 
Total sitting time during laboratory study 0.73 and 0.87, 0.91, 0.78 for sedentary, standing 
and stepping time respectively during the free-living component of the study).  
When comparing the LumoBack to the ActiGraph in the free-living setting, the LumoBack 
under-reported time spent sedentary; however, it could be said that the ActiGraph in this 
instance is actually over-reporting as is the case with accelerometers when measuring 
sedentary time (104). Furthermore, the ICC showed acceptable agreement between the 
LumoBack and ActiGraph (ICC: 0.8), as well as a MAPE of 5.07, which is within the 
guidelines of <10%. 
The large discrepancy between the two LumoBack measurements in the laboratory and in the 
free-living can be accounted for by the error in the measurement induced in the laboratory 
permutations both for the LumoBack and the activPAL (e.g. the sitting with feet under the 
chair for the LumoBack and the feet stretched out straight for the activPAL). Both of these 
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permutations caused error in the measurement of LumoBack and activPAL and these two 
behaviours might not be as prevalent in the free-living setting.  
The results from the study presented in this chapter are corroborated by the findings from 
Rosenberger et al. (259). Briefly this study compared the output from commercially available 
wearable devices to the current standards for objective measurement of sleep, sedentary 
behaviour, light physical activity and moderate to vigorous physical activity (MVPA) over a 
24 hour period in a free-living setting. Adults wore nine devices for 24 hours: ActiGraph 
GT3X+, activPAL, Fitbit One, GENEActiv, Jawbone Up, LumoBack, Nike Fuelband, Omron 
Pedometer, and Z-machine. Comparisons to standards were made for sedentary behaviour 
using the activPAL. Mean error for sedentary behaviour was 9.5% for the LumoBack. 
Equivalence testing suggested that the LumoBack can accurately measure sedentary 
behaviour. Bland-Altman plots had a mean difference of 18 minutes for the LumoBack over 
the course of a 24 hour period, with the LumoBack also having the smallest standard 
deviation of all the devices measuring sedentary behaviour. Therefore, in this study presented 
by Rosenberger, the LumoBack was seen to be an accurate measure of daily posture. 
Additionally, the mean difference for the LumoBack as a measure of steps was 1,281 
compared to the Omron pedometer, with the ActiGraph being the only device to have a lower 
mean difference (679 steps) (259). In the present study the LumoBack performed better than 
in Rosenberger et al’s study (4.64mins compared to 18min respectively). The difference in 
sedentary behaviour mean bias may be attributable to the length of time the participants wore 
the device. In the study conducted by Rosenberger et al, participants only wore the 
LumoBack for 24 hours so any discrepancy would be greater when compared to the seven 
days in the current study. Additionally, the difference in sedentary time between the 
LumoBack and the ActiGraph in the present study, match those found in Rosenberger’s study. 
Furthermore, because participants only wore the device for one day in the Rosenberger study, 
there was less variability in the daily behaviours which could potentially be a limitation of 
their study. Another limitation of the Rosenberger’s study is the standards used in the study 
are based on common field-based measures and do not represent gold standards used in the 
laboratory 
Additionally, the LumoBack has been examined for its reliability as a measure of step counts 
in laboratory and free-living conditions (177). Thirty-three healthy adults walked twice on a 
treadmill for 30 minutes whilst wearing the LumoBack. Additionally, 56 healthy adults wore 
the LumoBack for one working day. Validity was evaluated by comparing each activity 
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tracker with the gold standard (Optogait system for laboratory and activPAL for free-living 
conditions). The MAPE for the LumoBack during laboratory conditions were -0.2, and -0.4 
in free-living conditions. Bland-Altman plots revealed a mean difference in step counts of 8 
during the laboratory study and 17 during the free-living section of the study (177) whereas 
the mean difference of the LumoBack compared to the activPAL as demonstrated in the 
present study was 152. The LumoBack in the study reported in this chapter did however, 
report a higher MAPE for steps taken than compared to Kooiman et al ( 8.08 vs 0.4 (177). 
Again this could be related to the length of wear of the participants between the two differing 
studies. Further research is needed to determine possible reasons for the discrepancy in these 
two studies. Despite the difference in the two studies, the LumoBack still shows acceptable 
validity as a measure of steps taken. 
The strengths of this study are the testing of a novel consumer product which has self-
monitoring and feedback-friendly attributes, including the ability to connect to an app for 
feedback on behaviour, goal setting, vibratory function and the open SDK and API for 
customisation. Additionally, this validation study has differing permutations in the sitting 
condition, which allowing for the determination of the validity of the LumoBack in a more 
ecologically-valid setting. Limitations of the current study included not having laboratory 
validated standing and stepping time which was not possible due to not having access to 
downloadable data during the laboratory portion of the study so sedentary activities had to be 
prioritised. Furthermore, the standards used in the free-living study are based on common 
field-based measures and do not represent gold standards used in the laboratory. Therefore, 
the test device (LumoBack) and the comparison devices (activPAL and ActiGraph) could 
introduce substantial error in to the comparison. Whilst this error is minimised by the 
activPAL being extensively validated under both field and laboratory conditions the risk is 
still present. Furthermore, the functions of the LumoBack and its ability to measure its target 
behaviours can change with software and hardware update, and consequently not every 
possible update can be evaluated with research at one particular point in time. Additionally, 
during the free-living study, participants were asked to calibrate the LumoBack sensor every 
time they placed the sensor back on their person, however, if participants did not perform this 
re-calibration, the sensors posture algorithms would still be set to their previous calibration 
potentially producing an erroneous measure of posture . Another limitation was that the free-
living assessment contained fewer participants owing to the burden of wearing multiple 
sensors for a long period of time. Furthermore, the large standard deviations demonstrated the 
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large variability within the data suggesting that further research is need to corroborate these 
findings. 
4.5 Implications and Conclusions 
The LumoBack demonstrated acceptable criterion and convergent validity when compared to 
direct observation, activPAL, and ActiGraph under laboratory conditions and acceptable 
convergent validity as a measure of sedentary behaviour, standing and stepping behaviours 
compared to the activPAL under free-living conditions. The results from this validation study, 
in combination with previous validation studies, conducted to determine the accuracy of the 
LumoBack ActiGraph and activPAL as measures of sedentary behaviour indicate that the 
LumoBack has similar validity to the activPAL and the ActiGraph may over-report sedentary 
time in ecologically-valid settings. The current information on its validity makes the 
LumoBack an attractive device, for use as a sedentary behaviour measurement tool. 
Additional work is warranted to determine if differing body types (e.g. longer leg lengths 
altering waist angles during differing sitting permutation) could influence the validity of this 
device. For this to occur, researchers will need to expand the analytical techniques that are 
currently used because of the volume and complexity of wearable data. The LumoBack 
should also be further validated in other age groups the sitting and gait patterns may differ 
and therefore alter the validity of the device.  
As seen from Chapter 3 (page 46), the LumoBack is capable of providing immediate 
feedback on its measured behaviours, this in combination with its inexpensive cost and 
potentially a wear site that is more conducive to participant compliance (lower waist) may 
make the LumoBack a more pragmatic and practical option than other devices which require 
surgical dressing to attach (e.g. activPAL) or devices that are attached to a chair and therefore 
require multiple units (e.g. Darma) to use. Furthermore, the LumoBack appears to be a more 
accurate measure of sedentary behaviour than the ActiGraph in free-living situations. The 
results from this study, in combination with the measurement (e.g. posture monitoring) and 
self-monitoring (mobile application and vibratory function for real time feedback) attributes, 
may make the LumoBack a useful tool in interventions aimed to reduce sedentary behaviour. 
.
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Chapter 5 - Repurposing the LumoBack 
Posture Sensor as a sedentary behaviour 
self-monitor and feedback tool 
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5.1 Introduction 
In the systematic scoping review from Chapter Three (page 46) it was revealed that the 
LumoBack was one of the most promising self-monitoring tools of sedentary behaviour. Next, 
the validation study in Chapter Four (page 84) found the LumoBack to be a valid measure of 
sedentary behaviour. However, the LumoBack in its original format provided vibratory 
feedback on sub-optimal sitting or standing posture (e.g. slouching) and was therefore not 
optimised for use as a sedentary behaviour self-monitor and feedback tool. As a result, the 
LumoBack needed modification before it could be used as a sedentary behaviour self-
monitoring device. Therefore, the purpose of this chapter is to serve as a bridge to describe 
the alterations made to the LumoBack device to make it suitable for use as a sedentary 
behaviour self-monitoring device in interventions aimed at reducing sedentary behaviour. 
5.2 Repurposing of the LumoBack App 
5.2.1 Original LumoBack Posture Sensor 
The LumoBack (LumoBody Tech, Inc, Palo Alto, CA), which is a small (4.15 x 10 x 0.8cm, 
25g) and flexible posture sensor which is worn on the lower back (see figure 5.1). Designed 
to measure an individual’s posture, it uses inertial sensors, which collects data at a constant 
25Hz (aggregated on data output to five minute proportional epochs) and is controlled 
through a mobile application (app) via a BLE connection that can be used by both iOS and 
Android operating systems. The LumoBack has personalised calibration algorithms built in 
which adapt to each person’s body shape and movement behaviour. These are used to create a 
recommended optimal back posture model. The embedded posture sensors feed data to 
machine learning algorithms that continuously track the amount of time spent lying (used to 
infer sleeping), sitting (including car mode), and standing and also functions as a pedometer, 
tracking its wearers’ number of steps. The monitor connects wirelessly via BLE to a mobile 
application syncing with the app, with data transferred between the LumoBack and the app at 
600 bytes/sec. The LumoBack app includes an avatar that mimics the postures and daily 
activities of the wearer in real time. The data from the sensor, along with the on board 
analytics allow the app to provide visual feedback to promote good posture. The on-board 
sensor feedback is a vibratory pulse which alerts the wearer to the need to correct their sub-
optimal back posture. There is also a push notification function within the app which can alert 
the user to a (user-defined) period of prolonged sitting time (371).  
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Figure 5.1 - The LumoBack Posture Sensor and mobile application 
From Top to Bottom: the LumoBack device and associated strap. The LumoBack app with avatar and minimum 
cards (Left to right: Posture Card, Stand Ups, Steps, Sit Time, Sleep) that are displayed on the app.  
Within the app, the data are presented on minimum (min) cards; there are five min cards each 
displaying a different piece of information. These min cards are: 
• Posture Score - measure of how much you slouch, vs sit/stand up straight – provided 
as a percentage of time in straight posture. 
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• Sit time - amount of time spent sitting. 
• Stand Ups – number of times per day that the wearer stands up.  
• Steps – number of steps taken, distance travelled, and calories burned.  
• Sleep – time spent sleeping (inferred from lying time). 
Each of these min cards, once tapped, opens up into a maximum (max) card (figure 5.2) 
which provides further detail on the information that has appeared on the min card. The 
posture max card provides a swingometer (dial) of good or bad posture throughout the day, 
along with tabs for total straight time and total slouch time. In the Sit time max card, presents 
the wearers sit time is presented as a pie chart breaking down the day/week/month wear time 
into standing, stepping, sitting and driving (excluding lying time). The Stand ups max card 
consists of a single bar of progression towards daily stand ups goal. The Steps max card 
consists of an arc which shows the advancement towards daily step goals. The Sleep max 
card is extremely similar to the sit time max card in that it comprises a pie chart breaking the 
lying time into time spent lying on the back/front/left/right. In addition to the pie 
chart/swingometer etc on the max cards, there is a temporal bar chart of the accumulation of 
the behaviour of interest throughout the day/week/month. As previously alluded to, the 
LumoBack provides vibratory feedback when the wearer is in a slouched sitting or standing 
posture. This vibration can be feedback in either a one off buzz or a continuous pulse and can 
be feedback after a user-defined period of user-defined severity of slouching. Additionally, 
the LumoBack can provide a push notification which reminds the user to stand up after a 
period of user defined sitting. 
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Figure 5.2 - Examples of max cards. A Sit time Max card; B: Step Max Card; C: 
Posture Score Max Card; D: Sleep Max Card; E: Stand Ups Max Card 
 
Unfortunately, individuals, particularly during working hours, do not keep their phone readily 
available, it is usually turned off or kept out of sight so as to provide boundaries between 
work and non-work activities (372–374), which would negate the effect of the push 
notification as a feedback modality to aid in the behaviour change. Therefore, it was 
necessary to modify the LumoBack to create a firmware, application and device capable of 
repurposing the LumoBack to provide real time feedback of sedentary behaviour to the users. 
 
5.2.2 Modification to the LumoBack Mobile application 
5.2.2.1 Control Mode 
The first required development commissioned was the need for a control mode within the app. 
Due to the feedback continually being present on the app homepage, any period of 
measurement of physical activity or sedentary behaviour to acquire a baseline might be 
influenced by the presence of the feedback. This has been shown in pedometer studies 
assessing reactivity (375–377). Previous research has indicated that when comparing sealed 
and unsealed conditions of a pedometer study, the sealed condition when participants are 
aware of the device may elicit some degree of reactivity (375–379), therefore, a ‘control 
mode’ of the LumoBack app was developed and created (Figure 5.3). 
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Figure 5.3 - the differences between the original mobile app and the modified control 
mode  
From left to right, Left: normal LumoBack app, Middle: Turning off the min card in the LumoBack app settings, 
Right: New LU LumoBack app without control mode. 
 
As can be seen from Figure 5.3, the invention of the control mode made the min cards for all 
behaviours invisible to the user. This was, fundamentally, a cosmetic change. The min cards 
were still present, and the device is still relaying data to the app, the change just makes the 
data not viewable to the user. Because the LumoBack needs to be calibrated to the wearer’s 
body posture when it is worn and the Lumo avatar is integral in this process, the avatar was 
therefore not removed from the control mode. 
5.2.2.2 Sedentary Buzz 
In addition to the control mode, a change was made to the vibratory function of the device. 
Briefly, the LumoBack in its original format vibrated when the wearer was in a slouched 
posture, either during standing or sitting. The devices firmware was altered to allow for the 
posture buzz to be a sedentary buzz. Under this new firmware, the user can define the amount 
of sedentary behaviour (sitting and/or lying; in mins) after which a single, strong two second 
buzz will alert the user to their prolonged period of sedentary behaviour. The time before the 
sedentary buzz occurred could be set between one and 541 minutes (541 minutes was the 
  
120 
 
upper time limit within the system, this time would effectively turn off the sedentary buzz. 
This upper limit was allowed as it is implausible to sit for 9 hours in the target population of 
the thesis.  
   
  
Figure 5.4 - Setting up Sedentary buzz in the LumoBack terminal  
 
The sedentary buzz (Figure 5.4) was set up by altering small pieces of code in the mobile 
application terminal (coding log which is in the background of the application usually hidden 
from the general public). The investigator will change the time before the sedentary buzz 
occurred in the terminal using a simple piece of coding:  
Command: <sbt>  
Parameter <sedentary buzz delay in minutes>.  
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This would be followed up with another piece of coding:  
Command: <sbtget>  
Parameter <none>.  
This is necessary to make sure that the first piece of coding has been implemented correctly.  
The changes to the Lumo app were implemented by creating a new firmware (permanent 
software programmed into a read-only memory), with the new firmware connected to specific 
generated email addresses by Lumo BodyTech. When a specific email address is associated 
with a LumoBack device, the new firmware with the Sedentary Buzz supersedes the original 
LumoBack firmware.   
5.2.2.3 Mobile App Analytics 
There are three main steps to building a mobile application; firstly (and obviously) is building 
the mobile application, second is acquiring users for the app and finally is engaging and 
monetising users. To engage and monetise users mobile app developers utilise app analytics, 
which provide a plethora of details, including how many users have downloaded the app in 
total, how many of those users are active, how do users interact and engage with the app, 
which features do they most often use and which do they ignore and more. Mobile 
applications account for 89% of consumer media time on mobile devices (380). Companies 
investing in mobile app development use mobile app analytics to optimise their apps, without 
which developers risk their app reach and engagement being unclear. Using mobile app 
analytics companies can get insights related to three key metrics: business-related metrics 
(conversion, retention and engagement rates), app performance metrics (user’s experience 
with an app, knowing which pages have been viewed the most or least, which features of the 
app are mostly used or rarely used) and low-level metrics (information on any crash’s bugs or 
bad behaviour of the app). App performance metrics would be of particular interest from a 
public health perspective as it will provide insight into participants engagement with the 
intervention. One such type of mobile app analytic is Flurry Analytics. Flurry analytics 
enables users to analyse consumer behaviour through data observations. The platform 
provides features for user segmentation, consumer funnelling (describes the journey a 
consumer takes through an applications search system) and application portfolio analysis. In 
other words, Flurry analytics allows developers to see what their users are looking at on their 
app and for how long.  
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5.2.2.4 Data Aggregation and Download: Conversant Health 
As with most health and wellbeing mobile apps, the downloading of data is not always 
possible. However, due to the freely available Application programming interface (API; a 
method of connecting one website/software to another) have made it possible for data 
aggregation services to build websites and software (fee for services) whereby 
users/customers can download their data from wearable devices. One such company 
‘Conversant Health’ (35TUhttps://www.conversanthealth.com/U35T) was approached in order to 
facilitate the API integration from LumoBody Tech. Figure 5.5 displays the website which 
Conversant Health built for the intervention for the download of data.  
 
Figure 5.5 - Conversant Health platform built for the DeSIT intervention 
As new participants come in to the study, the investigator would register the participant into 
the Conversant system. Registration information could include any information that the 
investigator deem necessary (e.g. User ID, DOB, study registration data etc). Subsequently, 
the investigator would link the LumBack posture sensor to their account (via a Lumo 
BodyTech provided website). Every evening, the Conversant Health platform would query 
the Lumo API for all data between the time of their last sync and the current time, storing it 
into the Conversant Health databases. If the user is new (e.g. there was no previous sync 
time), it would use their registration date. Additionally, participant laboratory information 
could be added to the system via a participant data entry form. An upload function was also 
compiled on the system to allow for upload of additional auxiliary information (as long as the 
uploaded information had the participants registered information attached to it (i.e. their user 
ID). Every 15 minutes, the Conversant platform would aggregate the downloaded 
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data/uploaded data respective of each participant, as per the specification of the study 
protocol. These aggregations were then published and available for study investigators to 
download (in this instance all in CSV downloads).  
5.3 Summary 
In summary, the LumoBack was altered to create a control mode (no feedback on the mobile 
app) for baseline measurement and sedentary buzz for the intervention period. Additionally, 
access to mobile app analytics was also developed to measure exposure to the intervention 
and engagement with the app during the intervention period. Finally, data integration, 
aggregation and download capability was also developed to allow seamless downloading of 
data without further participant burden. Table 5.1 is a summary of the changes commissioned 
to alter and configure the LumoBack into a new sedentary behaviour self-monitoring and 
feedback tool. Preliminary evaluation of these commissioned changes showed that the 
changes were achieved, therefore making the repurposing successful.  
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Table 5.1 – Summary table of commissioned changes to the LumoBack Mobile Application 
Need Challenge  Commissioned Change 
Control Mode Need control mode in LumoBack app to prevent 
salient behaviour change information being available 
at baseline.  
Creation of a cosmetic change to the application 
user interface, whereby the min card removed from 
the user interface so that participants could access 
their behavioural data.  
Sedentary Buzz LumoBack, in its original format, possessed 
vibratory feedback based on bad posture rather than 
prolonged sedentary behaviour.  
A new firmware was created to enable a sedentary 
buzz (vibratory feedback) after a user-defined 
period of time.  
Mobile Application Analytics To assess the feasibility of the interventions using the 
LumoBack, engagement with the mobile app was 
necessitated. 
Flurry app analytics were integrated into the new 
Loughborough University LumoBack app allowing 
data to be collected on how often participants 
engaged with the LumoBack app (e.g. how often do 
they tap on the sit time min card, how long they 
spend on the sit time max card). 
Data Integration Aggregation and Download Due to the commercial device not having the 
extensive data analysis and downloading capability 
of research grade device, a service was sought for the 
integration, aggregation and download capability for 
LumoBack data.  
Conversant Health created a platform with the 
ability to integrate LumoBack data for download 
and analysis, as well as study management and 
flurry analytics data aggregation.  
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6.1 Introduction 
As an increasing body of evidence suggests that sedentary behaviours are associated with 
poor health outcomes (28), increased attention is being paid to the development of 
intervention methods that focus on reducing sedentary behaviour and increasing physical 
activity levels (34,35). Self-monitoring has been proposed as a promising avenue by which 
behaviour change can occur (41) and its use in interventions is on the rise. Furthermore, 
evidence from meta-regression studies (42,210) revealed that interventions aimed at 
increasing physical activity self-monitoring with one or more of four other self-regulation 
techniques, were significantly more effective than interventions not including self-monitoring 
(41,42,210). 
Along with the rise in self-monitoring, there has been a rise in commercial wearables and 
activity trackers. The rise in commercial activity trackers comes through their ability to create 
data and generate information on behaviour as well as being able to easily make meaning and 
take action from these devices (234,381). Research also suggests that individual self-
monitoring devices, such as pedometers, are a common element of successful physical 
activity interventions (211,382,383), and can increase physical activity (384–386) and 
decrease sedentary time (384,385). Recent advances in technology have seen the emergence 
of more sophisticated commercial activity trackers that go beyond just simple step counting 
to incorporate many of the strategies known to support behaviour change (387). Such 
strategies, including the provision of detailed, real-time feedback, long-term tracking, 
prompts/cues, and goal setting, as well as the measurement of multiple behaviours, give 
commercial trackers the potential to be effective behaviour change tools (244,387). Their 
potential as low cost behaviour change support tools has been recognised by workplace 
wellness programs in the US, where activity trackers are distributed to encourage employees 
to increase physical activity with the aim of getting healthy and therefore reducing their 
insurance premiums (388,389). However, as seen in Chapter Three (page 48), there is a lack 
of sedentary behaviour based commercial trackers.   
There is minimal research on the feasibility, acceptability and effectiveness of commercial 
activity trackers as intervention tools, traditionally interventions utilise research grade 
pedometers. A recent review aiming to synthesise the efficacy and feasibility results of 
electronic activity monitoring systems (pedometers were not included in this review as it did 
not meet the authors’ definition of an electronic activity monitoring systems) within 
published physical activity interventions, highlighted the large heterogeneity in the small 
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group of research studies and the mixed quality of research (239). Five of the 11 studies 
included in the review showed significant improvements in physical activity, and three of the 
studies found significant improvements in sedentary behaviour in the activity monitoring 
system (239) suggesting that interventions utilising wearable technology may be an effective 
intervention modality to decrease sedentary behaviour and increase physical activity. 
The mixed picture of intervention success of commercial activity trackers may be due to the 
fact that some cannot adequately measure exposure to the intervention. There is a need to 
accurately and objectively measure the exposure to the intervention modality to better 
understand the intervention effect on the study population. For example, in office-based 
standing desk interventions, self-reported log diaries would be provided to participants to 
document when they are at work as a means of measuring their exposure to the intervention. 
However, this methodology is open to bias, potentially diluting the intervention effect, 
subsequently, making the finding potentially invalid. Objective measurement of the exposure 
is therefore important to accurately quantify treatment effects. 
As already alluded to, there is little evidence investigating the use of activity trackers to target 
sitting and standing. Furthermore interventions focusing on increasing physical activity do 
not necessarily result in changes in sitting (34,35), likewise activity trackers that focus on 
steps and activity may not necessarily elicit changes in sitting (38). The LumoBack device 
was identified in Chapter 3 (page 46) as a potentially promising tool for individuals to self-
monitor sedentary behaviour. Additionally, the LumoBack has been shown to be an 
acceptably valid measure of sedentary behaviour both in the current dissertation (see Chapter 
4 page 84) as well as previously published literature (177,259). Therefore, the aims of this 
study were: 
• To determine whether a repurposed LumoBack Posture Sensor can reduce sedentary 
behaviour in a sample of apparently healthy adults over the course of five weeks. 
• To quantify the engagement of the participants with the technology determined by 
time engaging with the mobile app associated with the LumoBack.  
In an attempt to understand why individuals engaged with the intervention, investigation of 
health outcome data were used to quantify whether those with the “most to gain” (assessed by 
Metabolic Syndrome risk factor levels) were more engaged. 
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6.2 Methods  
6.2.1 Participants 
A convenience sample of participants were recruited using Loughborough University (UK) 
departmental mailing lists, consenting participants from previous research studies, physical 
and online university notice boards, as well as word of mouth. In total, 42 participants (≥25 
years and over) who owned and could operate an iPhone 4S or later model of Apple iPhone, 
who also had no underlying circumstances which would prevent them from being active were 
recruited into the study. 
6.2.2 Procedures 
Participants attended three visits at Loughborough University’s, National Centre for Sport 
and Exercise Medicine. Procedures were approved by the Loughborough University Ethics 
Approval Sub-Committee. When a person expressed an interest in the study, the participant 
information sheet was sent to the potential participant, which included full details of what the 
study entailed. Upon confirmation of participation in the study an appointment for the initial 
visit was made. At the initial visit, participants were offered the opportunity to re-read the 
participant information sheet (Appendix 3.1 page 258) and additionally, written informed 
consent was obtained. During visit one, participants were given a LumoBack and the 
initialisation and calibration process was explained. The initialisation process involved the 
assignment of each participant to a pre-determined username and password. The new 
firmware was linked to these specific login credentials, thereby initiating the new sedentary 
buzz firmware update. After initialisation, the participants were instructed on the appropriate 
wear of the LumoBack (i.e. worn like a belt centred on the lower back). Following this the 
participants were taken through the calibration process which involved following a number of 
on screen instructions depicted in Figure 6.1. 
 
Post calibration participants were asked to walk approximately 20 meters before sitting down 
on a chair. This allowed the investigator to assess whether the calibration process was 
successful by monitoring the Lumo avatar on the mobile application (app) to make sure it 
mimicked the participant's’ behaviour. Participants were then instructed to wear the 
LumoBack configured in control mode (i.e. no haptic feedback), during waking hours for 7 
days, whilst going about their normal routine. Each night when participants removed the 
LumoBack they were instructed to plug it in to a fully supplied charger. Although the battery 
did not require daily charging, this instruction was given because when placed on or removed 
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from charge, the LumoBack records the act in the data log. This is noteworthy because 
activity monitoring studies require participants to log on/off wear times in a diary, which is 
burdensome and given its subjective nature, open to inaccuracies or biases (390). 
Additionally, if the LumoBack was removed and placed on a flat surface with the logo visible, 
and the unit left idle the device would go into an “inactive” data state. Therefore, in lieu of 
the traditional wear time log diary, participants were provided with an information sheet 
(Appendix 3.2) which explicitly described methods by which they should remove the 
LumoBack. If the participant did not place the LumoBack on charge, they were encouraged 
to place the LumoBack in the inactive position.  
During the second visit, the LumoBack assigned to the participant was altered from control 
mode to intervention mode (i.e. haptic feedback via a sedentary vibration or ‘buzz’). The 
sedentary buzz was set so that the LumoBack would vibrate after 30 minutes of continuous 
sitting. The decision to use 30 minutes of continuous sitting as the trigger for the buzz was a 
pragmatic one. There is no consensus in the literature as to how often individuals should 
break up their long bouts of sedentary behaviour. However, there is both epidemiological 
evidence to suggest that individuals spend up to 75% of their workday sedentary, with much 
of this accumulated in prolonged bouts of >20-30 minutes (19,391). Furthermore, a series of 
experimental studies have found that there can be advantageous cardio-metabolic effects of 
breaking up siting time with either standing or light intensity activity (58,74,94,392). Whilst 
the studies differ on the frequency of the breaks (every 20 minutes or every 30 minutes), a 
pragmatic approach was taken to choose 30 minutes as a sit buzz of 20 minutes may be too 
frequent and may induce disenfranchisement from use of the LumoBack. 
Furthermore, during the second visit, a series of cardio-metabolic measures were taken 
including, body composition, blood pressure, and a lipid and glucose profile. The participants 
wore the LumoBack again for another 4 weeks before returning to the lab for a third and final 
session where the same cardio-metabolic measures were taken. Figure 6.2 is a schematic of 
the study procedures. 
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Figure 6.1 - Calibration process of the LumoBack 
Sequence of steps 
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6.2.3 Measurements 
6.2.3.1 Sedentary behaviour variables  
Sedentary behaviour [comprising lying time, sitting time (including car time)], standing time, 
and stepping time were measured using the custom repurposed LumoBack Posture sensor.  
6.2.3.2 Cardio-metabolic outcomes 
Participants arrived at the lab after an overnight fast of ≥12 hours. Lipid profile and glucose 
was determined using the Alere Cholestech LDX analyser (Alere Inc., Waltham, MA). The 
LDX analyser measures total cholesterol and HDL cholesterol by an enzymatic method based 
on method formulation of Allain et al  and Roeschlau et al (393). It measures triglycerides by 
an enzymatic method based on the hydrolysis of triglycerides by lipase to glycerol and free 
fatty acids and finally the LDX measures glucose by an enzymatic method that uses glucose 
to gluconolactone and hydrogen peroxide (393). The accuracy of Cholestech LDX 
measurements of total cholesterol (TC), calculated LDL, HDL, and triglycerides was 
compared to laboratory analyses, giving correlations of 0.91, 0.88, 0.77, and 0.93 respectively 
(all P<0.01). A study comparing CardioChek PA and Cholestech LDX with a standard 
venous blood sample tested in a laboratory, showed that the Cholestech LDX analyser 
demonstrated slightly better reproducibility than the CardioChek PA analyser when compared 
with laboratory gold standard analysis; however, the study was limited by the small sample 
size (n = 34) with no known risk factors, and did not determine superior accuracy of either 
device. In a comparative study of 100 samples, correlation coefficients between the Point-of-
Care (POC) and laboratory methods were >0.9 for Cholestech and >0.84 CardioChek. This 
translates into machines that are fairly accurate. However, at levels near decision thresholds 
of diagnosis and treatment, the machines may over-estimate triglycerides and HDL, and 
under-estimate LDL (394,395). There is a growing wealth of both epidemiological and 
experimental evidence now that shows the deleterious effect of sedentary behaviour, and 
therefore beneficial effects of breaking up sedentary behaviour, on lipid profile and glucose 
(58,75,94,97,99,392,396–399). Finger-stick blood measurement was taken from the middle 
finger on the non-dominant hand of the participant, with the puncture taking place 
approximately 5mm from the edge of the nail bed. A blood sample of 40 μl was used for the 
test. 
Height was measured using a stadiometer (Leicester Portable Height measure). The 
participants were asked to stand upright back to the vertical backboard of the stadiometer. 
The heels of the feet were placed together with both heels touching the back of the vertical 
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board. The participant’s feet were pointed slightly outward at approximately a 60 degree 
angle. The participants head was maintained in the Frankfort Horizontal Plane position (the 
head is in the Frankfort plane when the horizontal line from the ear canal to the lower border 
of the orbit of the eye is parallel to the floor and perpendicular to the vertical backboard) 
while the investigator lowered the horizontal bar snugly to the crown of the head with 
sufficient pressure to compress the hair. The participants were asked to inhale deeply and to 
stand fully upright without altering the position of their heels. The act of taking a deep breath 
helps straighten the spine to yield a more consistent and reproducible stature measurement. 
The measurement was recorded to the nearest 0.1cm (364). For measurement relating to 
weight and BMI, fat mass, visceral fat mass and fat free mass, the Tanita Body Composition 
Analyser MC-780MA (Tanita, West Drayton, UK) was used. Participants were asked to 
remove all footwear and any extra weight (heavy jumpers, coins in pockets, belts etc.). 
Participants were asked to step on the weight platform, making sure to place their heels on 
the posterior electrodes, and the front part of their feet in contact with the anterior electrodes. 
The participants were then asked to hold onto the grips of the analyser until the measuring 
process had completed. Body weight was measured to the nearest 0.1kg. 
Before blood pressure measurement could be taken the correct sized blood pressure cuff was 
determined. This was conducted by measuring the arm circumference of the participants. 
Participants were asked to stand upright facing away from the investigator, with their weight 
evenly distributed on both feet and their right arm bent at 90PoP at the elbow and their palm 
facing up. Holding the zero end of a measuring tape at scapula, the tape was extended to 
down the centre of the posterior surface of the arm to the tip of the olecranon process (elbow), 
making sure to mark the midpoint. The arm circumference measurement was taken at the 
upper arm by wrapping the measuring tape around arm perpendicular to the long axis of the 
upper arm. Participants were asked to sit, with both feet on the floor and to rest their right 
arm on a table top level with their heart, with their arm stretched out and palm facing 
upwards. The cuff was placed on the bare upper arm approximately one inch above the bend 
in the elbow, with the tubing falling over the front centre of the arm. The cuff was tightened 
evenly around the arm. The participant was then given five minutes to sit quietly. Three 
measures of systolic and diastolic blood pressure were taken using an Omron blood pressure 
monitor, with one minute of rest between each reading to get a stable and accurate average 
reading.  
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Three waist and hip measurements were taken, again in an attempt to get a stable reading. 
Waist circumference was measured in a horizontal plane, midway between the inferior 
margin of the ribs and the superior border of the iliac crest. The hip measurement was taken 
at the widest lateral extension of the hips. Waist and hip measurement was taken to the 
nearest 0.1cm. A health report was provided to the participant upon exit from the study (see 
Appendix 3.3). 
6.2.3.3 Mobile Application Analytics Flurry App Analytics  
App analytics allow for real-time data on user engagement with the app, and importantly for 
the use in interventions, there is no additional burden on the participant. The downloading of 
customised LumoBack app was already connected to app analytics software which meant the 
investigators could tunnel directly into the app use data. A mobile app analytics platform was 
used to determine user engagement by quantifying the number of bouts and time spent on the 
five min/max cards (the tiles present on the app during the sedentary buzz phase of the trial 
see chapter 5 120) within the app. App analytics were determined using Flurry App analytics 
(Flurry, Yahoo, San Francisco, US).  
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Figure 6.2 - DeSIT study procedure schematic 
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6.2.3.4 Data Treatment and Analysis 
LumoBack data were aggregated by the customised platform designed by Conversant Health 
under the specification of the study investigators. The DeSIT platform was able to provide 
three real-time interrogative analyses. These interrogative analyses included a flag in the 
system if a participant had >10 hours per day of non-wear/inactive time, the expectation of 
data for all expected time-points from the start of the study to the end point, and a biological 
implausibility notification to alert the study investigators if the LumoBack has been recording 
a behaviour for a prolonged period of time (i.e. >10 hours on one day). These were used as a 
method to signal to the investigator that there may be an issue with the participants 
involvement in the study and may require further attention. The minimum wear-time criteria 
for a participants data to be considered viable for analyse was set at >1 valid day of data, 
whereby a valid day was deemed to be achieved by >10 hours per day (i.e., 600 minutes) of 
wear time was recorded for the LumoBack. These wear time criteria were selected based on 
the wear time criteria typically applied in ActiGraph studies (20).  
Repeated Measures ANCOVA were used to determine if there were any significant 
differences in sedentary behaviour, standing time and stepping time as measured by the 
LumoBack, across the three time points (control period, week 1, week 5), when controlling 
for the global average wear time of the device. Participant mobile app analytics data were 
used to determine the number of bouts and duration of time spent per week on the specific 
tiles in the LumoBack app. From this a tap engagement ratio: 
𝑆𝑆𝑆𝑆𝑅𝑅𝑅𝑅𝑆𝑆𝑅𝑅𝑆𝑆𝑅𝑅 𝑇𝑇𝑆𝑆𝑇𝑇𝑅𝑅 𝐵𝐵𝑜𝑜𝐵𝐵𝑀𝑀𝐵𝐵 
𝑇𝑇𝑜𝑜𝑀𝑀𝑀𝑀𝑇𝑇 𝐵𝐵𝑜𝑜𝐵𝐵𝑀𝑀 𝑅𝑅𝑜𝑜𝑅𝑅 𝑀𝑀𝑇𝑇𝑇𝑇 𝑀𝑀𝑆𝑆𝑇𝑇𝑅𝑅𝐵𝐵   
and time engagement ratio: 
𝑆𝑆𝑆𝑆𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷 𝑇𝑇𝐷𝐷𝑇𝑇𝐷𝐷 𝑇𝑇𝐷𝐷𝐿𝐿𝐷𝐷 
𝑇𝑇𝑜𝑜𝑀𝑀𝑀𝑀𝑇𝑇 𝑀𝑀𝐷𝐷𝐿𝐿𝐷𝐷 𝐿𝐿𝑆𝑆𝐷𝐷𝐷𝐷𝑀𝑀 𝑜𝑜𝐷𝐷 𝑀𝑀𝑇𝑇𝑇𝑇 𝑀𝑀𝐷𝐷𝑇𝑇𝐷𝐷𝐿𝐿   
were calculated. Furthermore, using the SPSS visual binning tool, participant’s engagement, 
determined by total tile taps from the mobile app analytics tool, into equal quartiles based on 
the scanned cases. Using these groupings mixed measures ANOVA on a sub-sample of 
participants (those in the highest quartile against those in the lowest quartile) was used to 
determine if there were any significant interactions between behaviour and engagement group. 
In an attempt to determine why individuals engaged with the LumoBack, health outcome data 
were used to determine the number of Metabolic Syndrome (MetS) risk factors, using the 
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International Diabetes Federation (IDF) classification (see table 6.1) each participant had. 
Participants were dichotomized into whether they had ≤1 MetS risk factor or ≥2 MetS risk 
factors. Level of engagement between the two groups was compared.  
Statistical data analysis was conducted using IBM SPSS 22.0 (IBM SPSS Inc, Chicago, IL) 
with alpha level set at 0.05. LumoBack data aggregation was performed by Conversant 
Health, with wearable activity data were processed using KineSoft 3.3.80 (KineSoft, 
Loughborough, UK). 
Table 6.1 - International Diabetes Federation (IDF) metabolic syndrome definition 
Central Obesity Waist Circumference: Ethnicity – specific values, plus any two for 
the following:  
Raised Triglycerides ≥ 1.7 mmol/l (150 mg/dl) or specific treatment for this lipid 
abnormality 
Reduced HDL - Cholesterol < 1.03 mmol/l (40mg/dl) in males 
<1.29 mmol/l (50mg/dl) in females 
Or specific treatment for this lipid abnormality 
Raised Blood Pressure  Systolic: ≥  130 mmHg 
Or  
Diastolic: ≥ 85mmHg 
Or treatment of previously diagnosed hypertension  
Raised Fasting Plasma Glucose  Fasting plasma glucose ≥ 5.6 mmol/l (100 mg/dl) or previously 
diagnosed Type 2 diabetes If > 5.6 mmol/l or 100 mg/dl, oral 
glucose tolerance test is strongly recommended but is not 
necessary to define presence of the syndrome 
6.3 Results 
6.3.1 Participants 
Forty-one participants (53.7% female, 44.1 ± 11.3 years, BMI: 25.7 ± 3.7 kg/mP2P) took part in 
the study. 94.6% of the study population were White British, with all participants educated to 
at least A-level, with 83.8% completing an undergraduate university degree, and all in full 
time employment.  
6.3.2 Sedentary Behaviour and Physical Activity  
Table 6.2 shows the mean wear time of the LumoBack (min/day) at baseline, week 1 and 
week 5.  
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Table 6.2 - Mean Wear time (mins/day) for the LumoBack at baseline, week 1 and week 
5 
  Baseline Week 1 Week 5 
Wear Time [mins/day (SD)] 887 (46) 867 (61) 853 (64) 
 
Table 6.3 shows the sedentary behaviour, standing time and stepping time as measured by the 
LumoBack at baseline, week 1 and week 5 for the study population. Sedentary behaviour, as 
measured by the LumoBack, was highest at baseline, which decreased at week 1 after the 
sedentary buzz was activated, and was decreased again at week 5. At baseline, standing time 
was 197.2 mins/day, 195.3 mins/day at week 1 and 194.8 min/day at week 5. Furthermore, 
stepping time at baseline was 93.9min/day at week 1 this decreased to 89.2mins/day and 
increased at week 5 to 107.0 mins/day. When controlling for LumoBack wear time, the 
results of the repeated measures ANOVA revealed that sedentary behaviour was not 
significantly different between baseline, week 1 and week 5 [FR(2,56)R=0.212, p=0.809]. 
Furthermore, there were no significant differences in standing time [FR(2,56)R=1.036, p=0.362] 
and stepping time [FR(2,56)R=2.714, p=0.075] among the three time points.  
Table 6.3 – LumoBack measured behaviours at Baseline, week 1 and week 5 [Estimated 
Marginal Mean Minutes (SE)] 
Behaviour  Baseline  Week 1  Week 5  P ValueP+P  
Sedentary Behaviour 595.9 (17.2) 584.1 (16.2) 550.7 (17.3) .809 
Standing Time 197.2 (12.2) 195.3 (13.9) 194.8 (12.4) .362 
Stepping Time 93.9 (6.9) 89.2 (5.9) 107.0 (8.9) .075 
 + Repeated Measures ANOVA controlled for Global Average Wear Time of LumoBack. 
6.3.3 Mobile App Analytics 
Table 6.4 shows the temporal trend of participants LumoBack app usage. During week 1, the 
frequency of sit time card taps was 4.5 with a total duration of 2 minutes of time spent on the 
sit time card. Compared to week 1, there was a reduction in frequency of sit time card taps by 
36.2%, 30.0%, and 28.8% in weeks 2, 3, and 4 respectively. With total time spent on the Sit 
time tile reducing by 10.5%, 8.5%, and 15.9% compared to week 1 in weeks 2, 3 and 4 
respectively. Week 5 saw the frequency of sit time tile tap return to the level of week 1 with 
4.3 taps per week, however compared to week 1 the total time spent on the sit time tile 
increased by 17.9%, spending 2.3 minutes on the sit time tile.  
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Compared to week 1, where the average number of taps on the Posture score card was 3.4, 
and the total duration was 0.9 minutes, frequency and time on spent on the Posture score tile 
decreased steadily during week 2, 3, and 4 to an average tile tap of 1 tap per week, and 0.3 
minutes spent on the posture score. Similar to the sit time tile, there was a slight increase in 
week 5 compared to the preceding weeks in terms of frequency of taps on the Posture Card; 
however total times decreased to 0.2 minutes. 
In week 1, participants on average tapped on the Step tile 7.5 times, and spent on average a 
total of 3.9 minutes on the tile. Following a similar pattern to the previous two tiles, in that, 
frequency decreases in weeks 2, 3, 4, and 5 respectively. Participants on average tapped on 
the Stand Ups tile 3.1 times and spent on average a total of 0.9 minutes on the tile in week 1. 
Engagement with the stand ups tile decreased from week 1 in weeks 2, 3, 4, and 5 
respectively. Finally, in week 1, participants on average tapped on the sleep tile 1.5 times and 
spent on average a total of 0.4 minutes on the tile per week. Compared to week 1, in week 2, 
3, 4 and 5 respectively. Furthermore, total time spent on the sleep tile decreased, compared to 
week 1, in weeks 2, 3, 4 and 5.   
Table 6.4 shows the number of time participants swiped on the Lumo avatar on the app. 
Briefly, a person would swipe up or down on the LumoBack app if the avatar was not 
displaying correctly what the participant was doing. This would in turn feed into the machine 
learning algorithms to enable the LumoBack to correct its biomechanical model. Participants 
swiped up on the app 2.8, 1.1, 1.1, 0.9, 1.3 times and swiped down on the app, 1.4, 0.9, 0.6, 
0.5, and 0.4 times in weeks 1, 2, 3, 4, and 5. 
Table 6.4 - Average time spent on min/max card and average number of bouts on each 
min/max card [minutes spent (number of bouts)] 
Min/Max Card Week 1 Week 2  Week 3 Week 4 Week 5 
Sit Time 2.0 (4.5) 1.8 (2.9) 1.8 (3.1) 1.7 (3.2) 2.3 (4.3) 
Posture Score 0.9 (3.4) 0.4 (1.8) 0.3 (1.3) 0.3 (1.0) 0.2 (1.4) 
Steps  3.9 (7.5) 2.6 (5.1) 2.4 (4.8) 3.7 (5.4) 3.8 (5.7) 
Stand Ups 0.9 (3.1) 0.4 (1.8) 0.5 (2.0) 0.5 (1.6) 0.4 (1.3) 
Sleep 0.4 (1.5) 0.1 (0.8) 0.1 (0.6) 0.1 (0.5) 0.1 (0.6) 
Swipe Up to Stand * 2.8 1.1 1.1 0.9 1.3 
Swipe down to Sit * 1.4 0.9 0.6 0.5 0.4 
*Swipe Up to Stand and Swipe down to Sit only have bout information as it is an event monitoring metric 
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Figure 6.3 shows the tap engagement ratio and time engagement ratio. This ratio analysis will 
allow for the interpretation of time spent on a particular tile relative to total time on app. Tap 
engagement ratio shows that participant spent proportionally greater bouts and time on the 
steps tile than any other tile. However, the greatest increase in engagement with the app was 
in the sit time card with tap engagement starting in week 1 at 0.225 and increasing to 0.320 in 
week 5, whilst time engagement ratio increased from 0.272 in week 1 to 0.348 in week 5. 
A mixed measures ANOVA was used to determine whether there were any interaction effects 
between engagement group and sedentary behaviour, standing time and stepping time. When 
a sub-sample of participants were placed into engagement groups, when controlling for 
LumoBack wear time, the ANCOVA revealed no significant interaction effects between 
engagement groups and sedentary behaviour [FR(2,28)R=1.883, p=0.1], standing time 
[FR(2,28)R=0.286, p=0.753], and stepping time [FR(2,28)R=0.347, p=0.71] See Table 6.5). 
Table 6.5 – Sub-sample (n=20) of LumoBack measured behaviours at Baseline, week 1 
and week 5 grouped by level of engagement [Estimated Marginal Mean Minutes (SE)] 
 Low Engagement High Engagement 
Behaviour Baseline  Week 1  Week 5  Baseline  Week 1  Week 5  P ValueP+ 
Sedentary 
Behaviour 
640.2 
(30) 
617.3 
(30.1) 
558.6 
(35.8) 
562.4 
(28.3) 
588.5 
(28.4) 
561.2 
(33.7) 
.171 
Standing 
Time 
181.5 
(22.9) 
169.7 
(26.3) 
178.5 
(14.8) 
208.3 
(21.7) 
190.7 
(24.9) 
186.6 
(13.9) 
.753 
Stepping 
Time 
84.9 
(10.1) 
65.7   
(9.7) 
108.7 
(20.6) 
98.2 
(10.1) 
82.2   
(9.2) 
117.0 
(19.4) 
.710 
+ Mixed Measures ANOVA controlled for Global Average Wear Time of LumoBack. 
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Figure 6.3 – Tap and Time Engagement ratio during the intervention for all five 
min/max cards on the LumoBack app 
Tap Engagement Ratio = (𝑆𝑆𝑆𝑆𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷 𝑇𝑇𝐷𝐷𝑇𝑇𝐷𝐷 𝐵𝐵𝑜𝑜𝑢𝑢𝑀𝑀𝐿𝐿) / (𝑇𝑇𝑜𝑜𝑀𝑀𝑀𝑀𝑇𝑇 𝐵𝐵𝑜𝑜𝑢𝑢𝑀𝑀 𝐷𝐷𝑜𝑜𝐷𝐷   ), Time Engagement ratio = 𝑆𝑆𝑆𝑆𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷 𝑇𝑇𝐷𝐷𝑇𝑇𝐷𝐷 
𝑇𝑇𝐷𝐷 ) / (𝑇𝑇𝑜𝑜𝑀𝑀𝑀𝑀𝑇𝑇 𝑀𝑀𝐷𝐷𝐿𝐿𝐷𝐷 𝐿𝐿𝑆𝑆𝐷𝐷𝐷𝐷𝑀𝑀 𝑜𝑜𝐷𝐷 𝑀𝑀𝑇𝑇𝑇𝑇 𝑀𝑀𝐷𝐷𝑇𝑇𝐷𝐷𝐿𝐿) 
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6.3.4 Cardio-metabolic risk factors.  
Table 6.6 shows the cardio-metabolic risk factors at baseline and week 5 of the study. A two 
way, repeated measures ANOVA, controlling for age and sex, revealed no significant 
differences in number of risk factors when comparing baseline to week 5. 
 
Table 6.6 – Participant characteristics and cardio-metabolic health outcomes at baseline 
and week 5  
Characteristics  Baseline  Week 5 P-Value 
Female [n (%)] 22 (53.7)   
Age (years) 44.1 (11.3)P1P    
Anthropometric Measures    
Height (cm) 172.9 (8.2)   
Weight (kg) 80.2 (2.4) 78.5 (2.5) 0.332 
BMI (kg/mP2P) 26.2 (0.6) 25.7 (0.7) 0.311  
Fat Free Mass (kg) 55.3 (1.4) 53.7 (1.2) 0.215 
Fat Mass (kg) 23.9 (1.6) 23.4 (1.5) 0.568  
Visceral Fat % 28.3 (1.4) 29.0 (1.2) 0.208 
Waist Circumference (cm) 87.4 (1.7) 85.9 (1.8) 0.344 
Hip Circumference (cm) 96.4 (2.0) 96.0 (1.7) 0.607 
Waist – Hip Ratio 0.9 (0.1) 0.9 (0.1) 0.306 
Cardio-metabolic risk factors (mmol/L)    
Glucose 5.0 (0.1) 4.9 (0.1) 0.770 
HDL  1.3 (0.1) 1.3 (0.1) 0.140 
LDL  2.7 (0.1) 2.7 (0.1) 0.122 
Non-hdl  3.3 (0.2) 3.1 (0.2) 0.503 
TC/HDL 3.7 (0.3) 3.6 (0.2)  0.666 
Total Cholesterol  4.6 (0.2) 4.4 (0.2) 0.190 
Triglycerides  1.3 (0.2) 1.1 (0.1) 0.254 
Blood Pressure (mmHg)    
Systolic blood pressure  120.5 (1.7) 117.8 (1.4) 0.529 
Diastolic blood pressure  73.3 (1.1) 72.1 (1.1) 0.863 
P
1 
PEstimated Marginal Means (Standard Error) – controlled for age and sex 
6.3.5 Metabolic Syndrome by Engagement 
In terms of engagement with the Sit time card (see Table 6.6), those with ≥2 MetS risk 
factors, in general, had more engagement apps and spent more time per week compared to 
their ≤1 MetS risk factor counterparts. Indeed, those with ≥2 MetS risk factors spent more on 
the app compared to their ≤1 MetS risk factor counterparts at weeks 2, 3, 4, and 5 of the 
intervention period. In week 1, those in the lowest MetS group accrued slightly longer time 
on the app card compared to those in the highest group. A similar pattern occurs in the 
Posture Score card. Those with ≥2 MetS risk factors had more time and taps on Posture Score 
card in weeks 2, 3, and 5. Indeed, participants in the ≥2 MetS spent approximately 30 seconds 
more on the Posture Score Card with up to one extra tap on the Posture Score Card. 
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Again, those with ≥2 MetS risk factor had similar taps but longer time spent on the Steps card 
that those in the ≤1 MetS group. Those in the ≥2 MetS spent 35, 46, 68, and 158 seconds 
more on the Steps card than the ≤1 MetS group in weeks 1, 2, 3, and 4, indicating that the 
higher MetS group engaged to a greater degree than the lower MetS group. 
With regards to the Stand ups card those in the ≤1 MetS group had increased taps on the 
Stand Ups card in weeks 1 and 4, whilst accruing more time on the Stand Ups card in weeks 
1, 3, 4, and 5. Indeed, in weeks 3, 4 and 5, those in the lowest MetS groups spent 31, 17, and 
11 seconds more time on the Stand ups card, respectively. 
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Table 6.7 - Average time spent (mins/week) on min/max card and average number of bouts (bouts/week) on each min/max card [minutes 
spent on min/max card (number of bouts)] dichotomised into ≤1 MetS risk factor and ≥2 MetS risk factors 
Min/Max Card ≤1 MetS risk factor ≥2 MetS risk factors 
Week 1 Week 2  Week 3 Week 4 Week 5 Week 1 Week 2  Week 3 Week 4 Week 5 
Sit Time 2.0 
(4.8) 
1.4 
(2.7) 
1.3 
(3.0) 
1.4 
(3.0) 
1.9 
(4.2) 
1.8 
(4.0) 
2.4 
(3.1) 
2.5 
(3.4) 
2.0 
(3.4) 
3.0 
(4.3) 
Posture Score 1.1 
(3.6) 
0.3 
(1.4) 
0.2 
(1.1) 
0.3 
(1.0) 
0.3 
(1.4) 
0.7 
(3.2) 
0.5 
(2.3) 
0.4 
(1.5) 
0.2 
(0.9) 
0.2 
(1.6) 
Steps  3.6 
(7.3) 
2.3 
(4.8) 
1.9 
(4.6) 
2.7 
(5.0) 
3.8 
(6.1) 
4.2 
(7.8) 
3.1 
(5.4) 
3.1 
(5.0) 
5.3 
(6.1) 
3.9 
(5.1) 
Stand Ups 1.3 
(3.7) 
0.3 
(1.7) 
0.7 
(2.6) 
0.6 
(1.5) 
0.4 
(1.3) 
0.5 
(2.3) 
0.5 
(2.1) 
0.2 
(1.0) 
0.3 
(1.6) 
0.2 
(1.4) 
Sleep 0.2 
(1.3) 
0.2 
(0.6) 
0.2 
(0.5) 
0.3 
(0.4) 
0.3 
(0.6) 
0.3 
(1.6) 
0.3 
(1.0) 
0.2 
(0.7) 
0.3 
(0.6) 
0.3 
(0.4) 
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6.4 Discussion 
The aims of the current study were to assess whether there is any change in sedentary 
behaviour and/or physical activity when wearing the repurposed LumoBack posture monitor. 
Furthermore, in an attempt to understand why individuals engaged with the intervention, 
health outcome data were also used to quantify whether those with the “most to gain” (health-
wise, determined by assessing cardio-metabolic health) were more engaged. 
To the investigators’ knowledge there have been no previous studies investigating or 
examining the use of this device alone as a method of reducing sedentary behaviour or 
increasing physical activity. The goal behind the design and development of the LumoBack 
was to create a wearable device that could quantify posture with a view of correcting poor 
posture more efficiently and effectively than current alternatives (371). Due to the LumoBack 
application programming interface (API) and software development kit (SDK) being openly 
sourced and therefore making customisation readily possible, the LumoBack may offer 
valuable assistance with the goal to simply self-monitor sitting and physical activity 
behaviour during an intervention. However, the findings from the current study suggest that 
the customised LumoBack did not elicit a change in sedentary behaviour over a 5 week 
intervention. Although there are reductions in sedentary behaviour (measured by LumoBack) 
by almost 45 minutes between baseline and week 5, these changes were not statistically 
significant and may be explained by the reductions in wear time reported by the two devices. 
Furthermore, the LumoBack-measured behaviour showed no significant changes in standing 
time or stepping time, although stepping time did increase from ~94 mins/day at baseline to 
107 mins/day at week 5. The poor compliance may indeed be the reason for not finding an 
intervention effect. 
The finding that self-monitoring of sedentary behaviour did not elicit a behavioural change is 
corroborated with other studies in this area (400,401). For example, Project STAND, an 
educational intervention where participants were provided with a Gruve device 
(GruveTechnology, Inc, Anoka, MN), showed no significant differences in accelerometer 
determined sedentary time, nor any statistically significant findings in sedentary behaviour 
determined by the activPAL (400). More recently, an intervention by Ellingson et al. (401) 
used  the activPAL VT (abbreviation for vibrotactile) with a sedentary buzz of 30 minutes 
(similar to the current study) in a population of thirty young adults and found no significant 
within- or between-group differences in total minutes of objectively-measured sedentary 
behaviour or physical activity (401). However, Barwais et al. (402) conducted a four-week 
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randomised control trial to reduce sedentary behaviour and increase physical activity levels in 
sedentary adults. This study by Barwais and colleagues found that an online self-monitoring 
system [Gruve (GruveTechnology Inc)] (386) lead to greater than 20% reductions in self-
reported sedentary behaviour over a four week period. However, as these findings were based 
on self-reported sedentary behaviour, rather than the objective data, conclusions need to be 
interpreted cautiously.  
In the present study, engagement with the app was measured to determine if participant 
exposure to the intervention and those who engaged more with the app would also decrease 
their sedentary behaviour to a greater degree. Sedentary behaviour, when measured by the 
LumoBack, was lower in the high engagement group, and corroboratively, there was higher 
standing time and stepping time in the higher engagement group than the lower engagement 
group, with decreased sedentary behaviour seemingly displaced by stepping time. This is not 
surprising when findings from the app analytics showed that people were most engaged with 
the steps min card rather than the stand ups or sit time (which has information on standing 
time). Participants had the greatest number of engagement bouts and time spent on the steps 
min card, whilst also spending proportionally more time on steps each week compared to any 
other min card. However, the largest increases in proportional engagement were seen in the 
sit time min card, suggesting that there may be a delay in learning/participants educating 
themselves about the importance of reducing sedentary behaviour and what the important 
metrics are in determining sedentary behaviour. Furthermore, those with the ‘most-to-gain’ 
(i.e. those in the highest MetS risk factor group) appeared to engage generally more with both 
engagement bouts and time spent on cards, suggesting that those who were in the unhealthiest 
category engaged more with the intervention than those who were in the healthier category. 
There are a number of possible explanations for the non-significant results of this study. 
Firstly, due to this study being a proof of principle/feasibility study, it was challenging to 
appropriately determine the power necessary to detect a statistically significant difference. 
Nonetheless, these data can be used to suitably power future research. Secondly, sedentary 
behaviour is a highly variable behaviour. Indeed, data suggest that anywhere from 55-70% of 
the day can be spent sedentary (31,96). Furthermore, due to large proportions of the day 
being spent sedentary, small changes (relative to the total time) will make it difficult to 
achieve statistical significance. Thirdly, sedentary behaviour is an inherently insidious 
behaviour, which may be difficult to shift. Unlike physical activity, which is infrequent, short 
in bout length and usually requires planning, sedentary behaviour is a regular activity lasting 
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potentially several hours in length, and ubiquitous in nature. Our environment is queued up to 
facilitate sedentary behaviour (403). Living and office spaces are constructed in such a way 
to make sitting the dominant behaviour. Given this, sedentary behaviour may be a difficult 
behaviour to displace due to its permeating presence. Environmental changes may be useful 
in aiding this displacement (39,404). Indeed, a systematic review of behaviour change 
strategies used within interventions that sought to reduce sedentary behaviour in adults found 
that interventions based on environmental restructuring were the most promising (41). 
Furthermore, provision of sit-stand desks has been shown to be effective in reducing sitting 
time in adults (37). In addition, motivation to change will involve conscious decision making 
as well as less conscious ‘automatic’ processes. The latter involve acting in accordance with 
basic likes and dislikes and with rather little deliberation. Automatic processing will involve 
habitual reactions to the environment and acting out of habit (405). This is highly likely for 
sedentary behaviours where chairs are provided and sitting is the norm. Whether it is possible 
to create a situation where not sitting is seen as ‘enjoyable’, and hence the default option, has 
not been tested.  
Likewise, in the systematic review of behaviour change strategies, self-monitoring was the 
behaviour change technique that was shown to be particularly promising (41). Behaviour 
change theory is now suggesting that self-monitoring is just one (albeit an important one) of 
many ways that could change behaviour (42,187,209,210). Whilst the current study gave 
participants a small but better understanding about sedentary behaviour, and the adverse 
health effects associated with it, as well as the ability to explore the behaviour change 
technique of self-monitoring, when they leave contact with the investigator, they were 
essentially on their own to embed the strategies in to their lives. Without environmental 
restructuring or other behaviour change strategies, it may be difficult to incorporate and 
embed self-monitoring into individual lifestyles. There is also a need to assess how self-
monitoring in accordance with overt changes in the environment may change the outcomes of 
interventions. Combinations of multiple behaviour change techniques and strategies might be 
particularly important in individuals who do not see themselves as being at risk of the 
deleterious health effects of prolonged sitting. A recent cluster randomised control trial study 
by Healy and colleagues (40) implemented a multicomponent intervention employing 
organisational, physical environmental and individual behaviour change methods to reduce 
sedentary behaviour. The workplace-delivered multicomponent intervention was successful 
at reducing workplace and overall daily sitting time in both the short and long-term (40). 
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Consequently, interventions may be better constructed when using a combination of 
environmental restructuring and self-regulatory techniques.  
Fourthly, the LumoBack is a wearable outlier, in so far as, many wearable devices currently 
on the market are worn on the wrist (approximately 55% of wearables are worn on the wrist 
and approximately 60% of wearables are worn on the wrist hand or arm), it might therefore 
be the case that devices which are worn around the waist (which make up approximately 3% 
of the market (406), might not be suitable for behaviour change. Whilst the wrist might not be 
the best location for activity recognition (407,408), the large number of wearables worn on 
the wrist, in accordance with scientific literature, seems to suggest that this is the best place 
for user adherence (409), therefore, the LumoBack (worn around the waist on the lower back) 
might not be a wear-site conducive to participant adherence or engagement. Indeed, exit 
questionnaire data from this study revealed that 59.5% of participant found that a wear site at 
the waist was not an important contributing factor in whether or not they chose a wearable, 
compared to the 67.6% who indicated that using a wearable that can be worn at the wrist was 
important, of which 56.8% indicated that wearing a device at the wrist was very important.  
Fifthly, results from the mobile app analytics demonstrate that individuals were most engaged 
with the Steps card on the LumoBack app. Indeed, over half the time in each week spent on 
the LumoBack was spent engaging with the steps min card. This is not surprising when 
considering that the majority of consumer activity trackers measure physical activity, 
traditionally in the form of steps (see scoping review from chapter 3 page 48), and that 
knowledge of the potentially adverse health effect of sedentary behaviour and sedentary 
behaviour guidelines are low (410). Indeed most mass media campaigns and population level 
information has been focused on increasing MVPA (411), so it is not surprising that people’s 
perceptions of sedentary behaviour are not in keeping with what is known in the literature. 
However, daily MVPA (if meeting guidelines) only accounts for approximately 2-3% of our 
daily behaviour (20) (which also includes sleep, sedentary and light physical activity), whilst 
epidemiological data show that sedentary behaviour accounts for approximately two-thirds of 
the day (26,31,96). Consequently, a greater focus and education on sedentary behaviour 
guidelines [where available e.g. new Canadian 24 hours guideline (219)] and the associated 
adverse health effects might be needed.  Furthermore, unpublished data from the Mi-LAB at 
Loughborough University found that when individuals were presented with 20 feedback 
options (on a single A3 sheet of paper) and were requested to place four stickers on the four 
options that they thought would be most useful to monitor their health (no restrictions on 
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placing a certain amount on each topic, free to pick four from a single topic e.g. MVPA if 
desired), steps were the most frequently selected (n=20 of 33) as one of the top four feedback 
options to monitor their health (Unpublished Data). A participant’s greater interest in steps, 
combined with the low levels of knowledge around sedentary behaviour, may partially 
explain the lack of significant behaviour change seen in this intervention. On the other hand, 
the largest increases in min card bouts and time were seen with the sit time card across the 
weeks of the intervention. This suggests that it takes a longer period of time for participants 
to become engaged with the issue of reducing sedentary behaviour and with the metrics 
associated with sedentary behaviour (411). These might be more cognitively loading than the 
traditional step count metric. Therefore, more educational information might be needed from 
the outset of interventions; making participants knowledgeable of the detrimental effects of 
sedentary behaviour making feedback from the LumoBack having greater salience.  
Finally, whilst the systematic scoping review in Chapter 3 (page 48) found the LumoBack to 
have a number of self-monitoring and feedback attributes, feedback is an inherently 
personalised element, and feedback should be tailored to the individual. In the current study, 
we took the pragmatic decision to set the sedentary buzz of the LumoBack at 30 minutes. 
Two other studies which have used vibrating self-monitoring tools set at 30 and 60 minutes, 
also found no statistically significant changes in time spent in sedentary behaviour (36,401). 
This might suggest two issues: firstly, that perhaps vibratory feedback is not the most 
powerful feedback mechanism by which to act, despite its low cognitive loading, some 
individuals may be better suited to auditory feedback, or to omnipresent feedback like the 
FitBit Flower, and secondly, that the amount of time after which the sedentary buzz occurs 
needs to be a personalised and tailored time (i.e. participants decide whether to have the buzz 
at 20 minutes or 30 minutes). Future intervention should aim to take a person centred 
approach in the development of feedback. 
There are a number of strengths associated with this study. Firstly, this study is, to our 
knowledge, the first to use a novel, commercially-available piece of wearable technology, 
which has been validated as a measure of posture. Secondly, the usage of mobile app 
analytics to measure the user’s engagement with the LumoBack is also a novel component to 
measure the exposure to the intervention and one that should be utilised and investigated 
further in future interventions. Thirdly, this study commissioned and deployed a scalable 
online platform for the aggregation and download of LumoBack data. Whilst the company 
behind this platform is no longer running, there are a number of alternatives available which 
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can be used in lieu of the current system, which can be initiated and deployed in a short space 
of time and accessed from most devices connected to the internet. Fourthly, this study 
deployed the LumoBack as a continuous, pervasive intervention which is different from other 
intervention such as sit-stand desk which only work in their context of their deployment or 
educational programmes which traditionally occur in organised workshops. Finally, the 
LumoBack contains an objective measure of wear and non–wear time which is something 
that previously would have relied upon algorithms or diary logs to track. This is of particular 
importance when assessing sedentary behaviour given that the missing data from poor 
wear/non-wear recording at both the beginning and end of the day is likely to be sedentary 
behaviour. 
There are also a number of limitations associated with this study. Firstly, the participants in 
this study were a sample of mostly white-British, highly educated (due to it being a broadly a 
sample of convenience), which therefore may make these findings non generalisable to the 
general population. Secondly, there was no environmental change associated with this 
intervention, which, as already alluded to, may have meant that individuals who are 
motivated to change, may have lacked the capacity to do so when the prompt occurred. 
Thirdly, POC testing is not the gold standard for measuring lipid profile and glucose and 
more clinical laboratory techniques should be utilised in the future. Finally, there was no 
follow up beyond the five week intervention study, which may have given us an indication of 
how behaviour changed after commencement of the study. Fourthly, the need for individuals 
to own a iPhone to participate in this study decreases the generalizability of the study, as not 
everybody has a iPhone in the general population. Finally the study may not be long enough 
to allow for an effective behaviour change to take place. 
6.5 Conclusion 
In conclusion, self-monitoring of sedentary behaviour using the LumoBack on its own may 
not be sufficient to change behaviour. Future studies should look to assess different feedback 
methods and modalities in an attempt to optimise the salience of the feedback and to make it 
more likely to be heeded by the participants. Furthermore, follow up interventions should 
look to assess the use of real time sedentary behaviour feedback in conjunction with other 
behaviour change strategies and techniques (e.g. environmental restructuring) as part of 
multi-faceted designs that target reductions in sedentary behaviour. Furthermore, the use of 
mobile app analytics to determine intervention exposure and engagement not only as a ratio 
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of app time, but also as part of mobile use as a whole, should be further investigated. Finally, 
further research should look to conduct interventions over a longer period of time, longer 
than 5 weeks, as 5 weeks may not be long enough to instil behaviour change. Indeed small 
changes in behaviour may be more sustainable and prevent further increases in sedentary 
behaviour. These research directions show strong potential to add value to wearable 
technologies and increase their potency in lifestyle behaviour change interventions.  
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This thesis presents three studies and development of the user interface which each contribute 
novel and important components to the evidence informing the use of commercially available 
technologies as measurement and behaviour change tools in sedentary behaviour research in 
adults. The overall purpose of this three study thesis was to review, validate, develop, and 
apply a novel commercially available technology to generate new insights in its ability to be 
used as a behaviour change tool for self-monitoring sedentary behaviour with the intent of 
reducing such behaviour. This thesis has presented a systematic review, which scoped the 
current technologies that could be used to self-monitor and provide feedback on time spent in 
physical activity and/or sedentary behaviour, as well as quantifying the level and frequency 
with which self-monitoring attributes appears in these technologies. Using the information 
from the systematic scoping review, the LumoBack was identified as the most promising 
technology for monitoring and providing feedback on sedentary behaviour. Therefore, the 
second component of this thesis was to ensure that the LumoBack could provide accurate and 
reliable measures of sedentary behaviour. Having determined the validity and reliability of 
the LumoBack, the third and final study presented in this thesis was to determine whether a 
repurposed LumoBack Posture Sensor can reduce sedentary behaviour in healthy adults.  
7.1 Summary of main findings 
In Chapter Three, a systematic review was conducted to scope the current standing of 
wearable technologies that are available that can self-monitor physical activity and/or 
sedentary behaviour. The review identified 82 pieces of technology, 73 of which self-
monitored physical activity, the majority of which originate from the consumer electronic, 
health and fitness market. These devices tended to consist of an accelerometer for activity 
measurement (steps, calories burned, distance travelled) with varying levels of secondary 
sensors that provide additional metrics for behavioural and physiological measurement. 
Fortuitously, a greater number of these devices are now providing not just feedback on 
activity time, but also time spent in periods of inactivity which is now the fourth leading risk 
factor for chronic disease (23). Unfortunately, there is a dearth of monitors that measure 
sedentary behaviour, with only nine having been identified in the scoping review. However, 
unlike activity monitors that measure activity traditionally using one methodology (i.e. 
accelerometry), the commercially available postural allocation monitors utilise a variety of 
methods to determine sedentary behaviour, including inclinometry and pressure sensors. Both 
these types of devices usually utilise proprietary algorithms to convert the raw signals from 
the sensors to provide metrics of use. They also provide feedback, the majority of the time, 
153 
 
either via vibratory feedback (e.g. LumoBack) or via an omnipresent display on the device 
(e.g. Garmin Vivofit). These devices tend to, but not exclusively, connect to an app for 
feedback on physical activity and sedentary behaviour. For physical activity, this usually 
takes the form of energy expenditure or proprietary company points (e.g. Nike Fuel). For 
sedentary behaviour, this usually takes the form of time spent sitting/lying (e.g. LumoBack) 
These mobile apps allow the wearer to receive real-time continuous feedback along with 
goal-setting capabilities and customization of type and timing of feedback; this is an aspect 
not traditionally offered by research devices. 
From the systematic review, the LumoBack was identified as the most promising sedentary 
behaviour self-monitor due to its numerous feedback attributes and its ability to measure 
sedentary to the current definition and therefore warranted further investigation into its 
validity. In Chapter Four, an experiment was conducted to determine the validity of the 
LumoBack Posture Sensor compared to direct observation, ActiGraph and the activPAL in 
the laboratory and ActiGraph and activPAL in free-living settings. In both the laboratory and 
free-living setting the LumoBack was seen to be acceptably valid as a measure of sedentary 
behaviour, standing behaviour or stepping behaviour when compared to the activPAL and 
ActiGraph. Given the feedback attributes and immediacy of the self-monitoring capabilities 
of the LumoBack, it may be a potentially useful tool for behaviour change with a view to 
reducing sedentary behaviour.  
In its original format the LumoBack was not optimised to provide feedback on sedentary 
behaviour. Therefore the LumoBack was repurposed to provide vibratory feedback on 
sedentary behaviour. This included collaborating with Lumo BodyTech Inc. to repurpose the 
vibratory function of the LumoBack, originally used to signal sub-optimal posture, and use it 
as a feedback modality for prolonged user-defined sedentary behaviour. Other alterations 
included creation of a control mode for the app, which meant that the user did not have access 
to the feedback on the device, as well as the ability to track user LumoBack app usage.  
Now that the LumoBack had been repurposed, Chapter Five describes a proof of principle 
intervention whereby 42 participants were asked to wear the LumoBack for a period of six 
weeks, (one week of control period, five weeks of intervention) in an attempt to determine 
whether self-monitoring sedentary behaviour could change behaviour. The results indicated 
that the LumoBack as a sedentary behaviour self-monitor may not be sufficient on its own as 
a behaviour change modality to change behaviour. Furthermore, user engagement analysis 
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showed that individuals were mostly interested in the steps card of the LumoBack app with 
peaks in interest displayed around the time of the laboratory visits. Furthermore, those with 
the ‘most-to-gain’ (i.e. high Metabolic Syndrome risk factor group) engaged to a greater 
degree than those in the low Metabolic Syndrome risk factor group. This chapter suggests 
that there is a need for multi-faceted interventions employing multiple behaviour change 
strategies and techniques to change the insidious behaviour that is sedentary behaviour. 
7.2 General Discussion 
Despite almost six decades of research showing clear evidence that engagement in moderate 
to vigorous physical activity (MVPA) reduces the likelihood of developing an array of non-
communicable diseases, and the decade of work that shows increasing sedentary behaviour is 
detrimental to your health, surveillance studies have shown that population levels of 
sedentary behaviour are high (48,51,54,127,412) and the levels of guideline fulfilling MVPA 
are low (19,20,31,48). It is therefore apparent that current interventions are not creating the 
substantial changes that are needed to improve population level health and new intervention 
modalities are required. Self-monitoring as a behavioural modality for beneficially altering a 
range of behaviours and health outcomes is increasing (247,353,413–417), including its use 
in physical activity and sedentary behaviour interventions (38,41,42,210). 
Wearable technology offers potential for continuous and personalised real-time feedback, 
which has not been possible up until now. Indeed, new research finds that over 3 million 
wrist-worn wearable devices such as fitness trackers and smartwatches are estimated to have 
been sold in the UK in 2015, which is up 118% from unit sales in 2014. Furthermore, 1 in 5 
people plan on purchasing a piece of wearable technology in the next 12 months (231). 
Moreover, an estimated 48 million devices were sold worldwide (418), which is expected to 
rise in the coming years. Partner these figures with figures now showing that 76% of adults 
own a smartphone, there is a real sense that wearable technology might be the pervasive 
entity which can have a real influence on behaviour, certainly given the breadth of devices 
that are available in the current market which is apparent in Chapter Two. Wearables are 
inherently tied into the behaviour change technique of self-monitoring, with the majority of 
wearable also able to providing feedback on behaviour, able to allow for goal-setting, and 
importantly, able to provide feedback in light of these goals all of which, in combination have 
been shown to provide greater behaviour control (42,185,210,212).  
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Previous reviews have sought to provide an overview of research grade devices 
(104,123,419–421), or discussion on a particular commercial tracker (422,423) and how 
useful they are at measuring aspects of physical activity. This is presumably because of the 
sheer size of the consumer activity tracker market. There is also a dearth of reviews into the 
measurement tools of sedentary behaviour (52,104). Chapter Three took on the ambitious 
project of attempting to review both the research grade and commercial activity monitors that 
could be used to self-monitor physical activity and/or sedentary behaviour. The over 
whelming outcome from the review was the large number of devices that self-monitor and 
provide feedback on physical activity and there is a scarcity of devices that measure and self-
monitor sedentary behaviour in the current definition. Indeed, no current device measures all 
three aspects of the current sedentary behaviour definition, however there are some promising 
devices.  
There is a logical explanation for the absence of sedentary behaviour devices and a 
flourishing of physical activity devices. The majority of mass media campaigns that are 
currently used by health promoters are used to disseminate physical activity messages (411). 
Couple this with the well-published 10,000 steps goal (424–426), it is unsurprising that most 
commercial activity trackers are based around measuring physical activity, traditionally in the 
form of steps, as this is a metric that is easily understood and of low cognitive bearing to the 
public. Sedentary behaviour is less well understood by the public despite the growing media 
interest and often gets confused with physical inactivity (44). This is apparent in certain 
physical activity monitoring devices (e.g. Apple Watch) that claim to measure sitting time but 
it is expected that this is to be time spent inactive as only accelerometers are present in these 
devices. It may be more appropriate therefore to increase the educating of populations around 
sedentary behaviour as well as increasing the “popularity” or salience of sedentary behaviour 
in the same way that mass media campaigns such as ‘Change4Life’ have done for physical 
activity.  
It should also be noted that this fast-paced innovation of commercial trackers provides an 
obstacle to researchers, as the speed with which research can be conceptualised, developed, 
investigated and disseminated is of a slower pace. Although the review in Chapter Three was 
published in a peer-reviewed journal in Q1 2016, in the time between publication and this 
thesis going to print there have been a slew of new devices which may be of interest to 
researchers, which can monitor a wide variety of behavioural and physiological outcomes. 
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This will necessitate researchers and commercial sector entities working in partnership in this 
ever evolving area to make sure research can remain as up to date and relevant as possible. 
With the increase in these commercial activity trackers, there has been an increase in the 
number of validation studies assessing their ability to measure a multitude of metrics 
(168,170–173,175–178,181,422) with some showing encouraging results for their validity to 
measure physical activity (168,181), whilst others have shown to over-estimate or under-
estimate certain metrics (174,179). Undeniably, Rennie and Wareham (33,106) determined 
that for the currency of use in behavioural research to matter to both researchers and the 
public, accurate measurement of behaviour is necessary. Furthermore, accuracy and precision 
is imperative if consumer devices are to be used in research aiming to determine dose-
response relationships between behaviour and disease outcomes (427). Ttherefore, robust 
validations to determine the validity and reliability of these novel commercial devices is of 
paramount importance. The study presented in Chapter Four showed that the LumoBack has 
acceptable validity as a measure of sedentary behaviour, standing behaviour, stepping 
behaviour, as well as steps taken in adults. These findings are corroborated by previous 
studies (175,177); however, the validation in this thesis was the first to validate the 
LumoBack over the course of the traditional seven day free-living validation protocol. 
Commercial activity trackers are likely to be used more frequently for research purposes 
given their low cost, wear acceptability, immediate feedback capacity, and ease of syncing 
wirelessly with smartphones or smart devices for data retention. Therefore, free-living 
evaluations of these devices with robust comparative measures are imperative to better 
understand the accuracy and precision of these devices in estimating behaviours.  
With commercial devices becoming progressively more user-friendly, further work is needed 
before broad use in intervention studies can be realised. Behavioural lifestyle interventions 
that are delivered face-to-face and incorporate behavioural change strategies have been 
successful in interventions aimed at increasing physical activity behaviours (428). However, 
these types of interventions are labour intensive, expensive and require behaviour change 
experts. It is possible that consumer devices that allow for self-monitoring and the 
incorporation of previously-determined successful behaviour change strategies, could replace 
the high study burden of face-to-face interventions.  
Previous research has been focused on increasing MVPA, however as epidemiological 
evidence suggests the levels of guideline fulfilling MVPA in the population are still low 
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(19,21,22,49). Interventions aimed at reducing sedentary behaviour may provide the ‘biggest 
bang-for-our-buck’ in terms of a public health strategy, as decreasing sedentary behaviour is 
likely lead to increases in light physical activity (due to these two being highly and inversely 
correlated (50)) which can be a gateway to more beneficial MVPA. Self-monitoring of 
behaviour and outcomes have been shown to be effective in a number of behavioural and 
health-related interventions (211,246,413,415–417,429,430) and may be a useful intervention 
modality to reduce sedentary behaviour. At the time of this thesis, to the authors knowledge, 
there were only three other interventions utilising activity trackers to reduce sedentary 
behaviour (400–402), and in fact, one of the devices used was the activPAL VT (a research 
grade device), whilst the other two studies used the Gruve. Only one of these studies showed 
pre-post reductions in sedentary behaviour; however, these were self-reported reduction in 
sedentary behaviour, therefore, these results should be taken with caution. The results of the 
study found in Chapter Five corroborate the findings of these studies suggesting that self-
monitoring on its own did not induce a behaviour change in the study population. The result 
of the engagement analysis showed that individual were more engaged with steps on the 
LumoBack app which is not surprising given the level of information that is disseminated 
nationally on increasing steps. Further strategies may need to be incorporated into 
interventions along with self-monitoring, which also aim to increase the level of knowledge 
surrounding sedentary behaviour making feedback metrics less cognitively loading.  
At the same time as commercial activity trackers increasing in popularity, there is 
preponderance of other ‘ables’ coming on to the market. These include, Nearables (smart 
everyday items with small, wireless computing devices attached to them), Hearables (smart 
headphones designed for a range of purposes including wireless transmission to 
communication, medical monitoring and fitness tracking), Ingestibles (small pill size pieces 
of technology which mainly serve the two primary functions of wireless patient monitoring 
and diagnostic imaging), Embeddables (consisting of microchips that can be implanted into 
or onto the human body for the purpose of monitoring or affecting the body’s biometrics), 
Adhearable (which are usually used for sports, drug-delivery or patient monitoring), and 
Trainables (an adjunct of wearables designed to provide accurate real time feedback to allow 
individual to take an active role in their monitoring with the aim of maximizing behaviour 
change). Despite all these devices having differing applications and measuring different 
biometrics the one thing all of these types of ‘ables have in common is that they are designed 
to have the ability to self-monitor. In addition, given the plethora of ‘ables, which measure an 
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array of both behavioural and physiological metrics, individuals will have the ability to 
monitor the acute health benefits or disadvantages to positive or negative health behaviours 
respectively. This inter-connectivity of such a range of devices means that citizens are 
coming upon a time where they can become an active rather than passive nexus of their 
health. 
Furthermore, this increase in availability of electronic self-monitoring technologies provides 
an opportunity for researchers to utilise them on a large scale for behaviour change by 
integrating them into corporate wellness programmes and health care systems. Recent reports 
from the National Information Board in a review of the National Health Service (NHS) in the 
United Kingdom (UK) indicated the need for “citizens” to start playing a more active role in 
their health care by accessing, entering, and uploading data into their own online medical 
record. Under these new plans, citizens will be able to access and download their detailed 
medical records as well as contribute to it with information from their personal wearable 
technology or biosensors (248,249). And more recently still, the current UK Secretary for 
Health has announced that data from approved health apps will feed directly into personal 
health records, NHS England publishing a library of apps and devices in areas related to 
mental health and other chronic diseases by March 2017 (431). In addition, as more health 
care providers in the United States move to a value-based care system (i.e., “reward points” 
for positive lifestyle alterations that can be redeemed for discounts on a range of products 
and/or activities), mobile technologies that promote health and well-being by engaging in 
important health behaviours (e.g., decreased sedentary behaviours) will continue to grow and 
have the potential to be an integral piece of future health care systems.  
Other advantages of wearable technologies are their relatively low cost compared to their 
research grade counterparts, being compatible with a smart phone, and having an array of 
behaviour change techniques. Lyons et al (387)conducted a content analysis to determine the 
number of behaviour change techniques implemented in 13 consumer devices (387). The 
most common strategies implemented were self-monitoring, feedback provision, adding 
objects to the environment, and goal setting. Furthermore, the industry is developing at such a 
fast pace that very quickly the current wearables will be obsolete and there will be new and 
innovative ways of measuring behavioural and physiological parameters of health.  
There are some concerns with the increased use of commercial activity trackers. The 
innovation and development of these technologies now form part of the Internet of Things, a 
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development of the internet in which everyday objects have network connectivity, allowing 
them to send and receive data. This will mean that current fitness trackers now have the 
ability to double as a smart watch which can also be used to monitor home energy, put 
favourite TV shows on record, or turn a coffee machine on in the morning. All of these 
developments can be seen as ways to engineer activity out of our lives. This is part of the 
Megatrend (pattern or a movement which has a major impact on business and society as a 
whole) of de-industrialisation which is exemplified by the fact that in the 60’s 36% were 
employed in manufacturing and 49% were employed in services whereas as of 2011, 8% 
were employed in manufacturing and 81% were employed in services (432). This shows that 
the increase in modern technological advances has led to a services based economy which is 
epitomised by sedentary lifestyles. It may therefore seem counter intuitive that a portion of 
the Internet of Things which is part of the problem can also be a part of the solution.  
Furthermore, the ‘dirty secret of wearables’ is that a third of users stopped utilising their 
wearable technology six months after purchase (433). A possible reason for this is that habit 
formations may have taken place (research suggest the average time for habits to form is 66 
days (405)) so it may be the case that individuals no longer need the devices for behaviour 
change as it has already occurred. This is unlikely though as population levels of sedentary 
behaviours are high, and levels of MVPA are still low. Another option could be that the 
information provided by some activity monitors are inaccurate as can be seen with the recent 
lawsuit filed against Fitbit (434) for the inaccuracy of their heart rate function in their Fitbit 
Charge HR. Inaccuracy in the measurement may lead individuals to become disenfranchised 
with the device and stop using it; however, as self-monitoring theory (213) tells us that as 
long as a device is relatively accurate with good reliability it can still be a useful self-monitor. 
One other option is that there needs to be improvements in the fundamental consumer value 
proposition. After a period of usage, information from wearables which have remained the 
same from the beginning can make users either get jaded of the stagnated information, or they 
find the information adds nothing as they are already familiar with it and therefore 
participants may require newer layers of information. Whichever the reason, it is clear that 
developments need to be implemented in order to keep people from disregarding wearables 
after a period of time and making there persuasive and pervasive behaviour change tools. 
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7.3 Future direction 
There are essential research priorities that are apparent to build upon the findings in this 
thesis. There is a greater need for collaborative work between computer scientists, 
behavioural scientists, engineers and public health researchers in order to create technologies 
that may have a better uptake. A cursory search of Fitbit, Jawbone, Misfit, Garmin, Hexoskin 
and Withings advertised career opportunities has indicated that there is only one position 
between all of these companies that currently advertise looking for a behavioural scientist to 
help advance the salience of wearables to their users. Furthermore, the co-operative work 
between commercial companies and researchers should look to design methods of measuring 
all aspects of the sedentary behaviour definition, not just postural allocation, but also the 
energy expenditure and whether the individual is awake in order to obtain the most accurate 
estimate of sedentary behaviour possible. 
One of the limitations of current commercial activity trackers is the trade-off between raw 
data measurement and availability of the data for other feedback and battery life related 
requirements. If researchers are going to continue to increase their use of commercial trackers, 
they will require access to greater granularity of data that researchers are accustomed to in 
research grade devices, for data processing and analysis. It is difficult to see how this might 
occur as to accommodate raw data storage and feedback greater than seven day battery life 
would require an increase in the size of the device, and the main customer of commercial 
activity trackers (the general public) has no appetite of the acuity of data which researchers 
require.  
A major issue with current activity tracker use is the problem around stickiness. This is the 
concept describing the ability of the tracker to remain useful and therefore be used for a 
prolonged period without being discarded as is currently the case for a lot of wearable users. 
There are two ways this might occur. Firstly, to integrate activity trackers into other smart 
wearable systems. This would mean that when there is a trough in the practice of positive 
health behaviours the activity tracker remains useful for other reasons and will continue to be 
used, so that when there is a peak in the practice of positive health behaviours, their device is 
already being used and can be engaged with easily. Secondly, activity tracker developers 
should look for a means to evolve data feedback over time so users remain engaged with the 
device because they are receiving new pieces of information, thereby keeping their attention. 
However, it is unlikely this is to occur from the activity tracker company side as there are few 
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ways to monetise this, so there is little incentive for the wearable company to pursue this 
avenue. 
Likewise, work should look to focus on creating personalised feedback that are relevant to 
the individuals (i.e. real-time feedback of information must resonate with the individual and 
not be information that has been presupposed for them, as well as being aware of the 
environment in which the person is in so that the feedback can be acted upon). In a review of 
personal health technology for cardiovascular disease prevention, Franklin et al (435)reported 
that studies using self-monitoring tool are most effective for health behaviour change when 
they are combined with personalised feedback (435). This type of intervention has been 
coined as ‘lifestyle medicine’ by making individuals the centre of their health (436). 
Evidence suggests that personalised feedback following objective measurement may increase 
their awareness of physical activity levels (437,438), which may in turn stimulate intention to 
increase physical activity, which ultimately may lead to positive changes in behaviour 
(439,440) and may be part of the mechanism underlying the effectiveness of pedometers 
(211). Furthermore, research using fMRI to examine neural processes associated with 
affirmation effects during exposure to health messages and feedback, found self-affirmation 
(affirming core values of the individual) may exert its effect by allowing individuals to see 
the self-relevance and value in the message. In other words, for a health-message to be 
heeded by the individual, it must be presented in the method that resonates with individuals 
beliefs on what is important to them (441).  
Personalised feedback, however, may elicit negative effects on participant’s behaviours, if the 
behaviour is seen to be acceptable it may lead to false assurances and a subsequent deviation 
from appropriate behaviour. Furthermore, interventions utilising personalised strategies and 
feedback may cause heterogeneity within the data making it harder to determine the 
effectiveness of interventions. Despite these limitations, further investigation should look into 
combining self-monitoring with context aware personalised feedback. 
There is also an additional need for feedback to become context aware. It is important that the 
feedback or behavioural nudge occurs in a timely manner and aware of the environment and 
situation to which the user is in. For example, if a participant is using the repurposed 
LumoBack to provide vibratory feedback on sedentary behaviour, it is important that this 
occurs in an environment where this advice can be heeded, and not in one where is cannot 
(for example a dentist chair). The increase in the number of technologies that can measure 
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location and context is increasing and proliferating (120) and their use in combination with 
self-monitoring devices may provide context-aware feedback. The combination of context 
aware personalised feedback may increase the salience of the feedback and the likelihood of 
it being heeded by the user. 
Historically, people have always needed to be physically activity (e.g. hunter-gatherer, 
preponderance of manual jobs). However, with the technological revolution there is less need 
to be physically active. Currently, being physically inactive and sedentary is the unconscious 
easy option. Work should be conducted to create a situation whereby being physically active 
is the easy choice to make. One option might be to use a combination of behavioural and 
physiological trackers which can show the acute and immediate health benefits of increasing 
activity and reducing sedentary behaviour. This might be a more potent message to relay 
because temporal discounting literature shows that we are more likely to make an immediate 
decision if we can see the immediate rewards, rather than making an immediate decision for a 
future reward (i.e. relaying the message of ‘be physically active now to reduce the post-
prandial glucose excursion’ over the message of ‘be physically active to reduce the risk of 
developing type 2 diabetes in 20-30 years’ time’) (442–444). 
Finally, interventions should look to layer behaviour change strategies and techniques in to 
multi-component interventions such as the organisational intervention in office workers in 
Australia (38) which is deploying sit-stand desk whilst also utilising the LumoBack to self-
monitor sedentary behaviour. These types of multi-component interventions may have the 
potential to aid beneficial behaviour change.  
7.4 Final Comments 
This thesis presents evidence from three studies regarding the review, validation, 
development and implementation of a commercially available tracker for the measurement of 
sedentary behaviour. Whilst the results in this thesis are preliminary and require further 
investigation, they indicate that there is cause for concern around the lack of devices that are 
capable of measuring sedentary behaviour in its current definition. Those devices that can 
measure sedentary behaviour only do so to a certain degree of the current sedentary 
behaviour definition, namely the postural allocation segment. Having said that, those that do 
measure sedentary behaviour such as the LumoBack, by measuring postural allocation have 
been shown to be valid and reliable when tested and the validation conducted as part of this 
body of work has corroborated these past findings. As commercial trackers continue to 
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expand, it is likely that researchers will continue to use these devices as measurement tools, 
and behaviour change tools. The final study in this thesis developed and implemented one 
such commercial device (LumoBack) as a behaviour change tool in an attempt to reduce 
sedentary behaviour. Whilst the results did not reach significance, self-monitoring devices 
should be utilised as part of a pack of behaviour change strategies and techniques which can 
help to facilitate changes in sedentary behaviour. However these findings may be related 
specifically to the LumoBack device, as previous research has demonstrated that self-
monitoring in combination with other control theory components is the most robust behaviour 
change technique for altering physical activity and sedentary behaviour  
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Appendix 1.1 - Search Strategy example – MEDLINE (search result in brackets) 
UBehaviour 
1. MH "sedentary lifestyle" (1,560) 
2. AB "Sedent* behav*" OR TI "sedent* behav*" (1,390) 
3. AB Sedent* OR TI Sedent* (15,246) 
4. AB "TV View*" OR TI "TV view*" (432) 
5. AB "Video games" OR TI "Video games" (683) 
6. AB "screen time" OR TI "screen time" (344) 
7. AB "sedentary lifestyle" OR TI "sedentary lifestyle" (1,531) 
8. AB "computer use" OR TI "computer use" (953)  
9. AB "couch potato" OR TI "couch potato"  (24) 
10. AB "light activit*" OR TI "light activit*" (186) 
11. AB "physical activ*" OR TI "physical activ*" (48,221) 
12. AB "physical inactiv*" OR TI "physical inactiv*" (3,371) 
13. AB "physical fit*" OR TI "physical fit*" (5,022) 
14. MH Exercise OR TI exercise OR AB exercise (180,875) 
15. AB "moderate-vigorous physical activ*" OR AB "moderate£vigorous physical 
activ*" OR AB "moderate#vigorous physical activ*"  (67) 
16. TI "moderate-vigorous physical activ*" OR TI "moderate£vigorous physical activ*" 
OR TI "moderate#vigorous physical activ*" (5) 
17. TI MVPA OR AB MVPA (728) 
18. TI "energy expenditure" OR AB "energy expenditure" (15,039) 
19. MH "motor activity" OR AB "motor activity" OR TI "motor activity" (51,841) 
20. MH "activities of daily living" OR AB "activities of daily living" OR TI "activities of 
daily living" (51,841) 
21. AB Posture OR TI Posture (18,409) 
22. S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR 
S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 (356,020) 
 
UMeasurement 
1. AB Validation OR TI Validation OR MH Validation (84,533) 
2. AB Reliability OR TI Reliability (87,609) 
3. AB "activ* monitor*" OR TI "activ* monitor*"  (2,213) 
4. AB "objective measur*" OR TI "objective measur*"(8,708) 
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5. AB "device*" OR TI "device*" (201,464) 
6. AB Sensor OR TI Sensor OR MH Sensor (40,263) 
7. AB "wear* monitor*" OR TI "wear* monitor*" (45) 
8. AB Methodolog* OR TI Methodolog* (161,958) 
9. AB Assessment OR TI Assessment (499,305) 
10. AB "Motion Sensor*" OR TI "Motion Sensor*" (334) 
11. AB "Physiological Sensor*" OR TI "Physiological Sensor*" (89) 
12. AB "Ambulatory monitor*" OR TI "Ambulatory monitor*" (1,933) 
13. S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 OR 
S32 OR S33 (1,001,341) 
Together S35 AND S36 (41,991) 
Limiters – English Language, Human, All Adult 19+ years  
Total Number = (17,840) 
Appendix 1.2 – Links to online supplementary journal material relating to systematic 
review 
The below link directs to the online ome of the articles were there is access to online 
supplementary material including the search strategy and all supplementary tables. 
35TUhttp://www.jmir.org/2016/5/e90/U35T 
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Appendix 2.1: Laboratory Setting: Participant Information Sheet 
 
 
 
 
PARTICIPANT INFORMATION SHEET 
‘The validity of three devices for measuring sitting and changes in posture: A laboratory 
and free living study. 
You are being asked to take part in a research study. Before you decide, it is important for 
you to understand why the research is being done and what it involves. This information 
sheet is designed to help you decide whether you would like to participate in this study. 
Please take time to read the following information carefully to decide whether or not you 
wish to take part and discuss it with friends, and relatives. Please ask if you would like more 
information.  
What is the purpose of the research? 
The effects of excessive sedentary behaviour (i.e., sitting with low energy expenditure) on the 
health of the population is an increasing concern and has become a focus of much research in 
recent years. Recent evidence suggests that spending high amounts of time sedentary, 
independent of time spent in physical activity, is associated with an increased risk of type 2 
diabetes, cardiovascular disease, cancer and mortality. Recent research has also demonstrated 
that regularly breaking up prolonged sitting can have beneficial effects on health. 
It is really important that researchers have accurate devices to measure sitting so that they can 
fully understand the negative effects of sitting as well as the positive effects of breaking up 
sitting by changing to an upright position. Over the past couple of years several new devices 
and device functions have become available that may be useful in measuring sitting time and 
changes in posture (i.e., going from a sitting position to a standing position). The aim of this 
study is to examine the accuracy of several objective methods (activPAL, ActiGraph, 
GENEActiv and LUMOback) for estimating lying, sitting and upright time and detecting 
changes in posture. 
Do I have to take part?  
It is up to you to decide; participation is voluntary. We will describe the study and go through 
the information sheet with you. We will then ask you to sign a consent form to show that you 
have agreed to take part. You will be given a copy of the signed consent form. You are free to 
withdraw at any time without giving a reason.  
What will happen to me if I take part? 
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Visit 1: At the first visit you will have the opportunity to discuss the study with us and ask 
any questions you may have before being asked to sign our consent form. We will then 
measure your height, weight, body fat percentage and waist circumference and ask you to 
answer some questions about yourself, for example your date of birth, your postcode and 
ethnicity. You will then get to try out some of the activities that you will be asked to do 
during the experiment. This first visit should take no longer than 30 minutes. At the end of 
this visit we will arrange your full study visit (at a time and date convenient for you). 
Visit 2: We will again explain the procedure for the experiment and then we will fit the 
measurement devices. You will be fitted with the following; one activPAL to wear on the 
thigh, three ActiGraph monitors (one on the wrist, waist and thigh), three GENEActiv 
monitors (one on the wrist, waist and thigh) and one LumoBack to wear on the lower back. 
You will then be required to complete a circuit of 16 activities in the exercise laboratory. The 
activities will range from lying down, watching TV, typing, standing still, washing pots, and 
light walking. Each activity will last for 5 minutes. This visit should last for no more than 2 
hours. Once this has been completed you will be asked to wear the measurement devices 
(excluding the LumoBack) for two full days in your daily life and complete a log of any 
times that you remove the devices as well as times that you went to bed and got out of bed. 
After the two days you will be asked to return the monitors so that the data can be 
downloaded and processed.  
What do the monitors look like?  
 
ActiGraph G3TX+                   activPAL                GENEActiv         LumoBack 
 
 
 
 
 
 
 
 
What do I have to do if I want to take part in this study? 
If you decide to take part in the study we will contact you to arrange a convenient time and 
date for you to sign a consent form and we will arrange a date for the study measures to begin. 
What are the possible benefits of taking part? 
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You are unlikely to directly benefit from participating in the study however it will be possible 
for you to view your free-living data from the devices following completion of the study (this 
will show you how long you spend sitting, standing and walking).  
Will my taking part in the study be kept confidential? 
All information that is collected about you during the course of the research will be kept 
strictly confidential. Data will be stored either in locked filing cabinets or in password 
protected databases which are only accessible by members of the research team. Any 
information about you which is disseminated will have your name and address removed so 
that you cannot be recognised from it. Information collected will not be used for any other 
purpose than that explained here. 
What are the risks of taking part?  
Taking part involves minimal risk for you, just the inconvenience of taking the time to 
participate in the study.  
What will happen to the results of the research study?  
The results of the study may be published in a professional journal, but you will not be 
identified by name in any publications. You will be informed about the results of the study 
when it has finished. 
Who is organising and funding the research? 
This study is being organised and co-ordinated by the Leicester-Loughborough Diet, 
Lifestyle and Physical Activity Biomedical Research Unit.   
Who has reviewed the study?  
This study was reviewed by the Loughborough University ethics committee. 
Contact for Further information:  
Thank you for taking the time to read this information sheet. We will be pleased to discuss 
any questions or concerns that you may have.  
If you have any further questions about this research or would like to take part please contact 
the team on 0116 258 8929 (Sarah Bunnewell)/01509 228173 (Myanna Duncan) or email us 
at 35TUsarah.bunnewell@uhl-tr.nhs.ukU35T  / 35TUM.Duncan@lboro.ac.ukU35T  
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Appendix 2.2 Informed Consent 
 
 
 
 
Study ID Label  
 
 
Principal Investigator: Dr Charlotte Edwardson  
Contact: Diabetes Research Centre, University of Leicester, Leicester General Hospital, LE5 4P2  
  
 
CONSENT FORM version 1 27/08/2013 
Title of project:  Assessing the validity of three objective measures of sedentary 
behaviour in laboratory and free living environments. 
  Please 
Initial 
Every Box 
 
I confirm that I have read and understand the participant information sheet 
dated 27/8/2013 (Version 1) for the above study and have had the opportunity 
to ask questions.  
 
 
I understand that my participation is voluntary and that I am free to withdraw 
at any time, without giving any reason, without my medical care or legal rights 
being affected. 
 
 
   
 
 
____________________ _____________ _________________ 
Name of participant   Date   Signature 
  
 
____________________ _____________ _________________ 
Researcher    Date   Signature  
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Appendix 2.3 Health Screening Questionnaire 
 
 
 
 
 
 
Health screening questionnaire 
Principal Investigator:  Dr Charlotte Edwardson 
 
It is important that volunteers participating in this study are currently in good health 
and have no significant medical problems. This is to ensure (i) your own continuing 
wellbeing and (ii) to avoid the possibility of individual issues affecting the research 
outcomes. Please complete this brief questionnaire to confirm your fitness to 
participate. 
1. At present, do you have any health problem for which you are: 
(a) on medication, prescribed or otherwise ............  Yes  No 
 
(b) attending your general practitioner ...................  Yes  No  
(c) on a hospital waiting list ...................................  Yes  No  
 
2. Have you ever had any of the following: 
(a) Asthma  ............................................................  Yes  No  
(b) Diabetes  ..........................................................  Yes  No  
(b) Heart problems  ................................................  Yes  No  
(c) Problems with bones, joints or muscles  ...........  Yes  No  
(d) Disturbance of balance/ coordination  ...............  Yes  No  
(e) Severe memory problems  ................................  Yes  No  
 
3.    Do you have a heart pacemaker fitted? Yes  No  
 
4. Has any, otherwise healthy, member of your family under the age 
 of 35 died suddenly during or soon after exercise? Yes  No  
Participant ID:  
The validity of three devices for measuring sitting and changes in 
posture: A laboratory and free living study. 
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Appendix 2.4: Activity Log Sheet 
UActivity Log Sheet 
 
ID:                     Gender:               DOB:      /     /             Study Date:      /     / 
Height (m):                            Weight (kg):                       BMI: 
Activity  Start Time End Time Time taken for Activity 
Baseline sitting LumoBack  Post LumoBack sitting time  
Lying completely flat on 
back 
     
Lying on back with legs 
bent 
     
Lying on side with legs 
straight 
     
Lying on side with legs 
bent 
     
Sitting on chair with feet 
flat on floor (TV) 
     
Sitting on chair with legs 
crossed (TV) 
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Sitting on chair with right 
foot resting on left thigh 
(TV) 
   
  
Sitting on chair with legs 
stretched out forwards 
(TV) 
   
  
Sitting on chair with feet 
backwards under chair 
(TV) 
   
  
Sitting with upper body 
movement (computer) 
   
  
Sitting playing games on 
tablet/smart phone    
  
Standing still    
  
Washing pots    
  
Cleaning/dusting    
  
Hoovering /sweeping    
  
Self-paced free living walk    
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Appendix 2.4 Free Living Setting: Participants Information Sheet 
 
 
 
 
PARTICIPANT INFORMATION SHEET 
 
‘The validity of LumoBack posture sensor for measuring sitting and changes 
in posture: A free living study. 
 
You are being asked to take part in a research study. Before you decide, it is important for 
you to understand why the research is being done and what it involves. This information 
sheet is designed to help you decide whether you would like to participate in this study. 
Please take time to read the following information carefully to decide whether or not you 
wish to take part and discuss it with friends, and relatives. Please ask if you would like more 
information.  
 
What is the purpose of the research? 
The effects of excessive sedentary behaviour (i.e., sitting with low energy expenditure) on the 
health of the population is an increasing concern and has become a focus of much research in 
recent years. Recent evidence suggests that spending high amounts of time sedentary, 
independent of time spent in physical activity, is associated with an increased risk of type 2 
diabetes, cardiovascular disease, cancer and mortality. Recent research has also demonstrated 
that regularly breaking up prolonged sitting can have beneficial effects on health. 
 
It is really important that researchers have accurate devices to measure sitting so that they can 
fully understand the negative effects of sitting as well as the positive effects of breaking up 
sitting by changing to an upright position. Over the past couple of years several new devices 
and device functions have become available that may be useful in measuring sitting time and 
changes in posture (i.e., going from a sitting position to a standing position). The aim of this 
study is to examine the accuracy of LumoBack for estimating lying, sitting and upright time 
and detecting changes in posture. 
 
Do I have to take part?  
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It is up to you to decide; participation is voluntary. We will describe the study and go through 
the information sheet with you. We will then ask you to sign a consent form to show that you 
have agreed to take part. You will be given a copy of the signed consent form. You are free to 
withdraw at any time without giving a reason.  
 
What will happen to me if I take part? 
If you decide to take part in this study, you will be asked to come to physical activity and 
sedentary behaviour measurement lab in the new NCSEM building. In the first instance you 
will have the opportunity to discuss the study and ask any questions that you may have before 
being asked to sign the consent form. 
A series of anthropometric measurement will then be taken including height, weight, BMI 
and body fat percentage.  
You will be asked to wear the three devices; one activPAL to wear on the thigh, one 
ActiGraph monitors one on the waist, and one LumoBack to wear on the lower back for a 
period of 7 days. You will be asked to completer the a log of any times that you remove the 
devices as well as time that you went to bed and got out of bed. After the seven days, you will 
be asked to return the monitors so that the data can be downloaded and processed. 
 
What do the monitors look like?  
 
ActiGraph G3TX+                   activPAL                     LumoBack 
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What do I have to do if I want to take part in this study? 
If you decide to take part in the study we will contact you to arrange a convenient time and 
date for you to sign a consent form and we will arrange a date for the study measures to begin. 
 
What are the possible benefits of taking part? 
You are unlikely to directly benefit from participating in the study however it will be possible 
for you to view your free-living data from the devices following completion of the study (this 
will show you how long you spend sitting, standing and walking).  
 
Will my taking part in the study be kept confidential? 
All information that is collected about you during the course of the research will be kept 
strictly confidential. Data will be stored either in locked filing cabinets or in password 
protected databases which are only accessible by members of the research team. Any 
information about you which is disseminated will have your name and address removed so 
that you cannot be recognised from it. Information collected will not be used for any other 
purpose than that explained here. 
 
What are the risks of taking part?  
Taking part involves minimal risk for you, just the inconvenience of taking the time to 
participate in the study.  
 
What will happen to the results of the research study?  
The results of the study may be published in a professional journal, but you will not be 
identified by name in any publications. You will be informed about the results of the study 
when it has finished. 
 
Who is organising and funding the research? 
This study is being organised and co-ordinated by the Loughborough-Leicester Diet, 
Lifestyle and Physical Activity Biomedical Research Unit.  
  
Who has reviewed the study?  
This study was reviewed by the Loughborough University ethics committee. 
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Contact for Further information:  
Thank you for taking the time to read this information sheet. We will be pleased to discuss 
any questions or concerns that you may have.  
 
If you have any further questions about this research or would like to take part please contact 
James Sanders (35TUJ.Sanders2@lboro.ac.ukU35T)  
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Appendix 2.5 Activity Monitors Logbook for iOS users  
 
 
 
 
 
 
 
 
 
Activity monitor instructions 
& 
Daily logbook 
 
 
 
 
 
 
 
 
Please keep this booklet in a safe place so that you can return it to us at the 
end of the two day monitoring period when you come back the laboratory. 
If you have any questions or concerns, please contact: 
James Sanders 
35TUJ.Sanders2@lboro.ac.ukU35T 
07538330734 
The validity of three devices for measuring sitting and 
changes in posture: A free living study’. 
Participant ID: ______________ 
ActiGraph Numbers: 
__________       
activPAL Number:  
_____________ 
LUMOback: 
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1. General Information 
UHow long do I wear the monitors for? 
• Please wear all monitors for 7 full days removing them on the morning of day 7 
• Please wear the monitors continuously (i.e. for 24 hours/day) 
• If you wish to remove the monitors before you go to bed please put them on as soon 
as you wake up in the morning 
 
 
 
 
UWhat else do I need to do? 
• It is important that you fill in this logbook for all 7 days that you are wearing the 
monitors 
• This helps us match the monitor data to your waking hours and patterns during the 
day 
 
UReturning your activity monitors and logbook 
Please return the activity monitors (and any unused adhesive patches) and completed logbook 
to James Sanders (NCSEM PhD area) 
 
 
2. How to wear the activPAL thigh monitor 
The activPAL is to be worn midline on the anterior aspect of 
the right thigh using medical dressing. 
 
The monitor should be positioned so that the man on the 
monitor is standing upright. 
 
 
3. How to wear the ActiGraph monitors  
The ActiGraph will be attached using adjustable elastic 
straps and should be positioned so that the small black 
WARNING:  
Please do not wear the devices when showering, bathing, or performing water-based 
activities. 
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cap is facing upwards. The hip monitor is to be worn on the right hand side of the body on the 
midaxillary line of the hip. 
 
4. How to wear the LumoBack 
The LumoBack will be attached using adjustable plastic straps. The LumoBack should we 
worn on base of the back with the logo outward facing, and readable.  
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5. Placement of the activity monitors 
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4. How to fill in the daily logbook 
• The logbook is divided into 7 days. Please complete each day’s questions as accurately 
as possible. 
 
• Record the exact times if you can - or to the nearest 5 minutes. 
 
• Start by writing the date in the top row. 
 
• Then record the time that you woke up, and the time that you put the monitors on for the 
first time that day (only if you removed it to go to bed). Tick which monitors you wore 
overnight and if you did not wear one of them overnight then records what time you put 
it back on at in the morning. If you did not put on one of the monitors at all that day then 
please cross the corresponding box instead of recording a time. 
 
• Next, record any times you removed the monitors for more than 15 minutes. Record 
removal time in ‘Off’ columns and the time that you put back on the monitors in the ‘On’ 
column. Also mark whether this time was ‘am’ or ‘pm’ in the row below and your reason 
for removal. Please DO NOT include removal times related to night time sleeping here – 
only record removal times during waking hours. 
 
• If you have any other comments, please note them down. 
 
NOTES: 
• Midnight = 12am; midday = 12pm 
• Sleep and awake times are very important. 
 
5. LumoBack FAQ’s 
 
Wearing the sensor 
1. Place the LUMO on your lower back, either directly on your skin or over a thin layer 
of clothing. The LUMO logo and circular Touch button should be facing out.  
2. Wrap the belt around your waist directly above your hip bones, and secure the Velcro 
near your belly button. 
3. If your belt doesn’t fit snuggly around your waist, take it off and adjust the Velcro 
straps inside the belt. 
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Checking the LumoBack charge. 
Tap the Touch Button to view charge level:  
Green - The sensor has more than one day of charge remaining.  
Orange - The sensor has one day or less of charge remaining. Recharge soon 
 
Charging the LumoBack 
1. Plug the sensor into a USB power source using the included cable.  
2. It takes about 2 hours to charge the sensor completely.  
3. A complete charge will last for about 5 days of continuous use 
 
When to calibrate your sensor.  
The LumoBack sensor works for everybody, but only if it is calibrated correctly. This process 
stores your good posture position on the sensor and determines when the sensor will vibrate, 
indicating bad posture.  
 
When should you calibrate? 
1. When you first setup your sensor. 
2. When your sensor is vibrating, but you are in good posture. 
3. When you put the sensor on a little bit differently than when you calibrated 
previously. 
 
How do I clean my Lumo? Is it water resistant? 
You can simply take a damp cloth or a wipe and wipe the sensor down.  Also, if needed you 
can remove the Velcro straps from the actual sensor moulding and you can hand wash the 
belt straps and line dry. 
   
LumoBack is not completely water resistant.  While it is ok to have moisture and sweat from 
normal use and activities, you can NOT submerge the Lumo Back sensor in water or shower 
with it, etc.  It has a Lithium battery and other hardware components that can be damaged if it 
gets wet. 
 
Removal of the LumoBack. 
Night Removal 
When removing the LumoBack at night please take it off immediately before you go to sleep 
and place it on charge using the charging plug and cord provided in your pack. It is best to 
place this on your bed side table so as a reminder to put it on the when you wake up in the 
morning 
It is important that you place the device on charge every night so that we can have a data 
stream to note removal time. 
 
Removal for water-based activities 
Please remove the device immediately before and immediately after the water based activities 
– making sure to place the device horizontal on a flat surface with Lumo sign facing upwards. 
 
Connectivity issues. What do I do? 
Please try the following: 
1. Turn the Bluetooth on your iOS device off and then on again through the iOS Settings 
icon.  Go to Settings>Bluetooth>On/Off in your iOS device. 
2. Kill the app:  first double-click on the home screen of your iOS device, then hold down the 
LumoBack icon in the tray for 3 seconds, then press the red delete button. 
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3. Restart the LumoBack app. 
4. If this doesn't work, try turning off your iOS device completely, and then turn it back on. 
 
Please make sure your battery is charged as the app works best when it is charged. 
 
The LumoBack will still be collecting data during this time even if it isn’t connected to the 
app. 
 
Any other problems please contact me. The details can be found on the title page. 
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 Example Day 1 Day 2 Day 3 
Date DD/MM DD/MM 
 
DD/MM DD/MM 
Did you WEAR THE MONITORS TO BED Ulast 
night? 
• ULumoBack  
• UActiGraph 
• UActivPAL 
 
 
 Yes  No  
 Yes  No 
 Yes  No 
 
 Yes  No 
 Yes  No 
 Yes  No 
 
 
 Yes  No 
 Yes  No 
 Yes  No 
 
 
 Yes  No 
 Yes  No 
 Yes  No 
 
What time did you WAKE UP today? 
 
U              7          am / 
USUpm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
What time did you put the monitors on? 
 
U         7:15          am / 
USUpm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
What time did you go to bed today? 
 
U         10             USUamUSU / 
pm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
If you Uremove the monitor for more than 15 mins please report below: 
The reason for removing the LumoBack  
 
Showering    
What time did you remove the LumoBack? 
 
U         7:30          am / 
USUpm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
What time did you put the LumoBack back 
on? 
 
U         7:45          am / 
USUpm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
The reason for removing the ActiGraph  
 
Showering    
What time did you remove the ActiGraph? 
 
U         7:30          am / 
USUpm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
What time did you put the ActiGraph back 
on? 
 
U         7:45          am / 
USUpm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
The reason for removing the activPAL  
 
Showering    
What time did you remove the activPAL? U         7:30          am / U                         am / U                         am / U                         am / 
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 USUpm pm pm pm 
What time did you put the activPAL back 
on? 
 
U         7:45          am / 
USUpm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
The reason for removing the LumoBack  
 
Showering    
What time did you remove the LumoBack? 
 
U         7:30          am / 
USUpm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
What time did you put the LumoBack back 
on? 
 
U         7:45          am / 
USUpm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
The reason for removing the ActiGraph  
 
Showering    
What time did you remove the ActiGraph? 
 
U         7:30          am / 
USUpm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
What time did you put the ActiGraph back 
on? 
 
U         7:45          am / 
USUpm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
The reason for removing the activPAL  
 
Showering    
What time did you remove the activPAL? 
 
U         7:30          am / 
USUpm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
What time did you put the activPAL back 
on? 
 
U         7:45          am / 
USUpm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
 
 
 
 Day 4 Day 5 Day 6 Day 7 
Date DD/MM 
 
DD/MM 
 
DD/MM DD/MM 
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Did you WEAR THE MONITOR TO BED Ulast 
night? 
• ULumoBack  
• UActiGraph 
• UActivPAL 
 
 
 Yes  No  
 Yes  No 
 Yes  No 
 
 Yes  No 
 Yes  No 
 Yes  No 
 
 
 Yes  No 
 Yes  No 
 Yes  No 
 
 
 Yes  No 
 Yes  No 
 Yes  No 
 
What time did you WAKE UP today? 
 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
What time did you put the monitor on? 
 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
What time did you go to bed today? 
 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
If you Uremove the monitor for more than 15 mins please report below: 
The reason for removing the LumoBack  
 
    
What time did you remove the LumoBack? 
 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
What time did you put the LumoBack back 
on? 
 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
The reason for removing the ActiGraph  
 
    
What time did you remove the ActiGraph? 
 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
What time did you put the ActiGraph back 
on? 
 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
The reason for removing the activPAL  
 
    
What time did you remove the activPAL? 
 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
What time did you put the activPAL back 
on? 
 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
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The reason for removing the LumoBack  
 
    
What time did you remove the LumoBack? 
 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
What time did you put the LumoBack back 
on? 
 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
The reason for removing the ActiGraph  
 
    
What time did you remove the ActiGraph? 
 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
What time did you put the ActiGraph back 
on? 
 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
The reason for removing the activPAL  
 
    
What time did you remove the activPAL? 
 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
What time did you put the activPAL back 
on? 
 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
 
 
If you have any other comments please note them here. 
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Appendix 2.6 Activity Monitors Logbook for Android users  
 
 
 
 
 
 
 
 
 
Activity monitor instructions 
& 
Daily logbook 
 
 
 
 
 
 
 
 
Please keep this booklet in a safe place so that you can return it to us at the 
end of the two day monitoring period when you come back the laboratory. 
If you have any questions or concerns, please contact: 
James Sanders 
35TUJ.Sanders2@lboro.ac.ukU35T 
07538330734 
The validity of three devices for measuring sitting and 
changes in posture: A free living study’. 
Participant ID: ______________ 
ActiGraph Numbers: 
__________       
activPAL Number:  
_____________ 
LUMOback: 
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2. General Information 
UHow long do I wear the monitors for? 
• Please wear all monitors for 7 full days removing them on the morning of day 7 
• Please wear the monitors continuously (i.e. for 24 hours/day) 
• If you wish to remove the monitors before you go to bed please put them on as soon 
as you wake up in the morning 
 
 
 
 
UWhat else do I need to do? 
• It is important that you fill in this logbook for all 7 days that you are wearing the 
monitors 
• This helps us match the monitor data to your waking hours and patterns during the 
day 
 
UReturning your activity monitors and logbook 
Please return the activity monitors (and any unused adhesive patches) and completed logbook 
to James Sanders (NCSEM PhD area) 
2. How to wear the activPAL thigh monitor 
The activPAL is to be worn midline on the anterior aspect of 
the right thigh using medical dressing. 
 
The monitor should be positioned so that the man on the 
monitor is standing upright. 
3. How to wear the ActiGraph monitors  
The ActiGraph will be attached using adjustable elastic 
straps and should be positioned so that the small black 
cap is facing upwards. The hip monitor is to be worn on 
the right hand side of the body on the maxillary line of 
the hip. 
 
4. How to wear the LumoBack 
WARNING:  
Please do not wear the devices when showering, bathing, or performing water-based 
activities. 
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The LumoBack will be attached using adjustable plastic straps. The LumoBack should we 
worn on base of the back with the logo outward facing, and readable.  
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5. Placement of the activity monitors 
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4. How to fill in the daily logbook 
• The logbook is divided into 7 days. Please complete each day’s questions as accurately 
as possible. 
 
• Record the exact times if you can - or to the nearest 5 minutes. 
 
• Start by writing the date in the top row. 
 
• Then record the time that you woke up, the time you got out of bed and the time that you 
put the monitors on for the first time that day (only if you removed it to go to bed). Tick 
which monitors you wore overnight and if you did not wear one of them overnight then 
record what time you put it back on at in the morning. If you did not put on one of the 
monitors at all that day then please cross the corresponding box instead of recording a 
time. 
 
• Next, record any times you removed the monitors for more than 15 minutes. Record 
removal time in ‘Off’ columns and the time that you put back on the monitors in the ‘On’ 
column. Also mark whether this time was ‘am’ or ‘pm’ in the row below and your reason 
for removal. Please DO NOT include removal times related to night time sleeping here – 
only record removal times during waking hours. 
 
• If you have any other comments, please note them down. 
 
NOTES: 
• Midnight = 12am; midday = 12pm 
• Sleep and awake times are very important. 
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5. LumoBack FAQ’s 
 
Wearing the sensor 
4. Place the LUMO on your lower back, either directly on your skin or over a thin layer 
of clothing. The LUMO logo and circular Touch button should be facing out.  
5. Wrap the belt around your waist directly above your hip bones, and secure the Velcro 
near your belly button. 
6. If your belt doesn’t fit snuggly around your waist, take it off and adjust the Velcro 
straps inside the belt. 
 
Checking the LumoBack charge. 
Tap the Touch Button to view charge level:  
Green - The sensor has more than one day of charge remaining.  
Orange - The sensor has one day or less of charge remaining. Recharge soon 
 
Charging the LumoBack 
4. Plug the sensor into a USB power source using the included cable.  
5. It takes about 2 hours to charge the sensor completely.  
6. A complete charge will last for about 5 days of continuous use 
 
When to calibrate your sensor.  
The LumoBack sensor works for everybody, but only if it is calibrated correctly. This process 
stores your good posture position on the sensor and determines when the sensor will vibrate, 
indicating bad posture.  
 
When should you calibrate? 
4. When you first setup your sensor. 
5. When your sensor is vibrating, but you are in good posture. 
6. When you put the sensor on a little bit differently than when you calibrated 
previously. 
 
How do I clean my Lumo? Is it water resistant? 
You can simply take a damp cloth or a wipe and wipe the sensor down.  Also, if needed you 
can remove the Velcro straps from the actual sensor moulding and you can hand wash the 
belt straps and line dry. 
   
LumoBack is not completely water resistant.  While it is ok to have moisture and sweat from 
normal use and activities, you can NOT submerge the LumoBack sensor in water or shower 
with it, etc.  It has a Lithium battery and other hardware components that can be damaged if it 
gets wet. 
 
Removal of the LumoBack. 
Night Removal 
When removing the LumoBack at night please take it off immediately before you go to sleep 
and place it on charge using the charging plug and cord provided in your pack. It is best to 
place this on your bed side table so as a reminder to put it on the when you wake up in the 
morning 
It is important that you place the device on charge every night so that we can have a data 
stream to note removal time. 
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Removal for water-based activities 
Please remove the device immediately before and immediately after the water based activities 
– making sure to place the device horizontal on a flat surface with Lumo sign facing upwards. 
 
Known Android Issues and advice.   
If you experience an issue in discovering your LumoBack Sensor or connecting to your 
LumoBack Sensor, it is recommended that you apply the following suggestion on your 
android device: 
• Turn off  Wi-Fi 
 
• Turn off Bluetooth 
 
• Turn on Bluetooth 
 
• Turning off Wi-Fi is key to getting a clean connection on your android device.  
 
To avoid reconnecting to your sensor often, when leaving the app, we advise you to press the 
"Home" button on your Android phone. This will keep the application running in the 
background while you continue to use other features of your phone. While you can also exit 
from the app by pressing the "Back" button on your android phone, your sensor will be 
disconnected from the application in that case. 
 
Your sensor will continue to function entirely on its own (giving posture feedback and 
collecting activity data) even when it is not connected to the app. 
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 Example Day 1 Day 2 Day 3 
Date DD/MM DD/MM 
 
DD/MM DD/MM 
Did you WEAR THE MONITOR TO BED Ulast 
night? 
 
 Yes  No   Yes  No  Yes  No  Yes  No 
What time did you WAKE UP today? 
 
U              7          am / 
USUpm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
What time did you put the monitor on? 
 
U         7:15          am / 
USUpm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
What time did you go to bed today? 
 
U         10             USUamUSU / 
pm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
If you Uremove the monitor for more than 15 mins please report below: 
The reason for removing the LumoBack  
 
Showering    
What time did you remove the LumoBack? 
 
U         7:30          am / 
USUpm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
What time did you put the LumoBack back 
on? 
 
U         7:45          am / 
USUpm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
The reason for removing the ActiGraph  
 
Showering    
What time did you remove the ActiGraph? 
 
U         7:30          am / 
USUpm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
What time did you put the ActiGraph back 
on? 
 
U         7:45          am / 
USUpm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
The reason for removing the activPAL  
 
Showering    
What time did you remove the activPAL? 
 
U         7:30          am / 
USUpm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
What time did you put the activPAL back 
on? 
U         7:45          am / 
USUpm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
239  
 
The reason for removing the LumoBack  
 
Showering    
What time did you remove the LumoBack? 
 
U         7:30          am / 
USUpm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
What time did you put the LumoBack back 
on? 
 
U         7:45          am / 
USUpm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
 Example Day 1 Day 2 Day 3 
Date DD/MM DD/MM 
 
DD/MM DD/MM 
The reason for removing the ActiGraph  
 
Showering    
What time did you remove the ActiGraph? 
 
U         7:30          am / 
USUpm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
What time did you put the ActiGraph back 
on? 
 
U         7:45          am / 
USUpm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
The reason for removing the activPAL  
 
Showering    
What time did you remove the activPAL? 
 
U         7:30          am / 
USUpm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
What time did you put the activPAL back 
on? 
 
U         7:45          am / 
USUpm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
 
 
 Day 4 Day 5 Day 6 Day 7 
Date DD/MM 
 
DD/MM 
 
DD/MM DD/MM 
Did you WEAR THE MONITOR TO BED Ulast 
night? 
 Yes  No  Yes  No  Yes  No  Yes  No 
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What time did you WAKE UP today? 
 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
What time did you put the monitor on? 
 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
What time did you go to bed today? 
 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
If you Uremove the monitor for more than 15 mins please report below: 
The reason for removing the LumoBack  
 
    
What time did you remove the LumoBack? 
 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
What time did you put the LumoBack back 
on? 
 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
The reason for removing the ActiGraph  
 
    
What time did you remove the ActiGraph? 
 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
What time did you put the ActiGraph back 
on? 
 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
The reason for removing the activPAL  
 
    
What time did you remove the activPAL? 
 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
What time did you put the activPAL back 
on? 
 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
The reason for removing the LumoBack  
 
    
What time did you remove the LumoBack? 
 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
What time did you put the LumoBack back U                         am / U                         am / U                         am / U                         am / 
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on? 
 
pm pm pm pm 
 Day 4 Day 5 Day 6 Day 7 
Date DD/MM 
 
DD/MM 
 
DD/MM DD/MM 
The reason for removing the ActiGraph  
 
    
What time did you remove the ActiGraph? 
 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
What time did you put the ActiGraph back 
on? 
 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
The reason for removing the activPAL  
 
    
What time did you remove the activPAL? 
 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
What time did you put the activPAL back 
on? 
 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
U                         am / 
pm 
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Appendix 2.7 - Sitting on chair with feet flat on floor (Actual sitting vs devices) 
Note: A: Bland-Altman of LumoBack vs Direct Observation, B: Bland-Altman of ActiGraph vs Direction Observation, C: Bland-Altman plot of activPAL vs Direction Observation; 
Intersection between Green dotted line and 0 on Y axis  denotes the desired point of the data, Black solid line shows the mean difference, Red lines denotes the upper and lower 95% Limits of 
Agreement. 
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Appendix 2.8 - Sitting on chair with legs crossed (right over left) (Actual sitting vs devices) 
Note: A: Bland-Altman of LumoBack vs Direct Observation, B: Bland-Altman of ActiGraph vs Direction Observation, C: Bland-Altman plot of activPAL vs Direction Observation; 
Intersection between Green dotted line and 0 on Y axis  denotes the desired point of the data, Black solid line shows the mean difference, Red lines denotes the upper and lower 95% Limits of 
Agreement. 
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Appendix 2.9 : Sitting on chair with right foot resting on left thigh  (Actual sitting vs devices) 
Note: A: Bland-Altman of LumoBack vs Direct Observation, B: Bland-Altman of ActiGraph vs Direction Observation, C: Bland-Altman plot of activPAL vs Direction Observation; 
Intersection between Green dotted line and 0 on Y axis  denotes the desired point of the data Black solid line shows the mean difference, Red lines denotes the upper and lower 95% Limits of 
Agreement. 
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Appendix 2.10 - Sitting on chair with legs straight out in front  (Actual sitting vs devices) 
Note: A: Bland-Altman of LumoBack vs Direct Observation, B: Bland-Altman of ActiGraph vs Direction Observation, C: Bland-Altman plot of activPAL vs Direction Observation; 
Intersection between Green dotted line and 0 on Y axis  denotes the desired point of the data, Black solid line shows the mean difference, Red lines denotes the upper and lower 95% Limits of 
Agreement. 
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Appendix 2.11 - Sitting with feet back under chair  (Actual sitting vs devices) 
Note: A: Bland-Altman of LumoBack vs Direct Observation, B: Bland-Altman of ActiGraph vs Direction Observation, C: Bland-Altman plot of activPAL vs Direction Observation; 
Intersection between Green dotted line and 0 on Y axis  denotes the desired point of the data, Black solid line shows the mean difference, Red lines denotes the upper and lower 95% Limits 
of Agreement. 
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Appendix 2.12 - Sitting with upper body movement (computer) (Actual sitting vs devices) 
Note: A: Bland-Altman of LumoBack vs Direct Observation, B: Bland-Altman of ActiGraph vs Direction Observation, C: Bland-Altman plot of activPAL vs Direction Observation; 
Intersection between Green dotted line and 0 on Y axis  denotes the desired point of the data, Black solid line shows the mean difference, Red lines denotes the upper and lower 95% Limits of 
Agreement. 
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Appendix 2.13 - Sitting playing game on phone   (Actual sitting vs devices) 
Note: A: Bland-Altman of LumoBack vs Direct Observation, B: Bland-Altman of ActiGraph vs Direction Observation, C: Bland-Altman plot of activPAL vs Direction Observation 
Intersection between Green dotted line and 0 on Y axis  denotes the desired point of the data, Black solid line shows the mean difference, Red lines denotes the upper and lower 95% Limits of 
Agreement. 
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Appendix 2.14 – Total Sitting time (All Activities)  (Actual sitting vs devices) 
Note: A: Bland-Altman of LumoBack vs Direct Observation, B: Bland-Altman of ActiGraph vs Direction Observation, C: Bland-Altman plot of activPAL vs Direction Observation; 
Intersection between Green dotted line and 0 on Y axis  denotes the desired point of the data, Black solid line shows the mean difference, Red lines denotes the upper and lower 95% Limits of 
Agreement. 
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Appendix 2.15 – Total sitting time (All activities – Sitting with feet back under chair removed)  (Actual sitting vs devices) 
Note: A: Bland-Altman of LumoBack vs Direct Observation, B: Bland-Altman of ActiGraph vs Direction Observation, C: Bland-Altman plot of activPAL vs Direction Observation; 
Intersection between Green dotted line and 0 on Y axis  denotes the desired point of the data, Black solid line shows the mean difference, Red lines denotes the upper and lower 95% Limits of 
Agreement  
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Appendix 2.16 – Bland-Altman plot: Sitting on Chair with Feet Flat on Floor 
(LumoBack vs activPAL/ActiGraph) 
 
 
Figure 6.1. -  Sitting on Chair with Feet Flat on Floor 
Note: A: Bland-Altman of LumoBack vs ActiGraph, B: Bland-Altman plot of LumoBack vs activPAL; Green 
dotted line denotes the desired line of data points, Black solid line shows the mean difference, Red lines denotes 
the upper and lower 95% Limits of Agreement. 
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Appendix 2.17 – Bland-Altman plot: Sitting on chair with Legs Crossed (Right over 
Left) (LumoBack vs activPAL/ActiGraph) 
 
 
Figure 6.2 - Sitting on Chair with Legs Crossed (Right over Left) 
Note: A: Bland-Altman of LumoBack vs ActiGraph, B: Bland-Altman plot of LumoBack vs activPAL; Green 
dotted line denotes the desired line of data points, Black solid line shows the mean difference, Red lines denotes 
the upper and lower 95% Limits of Agreement. 
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Appendix 2.18 – Bland-Altman plot: Sitting on Chair with Right Foot resting on Left 
Thigh (LumoBack vs activPAL/ActiGraph) 
 
 
Figure 6.3 - Sitting on Chair with Right Foot resting on Left Thigh 
Note: A: Bland-Altman of LumoBack vs ActiGraph, B: Bland-Altman plot of LumoBack vs activPAL; Green 
dotted line denotes the desired line of data points, Black solid line shows the mean difference, Red lines denotes 
the upper and lower 95% Limits of Agreement. 
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Appendix 2.19 – Bland-Altman plot: Sitting on Chair with Legs Straight out in Front 
(LumoBack vs activPAL/ActiGraph) 
 
 
Figure 6.4 - Sitting on Chair with Legs Straight out in Front 
Note: A: Bland-Altman of LumoBack vs ActiGraph, B: Bland-Altman plot of LumoBack vs activPAL; Green 
dotted line denotes the desired line of data points, Black solid line shows the mean difference, Red lines denotes 
the upper and lower 95% Limits of Agreement. 
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Appendix 2.20 – Bland-Altman plot: Sitting on Chair with Feet Back under Chair 
(LumoBack vs activPAL/ActiGraph) 
 
 
Figure 6.5 - Sitting on Chair with Feet Back under Chair 
Note: A: Bland-Altman of LumoBack vs ActiGraph, B: Bland-Altman plot of LumoBack vs activPAL; Green 
dotted line denotes the desired line of data points, Black solid line shows the mean difference, Red lines denotes 
the upper and lower 95% Limits of Agreement. 
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Appendix 2.21 – Bland-Altman plot: Sitting on Chair with Upper Body Movement 
(Computer) (LumoBack vs activPAL/ActiGraph) 
 
 
Figure 6.6 - Sitting on Chair with Upper Body Movement (Computer) 
Note: A: Bland-Altman of LumoBack vs ActiGraph, B: Bland-Altman plot of LumoBack vs activPAL; Green 
dotted line denotes the desired line of data points, Black solid line shows the mean difference, Red lines denotes 
the upper and lower 95% Limits of Agreement. 
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Appendix 2.22 – Bland-Altman plot: Sitting on Chair Playing Game on Phone 
(LumoBack vs activPAL/ActiGraph) 
 
 
Figure 6.7 - Sitting on Chair Playing Game on Phone 
Note: A: Bland-Altman of LumoBack vs ActiGraph, B: Bland-Altman plot of LumoBack vs activPAL; Green 
dotted line denotes the desired line of data points, Black solid line shows the mean difference, Red lines denotes 
the upper and lower 95% Limits of Agreement. 
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Appendix 2.23– Bland-Altman plot: Total Sitting time (All Activities) (LumoBack vs 
activPAL/ActiGraph) 
 
 
Figure 6.8 – Total Sitting Time (All Activities) 
Note: A: Bland-Altman of LumoBack vs ActiGraph, B: Bland-Altman plot of LumoBack vs activPAL; Green 
dotted line denotes the desired line of data points, Black solid line shows the mean difference, Red lines denotes 
the upper and lower 95% Limits of Agreement. 
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Appendix 2.24 – Bland-Altman plot: Total Sitting time (All Activities – Sitting with Feet 
Back under Chair) (LumoBack vs activPAL/ActiGraph) 
 
 
Figure 6.9 – Total Sitting Time (All Activities – Sitting with Feet Back under Chair) 
Note: A: Bland-Altman of LumoBack vs ActiGraph, B: Bland-Altman plot of LumoBack vs activPAL; Green 
dotted line denotes the desired line of data points, Black solid line shows the mean difference, Red lines denotes 
the upper and lower 95% Limits of Agreement. 
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Appendix 3.1: DeSIT Participant Information Sheet 
 
 
 
DeSIT: Decreasing Sedentary Time using Innovative Technology: A Proof of Principle 
Intervention  
Participant Information Sheet 
Main Investigator 
Name:  James Sanders (PhD Student),  
Address: Sir John Beckwith Building, SSEHS, Loughborough University, Loughborough, 
LE11 3TU  
Email Address: 35TUJ.Sanders2@lboro.ac.ukU35T  
Contact number:  01509 226452 
Other Investigators 
Name: Dr Dale Esliger 
Sir John Beckwith Building, SSEHS, Loughborough University, Loughborough, LE11 3TU  
Email Address: 35TUD.Esliger@lboro.ac.ukU35T  
Contact number:  +44 (0) 1509 223280 
What is the purpose of the study? 
Modern environments and technological advancements have radically altered the way we live 
our lives. The need to undertake purposeful physical activity has all but disappeared and 
sedentary behaviour, defined as ‘any waking behaviour in a sitting or reclining posture with 
an energy expenditure ≤1.5metabolic equivalent’ is now the main behaviour.  
There is mounting evidence that the amount of time spent sedentary is an important 
determinant of health status independent of physical activity levels. Additionally, it is 
estimated that 60-70% of the average waking day is spent in sedentary pursuits and as little as 
3-5% of the population achieve the recommended levels of moderate-to-vigorous physical 
activity.  
 
Over the last decade, there has been a plethora of wearable technologies that have been 
developed to support physical activity and sedentary behaviour behaviour change, of which 
the greatest growth has been seen in self-monitoring tools. Self-monitoring for behaviour 
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change has a strong theoretical foundation and as such, when used in interventions, self-
monitoring in conjunction with feedback, has been proven to be an effective behaviour 
change strategy across a variety of behaviours including smoking, diet and physical activity 
and is considered a foundation of lifestyle behaviour change interventions. With the 
increasing amount of wearable technology, it has been suggested that use of electronic 
approaches might lessen the burden of traditional methods (diaries, and questionnaires etc.) 
and may improve adherence to self-monitoring and thus result in greater achievement 
towards behavioural goals.  
Therefore, the purpose of this study is to assess the potential beneficial effects of using 
wearable technology to reduce sedentary behaviour  
Who is doing this research and why? 
This study is being conducted by as part of JS’s PhD research, supervised by Dr Dale Esliger. 
This study is part of a Student research project supported by Loughborough University. 
Are there any exclusion criteria? 
You will not be able to take part in the study if you are in one of the following criteria:  
- Younger than 30 or older than 69 
- Are pregnant 
- Not willing to give signed consent 
- Cannot adhere to the study protocol 
- Do not have an iPhone 4S or later smartphone  
Will I be required to attend any sessions and where will these be? 
Yes. Should you agree to participate in the study, we will book your appointment in a time of 
your choosing before 12pm (midday). You will be required to attend in total four laboratory 
based sessions. The first lasting approximate 10-20mins and 3 more lasting approximately 
30-45mins. These sessions will take place in the Physical Activity and Sedentary Behaviour 
Measurement Lab in the National Centre for Sport and Exercise Medicine.  
Is there anything I need to do before the sessions? 
Participants are asked to be over-night fasted and asked to please drink a glass of water at 
least 1 hour before your allocated laboratory session. This will help with us acquiring an 
accurate measurement from the finger stick blood test. 
For Lab sessions 1-4 you will also be required to bring with you, your iPhone 4S or later 
smartphone 
What will I be asked to do? 
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If you decide to take part within the study then you will be asked to attend 4 laboratory 
appointments at Loughborough University over a 9 week period. These appointments will be 
held in the Physical Activity and Sedentary Behaviour Measurement lab in the National 
Centre for Sport and Exercise Medicine.  
Lab session #1 
At the first testing session, we will explain the study procedures and answer any question you 
may have before asking you to sign an informed consent form and a health screening 
questionnaire. You will then be fitted and set-up with your wearable technology. See fig 1. 
 
 
 
 
Figure 1 – ActiGraph wGT3X+BT (Red) LumoBack Posture Sensor (Black). 
 
The red device (ActiGraph accelerometer) is a small instrument (4.6cm x 3.3cm x 1.5cm, 19g) 
that sits on a provided elastic belt around your waist and can be worn discretely under 
clothing and will be used to measure you physical activity throughout the week.  
The black device (LumoBack Posture sensor) is also a small instrument (4.15 x 10 x 0.8cm, 
25g) also using a provided elasticated belt, will be worn on the lower back either on the skin 
or over a thin layer of clothing and will be used to measure your sitting time of the 
measurement period. The LumoBack connects to the LumoBack mobile app which will be 
provided to you should you agree to participate in the study. 
You will be required to wear these devices for a period of 7 days, only removing them during 
sleep, bathing and water based activities.  
 
At the end of this first visit we will arrange for your next lab visit for the following week. 
Lab Session #2 
Pre-testing requirements (lab 2-4) 
Participants are asked to be over-night fasted and asked to please drink a glass of water at 
least 1 hour before your allocated laboratory session. This will help with us acquiring an 
accurate measurement from the finger stick blood test. 
We will again run through the study test procedures. A series of screening measurements will 
be taken. These will consist of height, weight, BMI, body fat%, waist circumference, grip 
strength and blood pressure as well as a finger stick blood test. This will consist of a small 
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finger prick blood sample (0.04ml) which will be analysed for blood cholesterol, lipid 
concentrations and blood glucose levels.  
The activity monitors you had worn previously will be collected and downloaded. The black 
device will be reinitialised to provide vibratory (short buzz) feedback to you after prolonged 
sedentary behaviour.  The black device will then be returned to you.  
You will be asked to wear the black device for the following 4 weeks, only removing it 
during sleep, bathing and water based activities. A diary will be provided to document the 
removal/replacement of the device. 
Lab Session #3  
Lab sessions 3 will follow an identical format to lab session 2. 
Lab Session #4 
Lab session 4 will follow an identical format to lab sessions 2 and 3. The only exception is 
that as this will be the final session the black device will be collected in by the research team 
and not returned to you. A series of questions will be asked about you experiences whilst 
using and wearing the device. 
How long will it take? 
Lab session #1 will take 10-20mins. Each lab session thereafter will take approximately 30-
45mins. And the total time of the study will be 9 weeks. Please see figure 2.  
Once I take part, can I change my mind? 
Yes.  After you have read this information and asked any questions you may have we will ask 
you to complete an Informed Consent Form, however if at any time, before, during or after 
the sessions you wish to withdraw from the study please just contact the main investigator.  
You can withdraw at any time, for any reason and you will not be asked to explain your 
reasons for withdrawing. 
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Deployment, familiarisation 
and checks: 
ActiGraph and LumoBack 
monitor placed onto the 
participant 
Baseline  
Monitors worn  
ActiGraph – waist 
LumoBack – Lower back  
Screening and consent: 
Eligibility assessed 
Lab 
Session #1 
Lab 
Session #2 
Study Start  
7 days  
Collection, download and 
redeployment  
ActiGraph collected and 
LumoBack monitor  vibratory 
feedback initialised  
Measurements  
- Anthropometrics 
- Body composition 
- Waist circumference 
- Hip circumference  
- Fingerstick blood test 
- Blood pressure 
- Grip strength 
Monitors worn  
LumoBack – Lower back  - 4 
weeks 
ActiGraph – Waist worn for one 
week 
Measurements  
- Anthropometrics 
- Body composition 
- Waist circumference 
- Hip circumference  
- Fingerstick blood test 
- Blood pressure 
- Grip strength 
Monitors continuing to be 
worn.  
LumoBack – Lower back  
ActiGraph – Waist – Worn for 
one Week 
Lab 
Session #3 
1+3 
weeks  
Measurements  
- Anthropometrics 
- Body composition 
- Waist circumference 
- Hip circumference  
- Fingerstick blood test 
- Blood pressure 
- Grip strength 
Monitors Collected in. 
LumoBack – Lower back  
Lab 
Session #4 
4 weeks  
Study 
Finish  
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Are there any risks in participating? 
There is a small, single finger prick to one finger on your non-dominant hand. As this will 
cause a small puncture just below the skin, there is a very small chance that you will 
experience a small amount of discomfort. However, the discomfort should only be 
momentary, and will not affect you from carrying on with your day.  
 
Will my taking part in this study be kept confidential? 
All information that is collected about you during the course of the research will be kept 
strictly confidential. Data will be stored either in locked filing cabinets or in password 
protected university managed PC’s which are only accessible by members of the research 
team. Any information about you which is disseminated will have any identifiable 
information removed so that you cannot be recognised from it. Information collected will not 
be used for any other purpose than that explained here. The data from this study will be kept 
for a maximum period of 6 years. Once the blood sample has been analysed it will be 
disposed of immediately. However, once the results of the study are published or a 
dissertation has been submitted (expected to be by December 2015), it will not be possible to 
withdraw your individual data from the research. 
What will happen to the results of the study? 
The results will be coded (for anonymity) and analysed by the research team. The results may 
be published in scientific journals and/or presented at relevant conferences. Furthermore, the 
results will be written up as part of JS’s PhD thesis. 
What if I am not happy with how the research was conducted? 
If you are not happy with how the research was conducted, please contact Ms Jackie Green, 
the Secretary for the University’s Ethics Approvals (Human Participants) Sub-Committee: 
Ms J Green, Research Office, Hazlerigg Building, Loughborough University, Epinal Way, 
Loughborough, LE11 3TU.  Tel: 01509 222423.  Email: 35TUJ.A.Green@lboro.ac.ukU35T 
The University also has a policy relating to Research Misconduct and Whistle Blowing which 
is available online at 35TUhttp://www.lboro.ac.uk/committees/ethics-approvals-human-
participants/additionalinformation/codesofpractice/U35T .   
I have some more questions; who should I contact? 
For any further questions please contact James Sanders and/or Dr Dale Esliger, whose contact 
details are shown at the top of this information sheet. 
Figure 2 – Study outline  
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Appendix 3.2: LumoBack information sheet and FAQ 
 
 
 
 
 
 
 
 
 
 
 
Activity monitor instructions Manual  
 
 
 
 
 
 
 
If you have any questions or concerns, please contact: 
James Sanders 
35TUJ.Sanders2@lboro.ac.ukU35T 
07538330734 
 
 
 
 
 
 
DeSIT: Decreasing Sitting using Innovative 
Technology 
Participant ID: ______________ 
ActiGraph Numbers: 
__________       
LUMOback: 
                           . 
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3. General Information 
• Please wear the LumoBack for the duration of the study period 
• Please wear the ActiGraph for the next 7 day period 
• Please wear the monitors continuously only removing for sleep and water based 
activities. 
• If you wish to remove the monitors before you go to bed please put the LumoBack on 
charge, preferably in a place where you will remember to put it on in the morning (e.g. 
your bedside table) and remember to put them on as soon as you wake up in the 
morning. 
• If you decide not to put it on charge overnight – please place the LumoBack down 
horizontally on a flat surface with the Lumo logo facing upward – this will put the 
Lumo into Inactive mode after 5 mins and will allow the research team to determine 
wear and non-wear times. 
 
 
 
 
 
UReturning your activity monitors and logbook 
Please return the activity monitors (and any unused adhesive patches) and completed logbook 
to James Sanders (NCSEM PhD area) 
 
2. How to wear the ActiGraph monitors  
The ActiGraph will be attached using adjustable elastic 
straps and should be positioned so that the small black 
cap is facing upwards. The hip monitor is to be worn on 
the right hand side of the body on the midaxillary line of 
the hip. 
 
3. How to wear the LumoBack 
The LumoBack will be attached using adjustable plastic straps. The LumoBack should we 
worn on base of the back with the logo outward facing, and in a readable orientation.  
 
WARNING:  
Please do not wear the devices when showering, bathing, or performing water-based 
activities. 
 
270  
4. Placement of the activity monitors 
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5. Removal of the LumoBack. 
Night Removal 
When removing the LumoBack at night please take it off immediately before you go to sleep 
and place it on charge using the charging plug and cord provided in your pack. It is best to 
place this on your bed side table so as a reminder to put it on the when you wake up in the 
morning 
It is important that you place the device on charge every night so that we can have a data 
stream to note removal time. 
 
Removal for water-based activities 
Please remove the device immediately before and immediately after the water based activities 
– making sure to place the device horizontal on a flat surface with Lumo sign facing upwards. 
 
6. LumoBack FAQ’s 
 
Wearing the sensor 
7. Place the LUMO on your lower back, either directly on your skin or over a thin layer 
of clothing. The LUMO logo and circular Touch button should be facing out.  
8. Wrap the belt around your waist directly above your hip bones, and secure the Velcro 
near your belly button. 
9. If your belt doesn’t fit snuggly around your waist, take it off and adjust the Velcro 
straps inside the belt. 
 
Checking the LumoBack charge. 
Tap the Touch Button to view charge level:  
Green - The sensor has more than one day of charge remaining.  
Orange - The sensor has one day or less of charge remaining. Recharge soon 
 
Alternatively – touch the three horizontal bars on the top left corner of the app which will 
display the side menu will display the battery charge next to the Lumo tab. 
 
Charging the LumoBack 
7. Plug the sensor into a USB power source using the included cable.  
8. It takes about 2 hours to charge the sensor completely.  
9. A complete charge will last for about 5 days of continuous use 
 
When to calibrate your sensor.  
The LumoBack sensor works for everybody, but only if it is calibrated correctly. This process 
stores your good posture position on the sensor and determines when the sensor will vibrate, 
indicating bad posture.  
 
When should you calibrate? 
7. When you first setup your sensor. 
8. Everytime you put the sensor back on after any period of removal. 
 
How do I clean my Lumo? Is it water resistant? 
You can simply take a damp cloth or a wipe and wipe the sensor down.  Also, if needed you 
can remove the Velcro straps from the actual sensor moulding and you can hand wash the 
belt straps and line dry. 
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Lumo Back is not completely water resistant.  While it is ok to have moisture and sweat from 
normal use and activities, you can NOT submerge the LumoBack sensor in water or shower 
with it, etc.  It has a Lithium battery and other hardware components that can be damaged if it 
gets wet. 
 
Connectivity issues. What do I do? 
Please try the following: 
5. Turn the Bluetooth on your iOS device off and then on again through the iOS Settings 
icon.  Go to Settings>Bluetooth>On/Off in your iOS device. 
6. Kill the app:  first double-click on the home screen of your iOS device, then hold down the 
LumoBack icon in the tray for 3 seconds, then press the red delete button. 
7. Restart the LumoBack app. 
8. If this doesn't work, try turning off your iOS device completely, and then turn it back on. 
9. Alternatively – try turning the LumoBack on and off again – this can be achieve by touching 
the button on the device for a period of 5 seconds until the red light flashes. Perform the same 
action again to turn it back on. A green light should flash to let you know it is turned on 
again.  
 
Please make sure your battery is charged as the app works best when it is charged. 
 
The LumoBack will still be collecting data during this time even if it isn’t connected to the 
app. 
 
Any other problems please contact me. The details can be found on the title page. 
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Appendix 3.3 Participant Health report 
ID Number: U                                      . 
Lab Session:U                                       . 
DateU:                                                    . 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
If you have any questions or concerns, please contact 
James Sanders (J.Sanders2@lboro.ac.uk) 
Dr Dale Esliger (D.Esliger@lboro.ac.uk) 
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1) Body mass index (BMI) is a simple index of weight-for-height that is commonly used to 
classify overweight and obesity in adults. It is defined as a person's weight in kilograms 
divided by the square of his height in meters (kg/m2). 
BMI provides the most useful population-level measure of overweight and obesity as it is the 
same for both sexes and for all ages of adults. However, it should be considered a rough 
guide because it may not correspond to the same degree of fatness in different individuals. 
Raised BMI is a major risk factor for non-communicable diseases such as: 
• cardiovascular diseases (mainly heart disease and stroke), which were the leading 
cause of death in 2012; 
• diabetes; 
• musculoskeletal disorders (especially osteoarthritis - a highly disabling degenerative 
disease of the joints); 
• some cancers (endometrial, breast, and colon). 
The risk for these non-communicable diseases increases, with an increase in BMI. 
BMI (Kg/mP2P) 
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2) Body Composition 
2.1) Weight  
Weight (Kg) 
 
 
2.2) Body Fat percentage: Our body is composed of two types of fat: 
a) Essential Body Fat: necessary to maintain correct functionality of our body. The   
percentage body fat is 3-5% in men and 8-12% in women. 
b) Storage Fat: this is the fat accumulated in our body and used to protect internal 
organs as well as an energy reserve. 
In general, having excess body can lead to an increase in the stiffness of artery walls, 
therefore increasing the risk of developing cardiovascular diseases. 
Body Fat Percentage Body Fat Mass 
  
 
Classification Male Female 
Unhealthy Range (too low) 5% and below 8% and below 
Acceptable range (lower 
end) 
6-15% 9-23% 
Acceptable range (higher 
end) 
16-24% 24-31% 
Unhealthy Range (too high) 25% and above 32% and above 
 
2.3) Visceral Fat Percentage 
Visceral Fat Percentage Visceral Fat Mass 
  
 
Visceral fat is the fat that is in the internal abdominal cavity, surrounding the vital organs in 
the trunk (abdominal) area. Research shows that even if your weight and body fat remains 
constant, as you get older the distribution of fat changes and is more likely to shift to the 
trunk. Ensuring you, have healthy levels of visceral fat my reduce the risk of certain diseases 
such as heart disease, high blood pressure, and the onset of type 2 diabetes. 
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Low 
Risk  
High 
risk  
1-12 13-59 
 
2.4) Fat Free Mass Percentage 
Fat Free Mass % 
 
 
This feature indicates the weight of muscle in your body. The muscle mass displayed 
includes the skeletal muscles, smooth muscles (such as cardiac and digestive muscles) and 
the water contained in these muscles. Muscles play an important role as they act as an engine 
in consuming energy. As your muscle mass increase, your energy consumption increases 
helping you reduce excess body fat levels and lose weight in a healthy way. 
3) Waist Circumference (WC): This is an important indicator of how healthy we are. This is a 
proxy measure used to assess abdominal fat for chronic disease risk. A high waist 
circumference or a greater level of abdominal fat is associated with an increased risk of type 
2 diabetes, high cholesterol, high bloody pressure and heart disease. 
Waist Circumference 
(cm) 
 
 
3.1) Waist-to-Hip Ratio – having a larger waist circumference (when compared to having 
fat around the bottom or thighs) is an indicator of greater risk of developing heart disease, 
high blood pressre and diabetes 
Hip 
Circumference 
(cm) 
Waist-to-Hip 
Circumference 
(cm) 
  
 
Indicator Cut-off points (cm) Risk of metabolic 
complications Men Women 
Waist 
Circumference 
>94 >80 Increased 
Waist 
Circumference 
>102 >88 Substantially 
increased 
Waist-to-hip ratio ≥ 0.90 ≥ 0.85 Substantially 
increased 
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4) Blood Pressure 
Systolic Blood 
Pressure  
Diastolic Blood 
Pressure  
Resting Heart 
Rate  
   
 
When measuring blood pressure we obtain 2 reading  
a) Your systolic blood pressure: the highest pressure when your heart beats pushing the 
blood around your body. 
b) Your diastolic blood pressure: the lowest pressure when your heart relaxes between 
beats. 
 
5) Capillary Blood Test  
Blood Component mmol/l Desirable range 
Blood Glucose  3.9-5.5 
Triglycerides  <1.7 
HDL Cholesterol  >1.6 
LDL Cholesterol  <2.0 
Total Cholesterol  <4.0 
 
Triglycerides: It is a type of fat (lipid) fund in the blood. When you eat, your body converts 
any calories it doesn't need to use right away into triglycerides. The triglycerides are stored in 
your fat cells. Having a high level of triglycerides, a type of fat (lipid) in your blood, can 
increase your risk of heart disease. 
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Low Density Lipoproteins: These lipoproteins carry cholesterol throughout your body, 
delivering it to different organs and tissues. But if your body has more cholesterol than it 
needs, the excess keeps circulating in your blood. Over time, circulating LDL cholesterol can 
enter your blood vessel walls and start to build up under the vessel lining. Deposits of LDL 
cholesterol particles within the vessel walls are called plaques, and they begin to narrow your 
blood vessels. Eventually, plaques can narrow the vessels to the point of blocking blood flow, 
causing coronary artery disease. This is why LDL cholesterol is often referred to as "bad" 
cholesterol 
High Density Lipoproteins (HDL) Cholesterol: Often referred to as “good” cholesterol, 
they act as cholesterol scavengers, picking up excess cholesterol in your blood and taking it 
back to your liver where it's broken down. The higher your HDL level, the less "bad" 
cholesterol you'll have in your blood. 
Total Cholesterol: Your total blood cholesterol is a measure of the cholesterol components 
LDL (low-density lipoprotein) cholesterol, HDL (high-density lipoprotein) cholesterol, and 
VLDL (very low-density lipoprotein, which is the triglyceride-carrying component of lipids). 
Blood Glucose: This is the main sugar found in the blood and the body’s main source of 
energy. Keeping it within normal ranges is very important to prevent future health 
complications. 
 
 
 
